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Abstract 
Background: UK ambulance clinicians are able only to terminate resuscitation 
attempts that have resulted in an asystolic (flat line) cardiac rhythm, following twenty 
minutes of advanced life support. All other attempted resuscitations must be 
transported to hospital for further treatment. Despite this, there are still large 
numbers of patients transported to hospital who do not survive. 
Thirteen studies were identified that purported to validate termination of resuscitation 
guidelines. This evidence could not be used to reduce the number of futile 
transportations to hospital of adult cardiac arrests of presumed cardiac aetiology 
within the geographical area of interest, due the variances in emergency medical 
systems. 
Methods: Binominal logistic regression identified variables associated with 
outcomes in a dataset of 4,870 adult cardiac arrests of presumed cardiac aetiology 
(Phase 1). The clinical decision rule was validated retrospectively against an 
independent dataset of 2139 patients (Phase 2). It was then validated prospectively 
(Phase 3). Finally, the financial benefit of introducing the guideline was assessed. 
Assumptions were made on the potential resources required to treat each patient 
and the impact from an acute care perspective was assessed as the difference in 
cost when applying the guideline, compared to current practice. 
Results: The clinical decision rule (terminate on scene if the initial rhythm was not 
shockable and there is no return of circulation) was shown in Phase 1 to have a 
specificity of 99.0% (95% CI: 97.7% to 99.7%) and sensitivity of 53.1% (95% CI: 
51.6% to 54.6%). The transport rate was 52.4%. There were five (0.2%) unexpected 
survivors. This compared favourably with existing guidelines. In Phase 2 the 
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guideline recommended termination for 832 patients. Of these, 829 (99.6%) died and 
three (0.4%) survived (Specificity = 99.1%, 95% CI:  97.4% to 99.8%, Sensitivity = 
46.5%; 95% CI: 44.1% to 48.8%). The transportation rate was 60.7%, which was 
lower than for existing guidelines when applied to the same dataset. Of 656 patients 
in Phase 3, the guideline recommended termination of 162 patients. None of these 
survived to hospital discharge (Specificity = 100%, 95% CI:  95.6% to 100%, 
sensitivity = 29.3%, 95% CI: 25.6% to 33.4%). The transportation rate during this 
phase was 75.3%. When plotted on a ROC space, the guideline showed better 
predictive power, when compared to existing guidelines. The minimum cost saving 
was shown to be £33,739 per 1000 adult OHCA patients currently transported to 
hospital. 
Conclusion: Introducing the decision rule to the trust in question would reduce the 
number of transportations to hospital of adult patients suffering cardiac arrest of 
presumed cardiac aetiology. Further research is needed to apply the findings to 
other locations or emergency medical systems. In order to strengthen the validity of 
the tool, it should be assessed prospectively in either one large prospective study or 
several smaller studies, but within different settings. Ideally, to prevent bias, such a 
validation would be performed by a different research group 
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“Despite rumour, Death isn’t cruel – merely terribly, terribly good at his job” 
Terry Pratchett 1 
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1. Chapter One - Introduction 
Each year in the United Kingdom (UK) approximately 30,000 people receive 
resuscitation for an Out of Hospital Cardiac Arrest (OHCA), from which only about 
7% survive to go home from hospital 2. Data gathered by the Department of Health 
has shown that the vast majority of adults suffering an OHCA and who are 
transported to hospital do not survive 3. The 2015 Resuscitation Council (UK) 
guidelines state that in most circumstances where return of spontaneous circulation 
(ROSC) is not achieved before transport and where Advanced Life Support (ALS) 
has addressed any potentially reversible causes, there is little benefit in transporting 
the patient to hospital 4. However, the guidelines go on to say that there is little 
evidence to support the termination of resuscitation in all circumstances.  
This thesis aims to determine whether it is possible to predict when a pre-hospital 
resuscitation attempt, of presumed cardiac cause, would not benefit from transport to 
hospital and can therefore be terminated safely, whilst minimising the potential for 
stopping the attempt during a potentially survivable resuscitation. The thesis will first 
explore the notion of death as a set point in time and discuss other theories as to the 
nature of death. It will then discuss the understanding of futility and its application as 
a medical term.  
Current decision rules designed to allow the termination of resuscitation attempts 
before transport to hospital will then be explored. The thesis will then utilise data 
collected retrospectively to determine whether futile transport can be predicted, from 
various factors associated with OHCA. It will use this information to create a 
termination of resuscitation clinical decision rule (TOR CDR) for ambulance crews to 
use in order to determine when a resuscitation attempt should be terminated and 
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when it should be continued with transport to a receiving hospital for further 
treatment. This CDR will then be validated both retrospectively and prospectively to 
ensure that the proposed guideline is robust. Finally, an estimation of cost savings 
will be performed to examine the economic benefits of any proposed CDR. 
1.1 Outline structure 
Chapter Two - Background 
This chapter provides the reader with background information on resuscitation. It 
reviews briefly the process by which death occurs, before discussing the practice of 
resuscitation in detail. It examines the theories on futility and how this is interpreted 
an applied to medical practice. The focus of this research is then discussed and 
justified, before the individual research aims and objectives are identified.  
Chapter Three - Literature review 
This chapter addresses the first objective of the dissertation (i.e. to evaluate critically 
the exiting validations of clinical decision rules relating to termination of 
resuscitation). It discusses the detail of the search strategy and defines how relevant 
articles were appraised. It then gives a comprehensive review of all relevant articles, 
before identifying areas in need of further research. 
Chapter Four - Methodology and methods  
Various methodologies available to researchers are discussed in this chapter. A 
rationale is provided regarding the choice of methodology chosen for this study, and 
then the statistical methods employed at the various stages of the study are 
discussed. The issues regarding regulatory approval and ethical matters before 
commencing the study are identified and explained. 
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Chapter Five - Derivation of a clinical decision rule (Phase 1)  
This chapter tackles the second objective of the thesis (i.e. to derive a TOR CDR for 
adult OHCA of cardiac aetiology that is appropriate for use by pre-hospital clinicians, 
and which reduces the number of futile resuscitation attempts transported to 
hospital). It then goes on to discuss and justify the research strategy (a retrospective 
cohort study) as well as the data collection techniques used in the empirical 
collection of data for this study. Details of the analysis of the quantitative data are 
provided, and the resulting clinical decision rule is validated against the original 
dataset, and the results compared with other CDRs.  
Chapter Six - Retrospective validation (Phase 2)  
This chapter addresses the third objective of the thesis (i.e. to validate 
retrospectively the clinical decision rule against an independent data-set of out-of-
hospital cardiac arrests). It takes the decision rule derived in the previous chapter 
and retrospectively validates it against another, subsequent dataset. The methods 
are explained and the results are discussed in detail. 
Chapter Seven - Prospective validation (Phase 3)  
This chapter addresses the third objective of the thesis (i.e. to validate prospectively 
the clinical decision rule). The study design (a prospective cohort study) is reviewed, 
before the statistical analysis is discussed in detail. The strengths and weaknesses 
of the study design are then analysed. 
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Chapter Eight – Estimate of cost savings 
Here the financial benefit of introducing the TOR CDR is assessed by using data 
gained from the outcomes of patients identified in phase 3. These costs are also 
assessed against the present situation and two other CDRs for comparison. 
Chapter 9 - Conclusion 
This chapter reviews and summarises the specific objectives of this thesis and 
reaffirms the conclusions presented in earlier chapters. It highlights the strengths 
and weaknesses of the study and suggests areas for further research. 
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2. Chapter Two - Background 
2.1 When does death occur? 
The practice of resuscitation has been described as the clinician’s attempt to wrest 
patients back from death 5. Before discussing how resuscitation is attempted, it is 
important to understand what is meant by death, when it occurs and whether the 
answers to these questions may affect medical practice. These questions are not 
new to medicine. Celsus wrote in the seventh century "Democritus, a man of well 
merited celebrity, has asserted that there are in reality, no characteristics of death 
sufficiently certain for physicians to rely upon”(p166) 6. Nevertheless, efforts have 
been made to describe death. Robert Veatch defines death as “a complete change 
in the status of a living entity characterised by the irreversible loss of those 
characteristics that are essentially significant to it” (p25) 7.  
Why a person should pass from being alive and fully functional to a state of death 
within minutes, often despite apparently successful resuscitation, is not clear.  Death, 
or at least the point at which life ends, may to a certain extent be seen as a social 
construct. It may be influenced by religious, legal and political criteria. To understand 
death one must inevitably understand what is meant by life. The definition of life is 
central to religions across the world. This can be seen in many Western cultures 
when one considers attitudes to abortion and the rights of unborn children. Similarly, 
concepts of death are firmly rooted in both ancient and modern religious and political 
thinking. Often death is seen in terms of a journey, with the point of death being the 
time when a person travels to a new existence, beyond the physical. Nevertheless, 
this does not contradict the medical assertion given earlier that death is irreversible, 
as there is still the recognition that although the spirit moves on, the physical body of 
the corpse remains dead.  
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As death is closely linked with religious and cultural beliefs, the question of when 
death occurs and when it is acceptable to attempt resuscitation, or indeed terminate 
that attempt, are also closely linked to religion and culture. For example, Judaism 
holds a rigorous belief in the sanctity of life.  
Biomedical matters in Jewish law are known as halakhah and there is literature 
covering all areas of medico-legal interest, including death. The definition of death 
becomes important, as it is prohibited to handle the dead on the Sabbath 8. The 
central text of Rabbinic Judaism, the Talmud, gives two possible definitions of death. 
The first is the absence of breath in the nostrils, and the second is the absence of 
activity in the heart. There has been much debate as to which of these takes 
precedence, but the favoured position appears to be that breathing is the primary 
sign of life and so the absence of breath is a sign of death. Death therefore occurs 
when breathing completely and irreversibly ceases 9. This definition does not 
recognise brain death as death. This has implications where patients’ breathing and 
heart functions are being artificially maintained through the use of ventilators and 
other interventions, despite evidence of brain death.  
Islam also has its own ethical framework for human life. The Quran says that “who 
so ever gives life to a soul, it shall be as if he had given life to mankind altogether” 
(5:32). Therefore attempts at resuscitation can be seen as an important part of the 
Islamic tradition. However, the determination of death is not universal within the 
tradition10. In Arabic, the word al-mawt means ‘death’ and it denotes a thing without a 
soul. According to Muslim scholars the processes of shrouding and other funerary 
requirements can only be initiated after ‘complete death’, when the soul has 
completely left the body. Although this term encompasses a myriad of 
interpretations, Muslim jurists appear to agree the main indicator for death is the 
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termination of respiration 11. Brain death, in and of itself, however, is not considered 
indicative of death.  If respirations and blood flow continue, even artificially, then it 
cannot be said for sure that the soul has departed. With this less strict interpretation, 
the Muslim tradition emphasises the need to consider the family’s definition of death 
when making end of life decisions. Nevertheless this has led to reports that turning 
off the ventilator of a brain-dead relative was considered murder as relatives 
believed that whilst the body was still warm and had a heartbeat, it was therefore 
alive 12.  
Inherently, any medical definition will assume that death is an irreversible condition. 
Criteria and tests that define a patient’s death should arguably ensure that once the 
requirements have been met, there can be no return, either with or without artificial 
assistance. Yet modern medicine has blurred the issue of what defines death, not 
least by the advances in intensive care medicine, where life support measures have 
become ever more advanced. Kellehear has noted that in European medicine, death 
was once defined as the point at which the heart stopped beating, but is now 
normally defined by brain death 13. This is due in part to advances in intensive care 
medicine and the complex decisions that arise in relation to stopping medical 
interventions, such as artificial ventilation. A diagnosis of brain death uses elements 
such as fixed and dilated pupils, lack of eye movement and the absence of 
respiratory reflexes as determinants, rather than the presence of breathing or a 
pulse. He goes on to say that death has been complicated by the fact that people 
who are brain dead can be kept alive almost indefinitely by artificial means, and is 
further complicated because one in a thousand patients who are diagnosed as brain 
dead go on to survive for a period of time when their life support machines are 
switched off.  
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Parnia has written much about resuscitation and the point at which death may occur 
14. He has argued that death should no longer be seen as a specific moment in time. 
His position is that death is a process. Whatever the cause of death, the end result of 
the process is that there is an insufficiency in the supply of oxygen and nutrients to 
the individual cells of the body. This results in the organs stopping. However the key 
to this, claims Parnia, is that this process is not instant. He likens this to a full-brain 
stroke.  
The processes that follow a stroke event are complex. During an ischaemic stroke, a 
blockage within a blood vessel in the brain occurs and reduces the oxygen available 
to cells (hypoxia).  This leads to a reduction of the cellular chemical called adenosine 
triphosphate (ATP). ATP provides the energy to maintain ionic gradients across cell 
membranes, which is a requirement for normal cell function. Without it the processes 
that normally occur across the cell membrane is impaired, producing an increase in 
sodium within the cell. Increased sodium in the cell then results in increased water 
content, which causes swelling, or cytotoxic oedema 15. Ischaemia also directly 
results in dysfunction of the brain’s blood vessels. The blood-brain barrier breaks 
down within four to six hours after damage. Once this has happened, water and 
proteins flood into the area surrounding the cells and this increases the oedema 
further. The oedema then results in further brain swelling that reaches a peak at 
three to five days, but which can resolve over several weeks as the water and 
proteins are reabsorbed 16. Specific genes are activated after a stroke that initiate the 
production of factors that sequentially cause increased inflammation and damage of 
the microscopic blood vessels within the brain 17. As a result, the area around the 
point of damage, known as the ischaemic penumbra, is increasingly affected. This 
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causes it too to become damaged and die within hours of the stroke’s onset. The 
dead tissue eventually degenerates in a process known as liquefaction necrosis.  
Parnia argues that death should be seen in the same way as a stroke. However, 
rather than being a localised event, death is a ‘whole-brain’ stroke, as there is a lack 
of supply to the whole brain when the heart stops beating 18. As all brain cells 
become deprived of oxygen, the stroke process described above occurs across the 
whole brain. As with a stroke, there is a transition process whereby this damage is at 
first reversible and then irreversible. This process, as with a stroke can go on for 
many minutes or hours after death has started. However, unlike the localised tissue 
ischaemia of a stroke, a return of oxygen to the brain, or tissue reperfusion, following 
cardiac arrest cannot be considered a definitive therapy. A return of spontaneous 
circulation (ROSC) will be achieved in about 30% of all cardiac arrest victims, as the 
heart starts beating again, but only about 6% will survive 2. Nearly 60% of those 
patients resuscitated from cardiac arrest will ultimately die from neurological 
dysfunction caused by the arrest process 19.  
This concept that death is a process supports the theories of Lamb. He has 
advocated that death should be seen as the “irreversible loss of function of the 
organism as a whole…(rather than)… death of the whole organism” (p14) 20. He 
argues that as cells from different organs continue to function long after the organism 
has ceased to function, criteria for determining the death of the whole organism 
could not be met without tests for putrefaction. On the other hand, loss of the 
organism’s function as a whole can be determined with precision, and is a biological 
concept, which can be determined by clinical criteria and tests. 
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Following on from the work of Lamb and Parnia, the traditional concepts of 
determining death by reference to the cessation of cardiac and pulmonary functions 
have arguably never adequately characterised death. Rather, they are an indirect 
way of determining the death of the whole organism. That is to say that diagnosing 
death on the basis that the heart and lungs have stopped is effectively no more than 
a prediction that brain death will occur, on the grounds that brain death follows 
inevitably from the permanent cessation of cardio-pulmonary function. As Puccetti 
rationalised; strictly, people do not die of heart attacks or lung cancer: These events 
merely destroy the cardiac or respiratory function, which in turn causes the death of 
the whole body, through lack of oxygen 21. Death of the heart and lungs is not in itself 
death, but a cause of death. Nevertheless, the brain is a critical organ that controls 
and regulates the bodies’ other organs. Permanent loss of cardiac function may 
therefore be seen as an indicator of a permanent loss of brain function, which is 
death. Thus, although the point of death itself is difficult to define, cardiac arrest has 
been defined by the international consensus workshop as “cessation of cardiac 
mechanical activity, as confirmed by the absence of signs of circulation” 22, which 
therefore leads to sudden death, unless reversed promptly. 
2.2 Resuscitation 
As death starts with the cessation of heart function, resuscitation is the practice of 
attempting to restart the heart, in order to prevent the death process. The science of 
resuscitation has a long history. For much of human history, death was viewed as 
irreversible.  The Greek authority, Galen (AD130-200) conducted experiments on 
animals and taught that the heat of life was created in the furnace of the heart. He 
believed that this fire was extinguished at death and this was one of the reasons 
death was seen as irreversible.  There has been a great deal of development in the 
   11 
 
practice of resuscitation medicine since these early days. However, the clinical 
problems surrounding resuscitation practice have been poorly understood and the 
science surrounding it has been limited.  
The modern practice of resuscitation is considered to have started with the work of 
Kouwenhoven, Jude and Knickerbocker, who described the method of closed-chest 
cardiac compression, which is recognised today as cardiopulmonary resuscitation 
(CPR) 23. It has been said that in the field of resuscitation there is a surprisingly 
limited amount of evidence, with very little of this being of high-level 24. It is 
rationalised that this is due partly to the legislation surrounding consent, which 
places restrictions on research in both the USA and Europe. In turn, this has led to 
the continued reliance on traditional treatments in the absence of new research 
developments. The lack of reliable evidence led amongst other things to the creation 
of the International Liaison Committee on Resuscitation (ILCOR). ILCOR was formed 
in 1992, and sought to identify, collect and review the international science and 
knowledge pertaining to the practice of resuscitation and to offer treatment and 
practice recommendations 24. This has led to ILCOR becoming a forum for 
cooperation between the various resuscitation organisations throughout the world, 
and an institution for the development of a consensus approach to practice.  
The first international consensus on resuscitation was established with Guidelines 
2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, 
established following a review of all the available literature 25. The process was 
repeated in 2005, 2010 and again in 2015 26. The latest guidelines resulted from a 
long process, during which ILCOR task forces identified specific areas relating to 
resuscitation practice, and then reviewed and evaluated all the available literature. 
This in turn allowed the final Consensus Conference to achieve agreement and 
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produce the consensus statements on resuscitation. Both the European 
Resuscitation Council (ERC) and the Resuscitation Council UK (RCUK) have used 
these consensus statements to update their own treatment and practice guidelines  
that are relevant for European and UK populations respectively 27,4. 
The practice of resuscitation can be broadly defined as either basic life support 
(BLS), or advanced life support (ALS). BLS is the provision of external cardiac 
compressions, with or without mouth-to-mouth ventilations 26. Increasingly, BLS has 
also included the use of automated external defibrillators (AEDs), which are capable 
of providing defibrillation, but which do not require the user to have training in their 
use, as they are fully automated and provide the user with voice prompts. ALS 
incorporates BLS, but adds to that the use of advanced airway interventions and the 
use of cardioactive drugs, such as adrenaline and amiodarone 26. In the UK pre-
hospital environment, Paramedics provide ALS, whereas other ambulance providers, 
such as technicians and volunteer first responders are limited to BLS. 
 Although CPR was first seen as a dramatic life-saving intervention, its promise has 
waned somewhat with experience. In the UK, sudden cardiac arrest accounts for 
around 100,000 deaths per year 28. Of these, it is estimated that 60,000 occur out of 
hospital and about 45% of these are treated by emergency medical services 
(EMS)29. Unlike portrayals in films, where 68% of OHCA result in survival 30, only 
about 24% of patients who have had resuscitation efforts initiated or continued by 
the ambulance service following a cardiac arrest will achieve ROSC by the time they 
are transported to hospital and about 6% of them will survive to hospital discharge 31. 
Despite these figures, resuscitation of OHCA remains an important part of an 
ambulance service’s raison d’etre. If an OHCA is suspected when the ambulance 
service is called, it results in a ‘Red 1’ response, which is the highest level of 
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response, and for which each ambulance service in England and Wales is targeted 
to arrive on scene within eight minutes, in 75% of all cases. Also both ROSC and 
survival are reported annually as part of the NHS England Ambulance Quality 
Indicators: Clinical Outcomes 2. 
Cardiac arrest presents initially as one of four heart rhythms, or cardiac arrhythmias. 
The first two are the so-called shockable rhythms, which include ventricular 
fibrillation (VF) and pulseless ventricular tachycardia (pVT), both of which can be 
resolved by defibrillation, or an electrical charge passed through the heart muscle. 
The others are the so-called non-shockable rhythms. Asystole is the flat line rhythm, 
most associated by lay people as cardiac arrest, and pulseless electrical activity 
(PEA). The latter is indicated by electrical activity in the heart, without the 
corresponding pulse. The treatment options available for resuscitation depend on the 
cardiac arrhythmia that caused the cardiac arrest, and any subsequent changes in 
that rhythm. 
VF has been described as an irregular, almost random electrical activity within the 
heart, which produces no useful contractions 32, 33. It has been argued by some 
authors that VF may actually be seen to be an organised pattern made up of either 
multiple propagating wavelets of activity, or alternatively as spiral wave re-entry 
patterns 32. However, it is beyond the scope of this thesis to discuss these theories 
further. pVT is a cardiac rhythm which originates in the lower parts of the heart, the 
ventricles rather than the sino-atrial node, which is the natural pace-maker of the 
heart. It is a regular rhythm, unlike VF, and produces a rate of about 120-220 min-1. 
pVT  may result from several cardiac abnormalities, including re-entry of the 
electrical pathway, or from the enhanced automaticity of the ventricular pacemaker 
cells in the heart, which means that the cells of the ventricles fire off signals before 
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they receive messages from the pace-maker 22. pVT is more commonly associated 
with serious underlying heart disease, though it does occur in patients with no 
underlying cardiac pathology.  The rhythm itself can maintain a pulse for a period of 
time, though it may also cause haemodynamic compromise in its own right, or may 
develop into VF if left untreated 32. 
PEA, which was previously known as electromechanical dissociation (EMD), is 
defined as organised electrical activity in the heart, but with no detectable pulses 34. 
Aufderheide has shown that a PEA may be classified as true PEA, pseudo-PEA and 
normotensive PEA 34. True PEA has the presence of electrical activity, but there is 
no corresponding myocardial (heart muscle) contraction. In pseudo-PEA, there is 
some myocardial contraction, but the resultant pressure in the blood vessels is so 
small that it is can be measured only by invasive monitoring. In normotensive PEA 
the myocardium contracts in time with the electrical rhythm, but no detectable pulses 
are present.  
All cardiac arrest events will deteriorate into asystole, if left untreated. Asystole is 
recognised by a ‘flat line’ trace on the electrocardiogram (ECG) and can be defined 
as the absence of any heart rhythm 35. However, this definition does not necessarily 
identify the intricacies of asystole. Ornato and Peberdy have commented that a slow, 
‘bradyasystolic’ rhythm can include long periods of absent heart rhythm with only 
occasional, isolated beats originating from the ventricles (idioventricular beats) 36. 
Also, it must also be noted that an asystole is not the same thing as a dead heart. 
Asystole can occur early in an arrest and is potentially, though rarely, reversible. 
However, as an arrest persists, severe cardiac ischaemia results unless effective 
cardiac compressions are administered. This in turn leads to progressive myocardial 
wall thickening causing the ventricular cavity to reduce in size. This results in a 
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“stony heart”, which has been shown in porcine models to result in a “strikingly firm 
and contracted heart” (p1008) 37. 
Definitive information about an initial arrhythmia at the time of collapse could only be 
recorded if an implanted device was in place at the time of death 38. However, VF is 
often quoted as the most common cause of sudden cardiac arrest 39, 40. 
Nevertheless, recent studies have shown that the incidence of VF as the initial 
rhythm in out of hospital cardiac arrests has declined in recent years 32.  
A population based study from Seattle, Washington has seen the adjusted annual 
incidence of cardiac arrest where VF is the first identified rhythm decrease by about 
56% from 1980 to 2000, or 43% when adjusted to include only those cardiac arrests 
of presumed cardiac cause 33. A similar Swedish study, looked at 19,215 sudden 
deaths between 1991 and 2001 and found that there was a decrease in VF among 
patients with a bystander witnessed cardiac arrest at home from 45% in 1991 to 28% 
in 2001 (P<0.0001) 34. By contrast, a prospective population-based cohort study of 
out of hospital cardiac arrests covering a population of 8.8 million in Osaka, Japan 
found that the age adjusted annual incidence of witnessed VF increased significantly 
from 2.0% to 3.3% (p for trend, 0.002) over the seven years of study. However, only 
20% of those cardiac arrests which were of presumed cardiac aetiology presented 
with an initial rhythm of VF, whereas 55% were asystole and 25% were PEA 35.  
Due to the nature of VF, with its inevitable decline into asystole if left untreated, it 
may be argued that response times of the initial medical responder have an effect on 
the first recorded cardiac rhythm, with a reduction in the occurrence of VF as 
response intervals increase. One retrospective, observational study sought to 
address this possibility. It looked at patients with out of hospital cardiac arrests of 
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presumed cardiac aetiology over a ten year period and investigated changes in 
incidence and survival, of those patients where there was an identifiable rhythm and 
where resuscitation was attempted. Although the presence of witnesses to the arrest 
event, public location, and shorter response intervals from the emergency services 
were found to be factors predictive of VF/pVT, none of these factors were found 
independently to explain the decrease in the incidence of this category of arrests. 
Over the course of the study, response intervals were shorter than those previously 
reported and they continued to decrease over the course of the study period.  There 
was also no decrease in the number of arrests in public locations 41. It has been 
hypothesised that the reduction in VF is due to the introduction of new treatment 
regimes, particularly the use of antiarrhythmic medications, which allow patients with 
ischaemic heart disease to live longer. If these patients do eventually suffer  a 
cardiac arrest, their heart disease has by this time reached its end stage, and so 
PEA or asystole is more likely than VF 34. 
There have been reports of VF spontaneously reverting to a normal, or sinus rhythm, 
with an associated cardiac output 42. However, these are accepted to be the 
exception to the rule and for the vast majority of cardiac arrests, intervention is 
required to reverse the condition. Current UK and European treatment guidelines for 
cardiac arrest emphasise the ‘chain of survival’ 4,27. This term was coined to 
recognise that survival from cardiac arrest is improved when a particular sequence of 
events is followed 43. Initially the sequence included early recognition and activation 
of emergency medical services, basic life support (BLS), early defibrillation and early 
advanced life support (ALS). However, it has since been adapted by replacing the 
term early ALS with “post resuscitation care” 24. Yet it is noted that despite advances 
in resuscitation practice and continued emphasis on this ‘chain of survival’, survival 
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from out-of-hospital cardiac arrest to hospital discharge remains at about 7% 
throughout the UK 29.  
One component common to all resuscitation attempts is the provision of effective 
external cardiac compressions, or cardiopulmonary resuscitation (CPR). The 
importance of effective cardiac compressions has been evident for some time. In 
1936 Wiggers suggested that  “(internal) cardiac massage which sustains coronary 
flow be started as soon as possible after the onset of fibrillation and be continued 
until the electrodes are ready for application to the heart” 40. 
The exact methods by which compressions maintain blood flow are uncertain and 
may be variable. Early studies using echocardiograph equipment placed in the 
oesophagus suggested a cardiac pump theory 44. This theory argues that 
compressions squeeze the heart’s ventricles between the sternum and the vertebrae 
of the back, which causes pressure within the heart. This pressure forces the mitral 
and tricuspid valves in the heart to close, and directs the blood from the ventricles 
into the pulmonary and peripheral circulation. During the decompression phase the 
pressure is reduced, and the ventricles are allowed to refill with blood. However, 
Rudikoff, Maughan, Effron  et al. subsequently noted that whilst they applied a 
constant compression force during forced ventilation, a compression started at end-
inspiration resulted in greater arterial pressure and blood flow, even though the 
sternum was farther from the vertebral column at this point 45. They also noted that in 
patients with flail (detached) sternums there was no increase in arterial blood 
pressure during chest compressions. This was counter-intuitive, as the added 
movement of the chest that this condition allows should have increased the potential 
pressure of the heart against the vertebrae. This was therefore not consistent with 
the cardiac pump theory. A later canine study provided persuasive evidence that 
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pressures created in the vasculature depended on increased pressure in the chest 
cavity, or intrathoracic pressure 45. Rudikoff, Maughan, Effron  et al. argued that the 
increased pressure caused during compression acted not just on the heart but also 
on the other intrathoracic organs. This pressure then transmits directly to 
extrathoracic arteries, which causes the arterial blood flow. Backward flow through 
the venous system is prevented because the thin-walled veins, which are without 
musculature, collapse due to the intrathoracic pressure. Once the compression is 
released, and pressure in the chest falls below venous pressure, the veins reopen. 
This allows blood to flow back into the chest and refill the heart, allowing the cycle to 
continue. However, the authors conceded that due to the differences in thoracic 
anatomy between canines and humans, caution was required if generalising their 
“thoracic pump” findings to man. Nonetheless, the hypothesis was supported by 
Criley, Niemann, Rosborough et al. who reported that patients having cardiac arrest 
in the catheterisation laboratory maintained blood flow without external 
compressions by repetitive coughing, which similarly increased thoracic pressure 46. 
 
It has latterly been argued that neither of these hypotheses fully explains how 
external cardiac compressions maintain blood flow. This has led to the “lung pump” 
theory.  This theory uses the principle of a cyclical pump, and suggests that chest 
compressions increase intrathoracic pressure, which affects all intrathoracic organs, 
including the lungs. The pulmonary valve in the right side of the heart closes during a 
compression, due to the extra pressure in the lungs. This prevents the blood 
returning to the right side of the heart. Instead, blood within the vasculature of the 
lungs is forced to exit through the left side of the heart and into the peripheral 
circulation. As the compression is released and intrathoracic pressure falls, the blood 
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volume in the lungs is restored by flow from the right side of the heart as the tricuspid 
and pulmonary valves open 47.  
Whichever model is correct; there is now a consensus that cardiac compressions 
must be continued throughout cardiac arrest events. Compressions provide both 
cerebral and myocardial perfusion pressure. Perfusion pressure of an organ is equal 
to the arterial pressure providing blood to that organ, minus the relative venous 
pressure of the blood leaving the same organ. So, cerebral perfusion pressure is 
established by the difference between mean arterial pressure and intracranial 
pressure. During compressions the arterial pressure is provided by each external 
compression and this provides the perfusion pressure. This process applies to all 
organs except the heart. The heart’s blood flow originates at the base of the large 
artery, the aorta, at the point it leaves the heart. The blood fills the coronary arteries, 
which provide the heart tissue with blood during the decompression phase of CPR, 
as pressure is released. Coronary perfusion pressure is therefore calculated as the 
pressure difference between the aorta and right atrium during the decompression 
phase of CPR.  
Myocardial perfusion is essential for ROSC to occur 48. Animal studies have shown 
that during prolonged cardiac arrest, survival is directly related to the coronary 
perfusion pressures generated by CPR 49. Also, VF can be delayed from 
deteriorating into asystole if coronary perfusion pressure is maintained 50. However, 
it is not certain whether coronary perfusion pressure is causally related to ROSC, or 
whether it is simply an indication of overall vascular status. Nonetheless, it appears 
that a coronary perfusion pressure of 15 mm Hg is necessary for ROSC, which is 
approximately 20% of normal myocardial flow 48.  
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Although myocardial perfusion is essential for ROSC to occur 48, perfusion of the 
brain is critical to neurological function 50, and is also a predictor of ROSC. The most 
important factor in determining cerebral perfusion during cardiac arrest is the arterial 
pressure generated during external chest compressions 51. Rubertsson and Karlsten 
measured cerebral perfusion during CPR using a porcine model. Manual CPR 
produced at best about 40% of baseline blood flow 52. CPR in humans has been 
shown to create mean cerebral perfusion pressure (CPP) of 30+/-8 mmHg when 
started immediately upon arrest 53.  
However, canine studies conducted by Shaffner, Eleff, Brambrink et al. found that a 
six minute delay in initiating CPR then required a higher CPP to restore cerebral 
blood flow, and following a twelve minute delay, cerebral blood flow could not be 
restored, even with a CPP of 35 mm Hg 54. They suggested that this may have been 
due to the swelling of the tissues that surround the capillaries of the brain, which in 
turn limits flow at low perfusion pressures, as discussed in earlier in this chapter. The 
effect of any delay in starting CPR is particularly relevant to resuscitation the 
prehospital environment, where skilled help is not necessarily at hand.  
Nevertheless, the importance of early CPR is a cornerstone of the ‘chain of survival’ 
concept 4. The definitive contribution it makes to survival is difficult to establish, as 
studies in this area suffer from the limitation that the interval from collapse to the 
arrival of help in OHCA is difficult to quantify accurately. Early work by Larsen, 
Eisenburg, Cummins et al estimated that for patients in VF, the chance of a 
successful outcome was reduced by 2.3% for every minute delay in CPR 55. 
However, Valenzuela, Roe, Cretin et al used a logistic regression model that 
included terms for both interval to CPR and interval to defibrillation, and found that 
the odds of survival decreased by 10% for every minute that CPR was delayed 56.   
   21 
 
Whilst cardiac compressions will maintain a degree of artificial circulation during a 
resuscitation event, the RC(UK) emphasise that a responder must consider and treat 
any reversible causes, in order to successfully resuscitate a patient 4. The reversible 
causes are commonly referred to as the 4Hs and 4Ts. The 4Ts refer to: hypoxia (low 
oxygen levels in the blood); hypovolaemia (reduced blood volume); hypo or 
hyperkalaemia (lowered or raised potassium levels), or other metabolic disorder; and 
hypothermia. The 4Hs refer to: thrombosis (a blocked blood vessel in either the heart 
or the lungs); tension pneumothorax (a condition where the lung function is reduced 
due to excess pressure in the space between the lung and the chest wall); cardiac 
tamponade (a condition where blood escapes into the area around the heart, 
causing pressure and reducing the pumping action of the heart); and toxins. Though 
a suspicion may be raised by the circumstances of the particular patient or situation, 
the recognition and treatment of these reversible causes is a challenge in the 
prehospital environment 4.  
For patients in VF/pVT rhythms, the present resuscitation guidelines recommend 
early defibrillation 24. This has been described as the “single most important factor in 
surviving cardiac arrest due to VF” 57. Beck described the first use of defibrillation in 
a human patient in 1947 40. The shock was administered directly to the patient’s 
heart during an operation for sternal resection. Like much of resuscitation practice, 
the science behind defibrillation is not fully understood 57. As previously mentioned, 
VF is a chaotic rhythm, caused by irregular, almost random electrical activity within 
the heart. Following experiments on cardiac fibrillation in canine models, it is 
believed that defibrillation causes a critical mass of cardiac cells to depolarise, or 
stop, and those that are not depolarised are not sufficient in number to continue the 
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chaotic fibrillation. This allows the heart’s natural pacemaker , the sinoatrial node, to 
retake control and regulate a normal rhythm 58.  
It is generally believed that the timing of any defibrillation is important, with early 
defibrillation proving more successful. This is explained by the 3-phase model of 
CPR described by Weisfeldt and Becker 59. This model describes the progression of 
resuscitation pathophysiology and its influence on correct resuscitation interventions. 
The so-called electrical phase persists for the first 4 minutes of VF. In this phase 
prompt delivery of defibrillatory shocks is recommended for correction of the 
arrhythmia. This is why there is emphasis on public defibrillators and the prompt 
delivery of shocks in current resuscitation guidelines 60.  
The circulatory phase lasts for approximately 4-10 minutes of VF and is 
characterised by depletion of energy-rich substrates, increased tissue acidosis and 
cellular dysfunction. It has been suggested that at this stage, CPR is of more 
importance, as it provides circulation of blood and a partial restoration of essential 
substrates including oxygen, as well as the removal of damaging metabolic factors 
that have collected during ischaemia.  
The final stage is the metabolic phase, which develops after about 10 minutes of an 
arrest. During this phase it is suggested that tissue injured as a result of global 
ischaemia result in the circulation of metabolic factors that then cause additional 
injury beyond the effects of any local ischaemia. Weisfeldt and Becker suggest that 
therapeutic hypothermia may protect against the effects of the metabolic phase, and 
suggest that the continued use of vasoconstricting drugs, such as adrenaline, which 
is recommended by current ALS guidelines, may have a harmful effect at this stage 
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by promoting organ ischemia, particularly in the visceral organs of the abdomen. 
This, they argue, leads to decreased survival. 
Despite this assertion, current guidelines recommend the use of adrenaline for all 
prolonged resuscitation attempts 26. Adrenaline has both alpha and beta-adrenergic 
actions, which means it affects the contractility of the heart as well as constricting 
peripheral blood vessels. It has been used in ALS for nearly forty years. As already 
discussed, CPR is used to maintain blood flow to the heart and brain before ROSC, 
and this represents only about 30% of normal values at best 61. It is thought that 
adrenaline improves this effect, through its action on adrenergic receptors, by 
increasing arterial and arteriolar vasoconstriction, which results in an increase in 
peripheral pressures 62. Its continued use in resuscitation is not without controversy 
63. There is some evidence that the use of adrenaline for OHCA was associated 
improved overall survival and neurologically intact survival among patients 
presenting with non-shockable rhythms 64. However, one prospective, randomised 
controlled trial showed that whilst improvements in ROSC are achieved with the use 
of intravenous adrenaline, there was no significant improvement in survival to 
hospital discharge (10.5% vs 9.2 % P= 0.61), but was unable to determine whether 
the effects on survival were due only to the adrenaline 65.  
As already noted, the use of adrenaline may promote organ ischaemia and have a 
negative effect on resuscitation 59.  Nonetheless, despite these issues, the present 
guidelines continue to advocate the use of adrenaline for resuscitation, due to the 
accepted benefit in short-term outcomes (achieving ROSC and admission to 
hospital) and the lack of sufficient evidence to determine the effects on survival to 
discharge and neurological outcome 26. At the time of writing, there is a large 
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randomised controlled trial being conducted in the UK, which hopes to answer that 
question 66.   
This section has given a brief overview of current resuscitation science and practice. 
It has shown that the science of resuscitation has a long history, but despite the 
advances over that time, the general principles have remained unchanged for 
decades. Furthermore, it has highlighted that the advances in practice that have 
been introduced have not seen dramatic improvement in patient outcomes over the 
same extended period. This may suggest that certain resuscitation attempts are 
unlikely to be successful, despite the best efforts of clinicians. The next section will 
look at the notion of futility in medicine and how it applies to the resuscitation 
scenario. 
2.3 Futility 
Having established that successful resuscitation attempts are rare, and survival rates 
have remained relatively unchanged for some time, it may be possible to determine 
at which point there is no reasonable chance of reversing the inevitable outcome of a 
cardiac arrest. That is to say, further resuscitation would be futile.  In the pre-hospital 
environment, this equates to terminating efforts on scene, as opposed to transporting 
the patient to a hospital with continued resuscitation efforts. This section looks at the 
concept of futility and how it applies to clinical practice.  
The word futility comes from the Latin word ‘futilis’, which means leaky. In Greek 
mythology, the daughters of Danaus were sentenced to spend eternity in Hades, 
carrying water in leaky sieves. They represent the futility of a repetitive task that can 
never be completed and their story suitably conveys the meaning of the term. It 
implies more than just something improbable, rare or unusual. An action is futile if it 
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will not achieve its aims, no matter how often it is repeated.  Also, futility must be 
distinguished from the notion of hopelessness, which is a subjective attitude, based 
on an emotional reaction. By contrast, futility relates to the objective possibility of a 
specific endpoint.  
The discussion of futility, when associated with medical procedures is wrought with 
ethical dilemmas. It is linked with questions as to the goals of medicine and what is 
acceptable if those goals are not, or cannot be realised. However, unlike scientific 
absolutes, medical futility is a term based on ethical choices as defined by society. 
So society’s expectations of medicine will invariably affect its position on medical 
futility. The World Medical Association (WMA) states that futile medical treatment is 
one which “offers no reasonable hope of recovery or improvement…(or from 
which)…the patient is permanently unable to experience any benefit” (p46) 67. It goes 
on to say that a physician is under no obligation to offer a patient futile or non-
beneficial treatment. 
Decisions on when to commence resuscitation attempts or when to cease those that 
have been started can be complex. For UK ambulance clinicians, the criteria 
indicating when a resuscitation attempt should not be initiated are relatively simple 
and clear in emergency situations, and are present in current guidelines 68. These 
guidelines identify those conditions that are unequivocally associated with death, 
such as massive cranial and cerebral damage, decomposition or rigor mortis. They 
also identify situations where there is no realistic chance that resuscitation would be 
successful. These include an interval of fifteen minutes since the patient collapsed, 
with no bystander CPR and the presence of an asystolic heart rhythm. The presence 
of do not attempt CPR (DNACPR) orders would also prevent the initiation of 
resuscitation. However, even these decisions may be complicated by the legalities 
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surrounding consent and capacity, and the physical presence of DNACPR 
paperwork. Indeed, much of the literature surrounding futility and resuscitation 
decisions is based on issues around DNACPRs. However, it is beyond the scope of 
this thesis to discuss these in detail as they pertain to decisions on when to start, 
rather than when to stop resuscitation. 
 The decision to cease resuscitation efforts that have already started, due to 
apparent futility of those efforts can be a hard decision to make. As well as medical 
considerations, often the expectations of relatives or other bystanders can influence 
those decisions. Marco found that of 1,256 American Emergency Physicians, 62% 
had made resuscitation decisions out of the fear of litigation or criticism, rather than 
for any expected medical benefit 69. As well as any practical considerations, the 
question of ethics surrounds this decision-making process. All policies, procedures 
and individual decisions must comply with human rights. Those relevant to decisions 
about resuscitation include the right to life; to protection from inhuman or degrading 
treatment; and to be free from discriminatory practice in respect of these rights 70. 
 Although there are many schools of ethics, the most common in Western culture is 
based on the four principles of biomedical ethics, introduced by Beauchamp and 
Childress 71.The four key principles are beneficence, non-maleficence, justice and 
autonomy. Beneficence directs that the clinician must provide benefit, but must 
balance that benefit against any risks. Non-maleficence means doing no harm. Both 
beneficence and non-maleficence can be seen as supporting the decision to stop a 
resuscitation attempt, when it has become futile. Not only are patently futile 
resuscitation attempts unlikely to provide any benefit for the patient, the practice of 
aggressive resuscitation can be seen to ‘harm’ the patient, in terms of fracturing ribs 
during CPR, and the invasive techniques of airway management and intravenous 
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access. Nevertheless, the principle of autonomy could be seen as an argument 
against a decision to stop efforts as it is made, necessarily, without the consent of 
the patient (excluding obviously, those DNACPR decisions made before the arrest).  
The concept of patient autonomy includes a patient’s right to be a fully informed 
participant in any decision-making in relation to their treatment, and this includes the 
right to refuse treatment, even if this is life-saving. However, that does not include 
the right to demand treatment that is futile 72. In an early paper on futility, Murphy, 
although discussing the decision to start resuscitation, argues that the administration 
of futile interventions is irresponsible. He goes on to argue that the notion of patient 
autonomy should be reconsidered in these circumstances, and that such decisions 
can be made without consulting them or their relatives 73. Younger responded to this 
paper, saying that this approach is a lapse back into the outdated notion of 
paternalism 74.  
Tomlinson and Brody acknowledged the argument that such a robust application of 
futility in decision-making could be seen as a return to paternalistic medical practice 
75. However, they argued that this is not the case: suggesting instead that if a 
treatment is objectively futile, then to even offer this as an option is to breach the 
patient-provider relationship, as it wrongly suggests that there is something to be 
gained from that treatment. They use this rationale to suggest that by restricting futile 
options patient autonomy is actually enhanced, as it prevents the giving of false 
hope. However, they add the caveat that futility is not an arbitrary standard, but is a 
measure of social judgement or ‘reasonableness’.  
Despite the inevitability of death, it has been argued that modern Western culture no 
longer accepts death as a natural part of life 76. As noted earlier, this view is 
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strengthened by the unrealistic success rates of resuscitation successes in modern 
media 30. Even in modern medicine, with its continuing emphasis on technology, 
death is being seen increasingly as a disease to be conquered 20. The ethicist Daniel 
Callahan has argued that modern medicine has a tendency to see death not as a 
biological fact, but as a moral evil and medical failure 77. This has resulted inter alia, 
in further developments in medical technology and intensive care medicine based on 
the desire to extend life at all costs. This can result in the bodies of patients who 
have suffered brain death being kept alive artificially, through the use of ventilators 
and other technologies.  
One of the many moral dilemmas that this leads to is determining when resuscitation 
efforts should be discontinued. The complexity of this question is compounded by 
the lack of certainty around benefit in modern medicine. In early nineteenth century 
medicine, all treatments were, by the definitions of the day, effective. There were 
limited expectations as to the effects of interventions, and so these expectations 
were invariably met. For example, emetics, as the name suggests, would cause 
vomiting, or purgatives would cause laxation 78. The medical theories of the time 
were concerned with no more than these outcomes and so it was considered that as 
these treatments were effective, they were therefore also beneficial.  
However, modern medicine makes a distinction between effectiveness and benefit. 
By accepting that the definitive goal of a treatment is to improve the patient's 
prognosis, comfort, or general health, then a treatment that fails to do this should be 
considered futile, even though it may produce a measurable effect. Therefore effect 
and benefit are distinct. A point is reached where the chance of success is so small, 
or the benefits so indiscernible that they would be futile to attempt. 
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For the practice of resuscitation, the attempt is futile if it will be of no benefit in 
prolonging life. The question then is whether this may go as far as to include the 
quality of life that is preserved or gained. Plunkitt, Matar and Basta have written that 
“CPR is not indicated unless there is a reasonable hope for a conscious life with a 
chance that the patient will be able to pursue and achieve some degree of 
happiness” 79.  
However, Baskett, Sanders and Steen have countered this by saying that such 
rationales are not universal. They maintain that there is no agreement on whether 
the goal of resuscitation is the prolonging of life or some other perceived notion of 
‘quality of life’ 80. Moreover, the inclusion of ‘quality of life’ implies a value judgement. 
They go on to say that futility, to have any meaning, must be quantified. However, 
there are difficulties with this. Whilst a number of factors may need to be taken into 
account when determining whether a resuscitation attempt should be stopped, many 
of these will be unknown, particularly during an out-of-hospital arrest, where the 
patient’s background, their standard of living and their co-morbidities, for example, 
may not be known and are difficult to establish in the heat of the moment. Some 
facts, when they are known, may directly affect decision making. For example, 
findings such as hypothermia or opiate overdose are legitimate cause to change the 
approach to stopping or extending resuscitation efforts.  Other decisions in the field 
may be based on emotional criteria, such as the decision to continue for longer 
because the patient is known to the responding team, or the patient’s relative youth.  
These purely emotional decisions,  argues Baskett, Sanders and Steen, do not stand 
up to evidence-based examination 80. What is more, they may result in the 
overtreatment of objectively futile attempts, and conversely the under-treatment of 
those for whom there is less emotional attachment. Some would argue that neither of 
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these positions can be supported ethically. Rather, decisions on futility should be 
made objectively, following an honest assessment of possible outcomes 81. 
In the pre-hospital environment, prolonged resuscitation efforts and subsequent 
transport of those cardiac arrest patients who will inevitably die, will undeniably divert 
limited medical assets away from other patients who might depend on them. These 
resources are not limited to the ambulance service, but include the hospital 
resources that are required to manage the patient once transported.  
Additionally, it is known that emergency ambulance transports are in themselves 
dangerous. Between 1991 and 2000 in USA, emergency transportation resulted in 
27 EMS deaths and the deaths of 275 pedestrians and other road users 82. 
Therefore, the emergency transport of patients with no chance of survival diverts 
resources and constitutes a risk to ambulance clinicians and bystanders, without the 
necessary benefits to justify this risk. However, these risks must be balanced against 
the possibility of stopping a resuscitation attempt on a patient who may survive if that 
attempt was continued and they were transported to hospital.  
There is nevertheless, a caveat when considering this dilemma. When weighing up 
these conflicting interests, it is important not to confuse the decision to terminate or 
transport, with issues of limited resources, which Jecker and Schneiderman call 
distributive justice 83. Resources may be impacted by the decision, but do not drive it. 
Decisions based on the needs of the wider population are in effect decisions on 
rationing resources, and are necessarily based on discrimination and value 
judgements. They are nonetheless important decisions. Healthcare is under 
pressure constantly to provide more and better care for less money. This may well 
influence decisions on options, which may provide limited improvements to certain 
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patient groups, and is recognised by the World Medical Association as a serious 
consideration when choosing treatment options 67. 
For the purposes of this thesis, however, futility is an individual, patient-based 
judgement and does not make comparisons between patients. It is not a decision 
based on a shortage of resources, even though the cessation of futile efforts may 
well increase resources available elsewhere in the system. Rather, futility must be 
based on the objective fact that the treatment is not medically beneficial and is based 
solely on the patient in question 84.   
Futility in this context means that continued efforts will not reverse the patient’s 
condition. This concept has continued to be the subject of much debate in recent 
years. Increasingly, medical professionals have argued that, in line with the goals of 
medicine since the times of Hippocrates, there is no moral obligation to treat patients 
when interventions cannot produce a sufficient quality of life. This notion can be 
traced back to Plato’s Republic, where he cites that  
“Asclepius…taught medicine for those who were healthy in their nature but were 
suffering from a specific disease…For patients whose bodies were always in a state 
of inner sickness, he did not attempt to prescribe a regimen, for that would make 
their life a prolonged misery . . . medicine was not invented for them and they should 
not be treated even if they were richer than Midas.” 85 
So it can be seen that futility has both a quantitative dimension (where the probability 
of achieving the desired result is unreasonably small) and a qualitative one (where 
the best possible outcome will not benefit the patient). This thesis will concentrate on 
the quantitative dimension, which will be discussed later. Nevertheless, it is 
important to understand the qualitative dimension. If one is creating a CDR for TOR, 
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it can be based on the premise that anyone who leaves hospital alive is a successful 
resuscitation.  
However, an alternative approach is to measure those who survive with meaningful 
neurological function. By this approach, survival in itself is not considered a success, 
but rather the quality of a patient’s subsequent life is considered important. What is 
meant by meaningful in this context is subjective. It will depend on society’s 
perspective as well as that of the individual patient.  
Some have argued that the Glasgow Coma Scale (GCS) could be used to determine 
meaningful in this context 86. The GCS is a tool created in 1974 as a way to classify 
the level of consciousness of patients with brain injury 87. The scale measures three 
factors: eye opening; verbal response; and motor response. This produces a score 
of between three and fifteen, with three being deeply unconscious and fifteen being 
normal brain functioning. Haukoos, Lewis and Niemann have suggested that a GCS 
of equal to or greater than thirteen indicate a good neurological outcome as this 
would show that the patient was awake, could follow commands, and were at worst 
disoriented and conversant 86.  
An alternative to the GCS is to use the cerebral performance category (CPC) scale. 
This scale categorises patients on a scale of one to five: 1, good cerebral 
performance; 2, moderate cerebral disability; 3, severe cerebral disability; 4, 
vegetative state; and 5, death. Using this scale, CPC scores of 1 and 2 are usually 
considered as ‘good’ outcomes, whereas CPC 3, 4 and 5 are considered ‘poor’ 
outcomes 88. However, it has been argued that that there is no standard method of 
determining CPC scores, which can lead to variation of interpretation 89.  
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A third option is to use the modified Rankin Scale (mRS). First developed by Rankin 
90 and subsequently modified by Farrell, Godwin, Richards, et al 91, this scale uses 
six categories of zero to five: 0, No symptoms; 1, no significant disability; 2, slight 
disability; 3, moderate disability; 4, moderately severe disability; and 5, severe 
disability. Although this scale does include descriptions of limitations in activity and 
changes in lifestyle, which assist with classification, it has also been criticised for 
being subjective and open to interpretation 92.  
That there are competing methods of defining the qualitative aspects of survival 
emphasises the difficulty in assessing these outcomes. The counter-argument to 
their use is that decisions made on qualitative grounds are again simply a new 
instance of medical paternalism and that quality of life decisions are inherently 
personal so should not be decided by medical practitioners. Brody, however, makes 
the interesting distinction between pre-emptive ‘do not attempt cardio-pulmonary 
resuscitation’ (DNACPR) orders and the decision to cease resuscitation attempts. He 
notes that whilst those arguing against futility say that any decision to enter a 
DNACPR should not be made without the patient’s consent, these same people do 
not object to clinicians making a decision to stop resuscitation after a prolonged 
attempt 93.  
Nevertheless, the Utstein resuscitation registry templates for OHCA recommend that 
neurological outcome may be reported using ether the CPC or the mRS, although 
they also recognise that ROSC and long-term survival (reported either as survival to 
hospital discharge or 30 day survival) are the core reporting outcomes 94.  
In England and Wales the law, as defined by the Mental Capacity Act 1985, gives 
primacy to patient autonomy. This requires that the patient has the right to be fully 
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informed of all aspects of clinical decision making relating to their treatment, and to 
be a participant in those decisions. This includes the right to refuse treatment even 
when this is recommended and could be life-saving. This notion of autonomy has, to 
a greater or lesser extent eclipsed the principle that futile treatments are not 
obligatory.  
Bernard Lo has argued that a unilateral decision by clinicians to withhold or cease a 
treatment is justified where that treatment has no pathophysiologic rationale, or 
where such a treatment has been started but the patient has failed to respond 82. 
However, he goes on to distinguish this from other uses of the term futility, such as 
when the likelihood of success is very small, but not zero.  This, argues Lo, can lead 
to problems with the concept of futility. However, Tomlinson and Brody pose the 
argument that just as a doctor can refuse to give a patient antibiotics, because the 
chance of them improving a cold are very remote, so too if likelihood of survival from 
cardiac arrest is very small,  then it is for the medical practitioner to determine that 
and make the decision 95. They argue that in principle, the value judgment on the 
withholding of antibiotics is no different to the withholding of CPR. If can be made in 
the one case, why not in the other?   
Lantos, Singer, Walker et al had previously advocated caution with such an 
approach. For them, a futile therapy is simply the end of a spectrum of therapies with 
low efficacy, the evidence for which can become confused by statistical errors, 
linguistic misunderstandings, or from disagreements about the goals of the therapy 
in question 96. Decisions on whether a treatment is futile may be based on imprecise 
data, or may be influenced by a clinician’s own belief system. This has led Brody to 
suggest that if decisions are made in only the clearest cases, then there will be an 
inevitable slide into making unjustified decisions in the less definite situations 93. 
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There is the risk that although an analysis of futility may appear to be based on a 
patient’s interest, it is in fact, driven by the interests of the clinician and others.  
The term futility suggests a dichotomous decision: either a treatment is futile, or it is 
not 97. However, one may more correctly see futility in terms of scale. The question 
remains, therefore, as to whether the notion of futility can be quantified. That is to 
say, is it possible to determine how many times a technique or procedure would 
have to fail before it can be said to be futile? It has been argued that logically, just 
because patients with certain conditions have never survived resuscitation in the 
past, then one cannot conclude that it is not a possibility that the next patient will 
survive, even though it is highly improbable 98.  This logic then leads to the 
recognition of a minimum acceptable probability of success that is greater than zero 
95. This is accepted by some, who have argued that futility should extend beyond 
absolutes, and should be the result of institutional or professional consensus, rather 
than the decision of the individual clinician 99. Moreover, it has been said that without 
an explicit definition, there is the danger that the threshold may creep up and 
encompass situations where success is a possibility 100.   
This is of particular importance in the pre-hospital environment, where decisions 
need to be made quickly by relatively junior clinicians and with some degree of 
certainty. Paramedics, although a registered profession in the UK, are not doctors. 
To expect the decision to be left to them, in the heat of the moment may be 
construed by some to be unfair, and on the evidence of the ethico-legal dilemmas 
already discussed, wrought with potential difficulties. There is little chance to consult 
with others when decisions on terminating a resuscitation attempt are to be made 
whilst that attempt is in progress. So, if this decision could be made for them and 
presented in the form of guidelines, then they could concern themselves with the 
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practicalities of the situation, without being encumbered with the burden of complex 
ethical decision-making. 
The European Resuscitation Council has stated that “CPR that has no chance of 
success in terms of survival or acceptable quality of life is pointless and may violate 
the right for mercy and dignity in the face of death” (p305) 101. It goes on to propose 
that institutional guidelines for pre-hospital TOR are required to reduce variances in 
decision-making. However, Ardagh has argued that futility is subject to such 
variations of interpretation that it is unlikely a consensus definition that is applicable 
to every patient undergoing resuscitation will ever be achieved 102.  
In 2002, Löfmark and Nilstun attempted to produce a model for futility 103. They 
reviewed 43 articles and despite creating such a model, suggested that there was no 
need to define futility in order to make an acceptable decision for a given situation. 
Nonetheless, various writers have sought to apply definitions of quantitative futility to 
the practice of resuscitation.  
At one extreme, the American Heart Association suggested in 1992 that a futile 
resuscitation attempt is one where “there have been no survivors reported under the 
circumstances in well-designed studies” 104. Others have taken a less restrictive 
approach. For example, Murphy has suggested that futility was observed in their 
series of patients when survival after CPR was no better than 2% 105, and Lantos, 
Singer and Walker, et al when survival was no better than 7% 106. Schneiderman and 
Jecker have written extensively on the subject. They started with a general 
understanding of medical futility, which they defined as “any effort to provide a 
benefit to a patient that is highly likely to fail and whose rare exceptions cannot be 
systematically produced “ 84. They then attempted to quantify this. They proposed 
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that where a treatment had been of no use in 100 cases, then it could be deemed to 
be futile. They argue that although the previous 100 cases do not necessarily mean 
the treatment will never work, it serves as an estimate of the effectiveness of that 
treatment. They go on to argue that whilst clinical trials are not available for every 
circumstance, the experienced clinician should use their own experience to create 
these so-called “futility characteristics”, which appears to step beyond their otherwise 
objective approach to the question of futility. Moreover, even their statistical 
approach is not without critics. Helft,  Siegler and Lantos maintain that, despite its 
claimed objectivity, this quantitative definition of futility is in fact subjective 107. They 
also note that individual patients may consider a treatment with a 1% chance of 
success as worthy of attempting, particularly if the alternative was death.  
Nevertheless, Lawrence, Schneiderman and Jecker support their position with 
statistical probability. Although they have accepted that the proposed 1% definition is 
arbitrary, they argue that it can be viewed in the same way one assesses the 
evidence in scientific papers: if there have been no successes in 100 consecutive 
cases, then statistically, one can be 95% confident that no more than 3 successes 
would occur in each 100 comparable trials (3 successes per 100 trials is the upper 
limit of the 95% CI) 108. They support this argument by suggesting the question of 
futility is not concerned with asking about the certainty of a treatment not working, 
but rather about how many times a treatment should be seen to fail before it is 
agreed that it does not work. This argument is persuasive and 1% has since been 
acknowledged by many as the working definition of medical futility 109,110,111,112. 
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2.4 Termination of resuscitation 
The concept of futility is important to any discussion on stopping resuscitation 
attempts. Larkin has emphasised that decisions around TOR are both simple and 
complex 113. He argues that the decision is a simple one in that the decision itself 
can be, and often is, made very quickly when all those on scene agree that nothing 
more can or should be done (which may or may not be with reference to a TOR 
guideline). However, it is also complex in that there is a great deal of uncertainty 
around the science of resuscitation, as has been previously discussed, and often the 
circumstances of a particular cardiac arrest are unknown. Furthermore, it has been 
said that survival from OHCA is a reflection of the EMS attending the incident and 
the subsequent hospital treatment, and that any TOR rule is in danger of becoming a 
self-fulfilling prophecy 114. The counter-argument to this is that whilst all patients 
suffering OHCA deserve an appropriate attempt at resuscitation, there are those for 
whom nothing is to be gained from transport to hospital 115.   
Nevertheless, Pepe has suggested that decisions on TOR are often determined by 
family and clinician comfort levels and the on-scene environment 116. This is 
supported by a systematic review conducted by Anderson, Gott and Slark that 
suggests that the reasons given by clinicians to stop a resuscitation attempt are 
many and varied and include internal factors, such as the clinician’s experience, as 
well as external factors, such as the expectations of family members and perceived 
patient characteristics 117.   
There have been many published studies relating to the predictors of success for 
resuscitation of OHCA. An early study by Silfvast looked at asystole as a defining 
characteristic of non-survival and recommended that resuscitation should be stopped 
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in adult patients, who were not hypothermic and were in an asystolic rhythm, 
providing that the airway had been secured and intravenous access had been 
achieved 118. This is understandable, as an asystolic heart has no on-going electrical 
activity. However, whilst Pepe, Levine, Fromme et al found there were no survivors 
out of 106 asystolic patients with unwitnessed OHCA for whom no CPR was 
initiated, there was a 1.6% survival rate for those incidents where resuscitation was 
attempted 119. This is supported by the work of Engdahl, Bang, Lindqvist et al, who 
found that survival amongst 1,635 patients presenting with an initial asystole was 2% 
120. This increase may be due to the improvement in resuscitation practice in the 
intervening years. Nevertheless, it is now commonly accepted that regardless of 
initial rhythm, if a patient suffering OHCA of presumed cardiac aetiology is in 
asystole following vigorous ALS, there is nothing to be gained by transporting that 
patient to hospital 27. 
Response interval has been another suggested predictor of futility 121. The response 
interval is the period of time between a patient’s collapse, and when a responder 
arrives at the patient to commence resuscitation. Although response intervals are 
undeniably important, detailed analysis has shown that survival from OHCA does not 
decline at a constant rate following the arrest 122. This had led Gold, Fahrenbruch, 
Rea, et al to conclude that models should not include factors external to the patient. 
They argue that incorporating physiological changes following a cardiac arrest are a 
more accurate way to ascertain survival rates 121. Despite this conclusion, others 
have looked at factors relating to the circumstances of the arrest to determine 
outcomes. Spaite, Hanlon, Criss et al suggested that unwitnessed OHCA were less 
likely to survive than witnessed ones (p < .001) 123. This was supported by Stratton 
and Niemann, who found no survivors to hospital discharge from 104 patients 
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suffering unwitnessed OHCA, irrespective of initial rhythm 124. Although the sample 
size was small, these results support the ‘chain of survival’ principles noted earlier. 
However, subsequent studies have shown that, whilst bystander-witnessed arrests 
are more likely to result in survival (OR 2.0, 95% CI = 1.6 to 2.7), the variable is not 
in itself a predictor of futility (survival in this study = 1.36%) 125. 
In 1993 Bonnin, Pepe, Kimball et al performed the first large-scale prospective study 
to find criteria for terminating resuscitation for OHCA 126. They prospectively 
monitored the outcomes from 1461 OHCA and found that patients who achieved 
five-minute ROSC on scene had approximately 32 times greater odds of survival 
compared with a patient who did not achieve ROSC. They concluded that apart from 
patients in persistent VF, transport of OHCA was futile if no ROSC was achieved on 
scene. A more recent prospective population-based observational study in Japan 
challenges this conclusion. Goto, Maeda and Nakatsu-Goto studied specifically 
those patients transported to hospital without ROSC 127.  They found that of 
398,121patients, 7,532 (1.89%) were alive one month after the event, despite being 
transported without ROSC. Although this study does not record survival to hospital 
discharge, it does suggest that lack of prehospital ROSC is not in itself a predictor of 
futility. 
Similar large-scale studies have suggested that whilst there is no single variable that 
can confidently predict futility, a combination of variables may be sufficient to do so. 
Two recent termination rules for EMS personnel used multiple variables to predict 
successfully which OHCA patients will not benefit from being transported to ED for 
continued resuscitation 111, 112. These rules use clinical variables to determine 
suitability for termination in the field. For BLS rescuers, these variables are: arrest 
not witnessed by EMS, no defibrillation, and no ROSC in the field 111. For ALS 
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providers the variables include the previous three and add no bystander CPR and 
the arrest was not witnessed by EMS 128.  
In 2010 a systematic review and meta-analysis by Sasson, Mary, Rogers et al 
looked at the associations between key clinical factors of survival from OHCA using 
over 30 years of data 129. This study, which involved more than 142 000 patients, 
found conclusively that bystander CPR, initial shockable rhythms, and ROSC were 
predictors of survival in the prehospital setting. Of the 36 studies found to consider 
bystander CPR, the pooled odds ratio for survival amongst this group compared with 
those who did not receive bystander CPR ranged from 1.23 (95% CI; 0.71 to 2.11) in 
the studies with the highest baseline survival rates to 5.01 (95% CI; 2.57 to 9.78) in 
the studies with the lowest baseline rates. Of the 58 studies that considered initial 
cardiac rhythm, the pooled odds ratio for survival among patients with an initial 
shockable rhythm compared to those found in non-shockable rhythms ranged from 
2.91 (95% CI; 1.10 to 7.66) in the studies with the highest baseline rates of survival 
to 20.62 (95% CI; 12.61 to 33.72) in the studies with the lowest baseline survival. 
Twelve studies were found that reported on prehospital ROSC. The pooled odds 
ratio for survival for patients who achieved prehospital ROSC compared to those 
who did not ranged from 20.96 (95% CI; 7.43 to 59.13) in those with the highest 
baseline survival rates to 99.84 (95% CI; 14.30 to 696.89) in the studies with the 
lowest baseline rates of survival.  
This systematic review and meta-analysis concluded the most powerful criterion by 
far that was associated with survival from OHCA is ROSC and that failure to achieve 
ROSC before transport suggests that the patient is unlikely to survive to hospital 
discharge. Nevertheless, despite these findings, the authors note that there were 
large variances in outcomes, which appear to be attributable to the different EMS 
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systems across the studies. Moreover, whilst the review identifies those variables 
which are associated with survival, there was no attempt to derive a TOR CDR as a 
result of these findings.   
More recent work has been done on the value of end-tidal carbon dioxide (ETCO2) in 
predicting survival. ETCO2 measures the concentration of carbon dioxide at the end 
of an exhaled breath, and is an indication of cardiac function and pulmonary blood 
flow.  It has been shown in a small prospective study that in patients undergoing 
resuscitation for OHCA, the ETCO2 values of those who achieved ROSC were 
significantly higher than those of the patients who died 130. If ETCO2 remains under 
10 mmHg during CPR, it is strongly associated with non-survival 131. This work 
shows potential, but has yet to be developed fully. 
The studies discussed above suggest that it is possible to determine variables within 
a particular EMS system that may be useful in determining futility, provided there is 
an acceptance that futility does not predict absolutes. Although it may be argued that 
unless a TOR CDR can determine futility with absolute certainty, then it should not 
be considered; throughout the history of resuscitation practice, there have been 
unexpected survivors.  
In a recent Danish study, Rajan, Folke, Kragholm et al it was shown that even where 
resuscitation continues for over 25 minutes, 20.4% of patients achieved ROSC, 
though only 13.8% survived beyond 30 days, compared to 59.6% of patients who 
achieved ROSC in under five minutes132. Nevertheless, there have been several 
reported cases where prolonged resuscitation attempts have resulted in unpredicted 
survival. Parnia has discussed the case of one individual from England, who 
underwent three and a half hours of resuscitation, before his heart was started and 
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went on to make a full recovery 18. Although the circumstances surrounding this 
particular event were unusual, in that the patient was suffering from profound 
hypothermia at the time of his collapse, the case emphasises the difficulties in 
prognostication, following a cardiac arrest.   
Pena, Aedo and Palomino performed a systematic review of the literature and found 
38 examples of what is known as the ‘Lazarus Phenomenon’ 133. This phenomenon 
refers to the unexpected recovery of a patient for whom resuscitation was not 
started, or efforts have been stopped, due to perceived futility. For these patients, 
the time interval between collapse or termination of resuscitation efforts and 
subsequent ROSC ranged from a few seconds to 33 minutes. Pena, Aedo and 
Palomino postulate that one reason for these unexpected events is the incidence of 
hyperinflation of the chest, caused by over-enthusiastic ventilations during 
resuscitation. The increased intrathoracic pressure caused by this hampers venous 
return, which in turn causes a decrease in cardiac output and coronary perfusion. As 
artificial ventilation is stopped, there is a decrease in intrathoracic pressure, which 
may result in successful mechanical pumping activity of the heart.  If this theory is 
accepted, then the ‘Lazarus effect’ may be seen a result of poor resuscitation 
technique, rather than any unexpected physiological response. However, this theory 
does not explain the three cases where no resuscitation was attempted (although at 
least one of these patients was fitted with an internal pace-maker). Nevertheless, 
Pena, Aedo and Palomino conclude that incidents of what they describes as 
‘spontaneous auto-resuscitation’ either after life support techniques have been 
terminated, or in the absence of any such techniques are considered rare, but may 
be a lot more common than expected.   
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Whatever the cause, these events serve to highlight the fallibility of any TOR 
guideline and the difficulties in determining with certainty when a resuscitation 
attempt becomes futile. However, to refrain from implementing any TOR guideline, 
due to a very remote possibility of survival would in itself be unethical. Nevertheless, 
decisions on futility must be clearly defined so as to prevent overenthusiastic 
application of the concept. If a decision is made using the term futility, every effort 
should be made to search for the best possible proof to back up that decision, to 
reduce the prognostic uncertainty, even if it can never be completely eliminated 134. 
Whether sufficient evidence can be established and verified, which will allow pre-
hospital clinicians to maintain aggressive resuscitation attempts for those who may 
benefit, whilst identifying those for whom further attempts and transport to hospital 
are futile, will form the basis of this thesis. 
As this thesis develops, it is important to acknowledge that TOR guidelines do 
already exist in UK ambulance Trusts, in line with the UK Ambulance Services 
Clinical Practice Guidelines 135. These guidelines allow for the recognition of life 
extinct in circumstances where resuscitation should not be attempted. They also 
allow for the termination of resuscitation in the presence of asystole, following twenty 
minutes of ALS (except in cases of hypothermia, drowning, poisoning, overdose or 
pregnancy). Therefore, this thesis is aiming to identify futile transportation of patients 
who are out with this group. These will be patients with a PEA, or persistent VF/pVT 
despite ongoing resuscitation.   
It is also important to note that OHCA can be caused by numerous events. These 
may be related to trauma, medication, respiratory issues, or a number of other 
factors. Each of these factors bring with them different treatment options both within 
the pre-hospital environment and within hospital. This thesis will look only at those 
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OHCAs which are of presumed cardiac aetiology. That is to say sudden cardiac 
death presumed to have been caused by malignant ventricular arrhythmia. For these 
purposes, an OHCA will be presumed to have been of cardiac origin, unless there is 
some evidence to the contrary. Similarly, the resuscitation of children has a different 
approach to that of adults. This is due in part to the fact that the majority of children 
have healthy hearts, and so cardiac arrests in this group are likely to have been 
caused by something other than a cardiac event 26. Therefore this thesis will limit 
itself to adult patients and will not seek to determine a guideline for the termination of 
resuscitation in children. 
2.5 Overall research aim and individual research objectives 
The overall aim of this research is to advance an understanding of when it is 
appropriate to terminate attempts at resuscitation for adult patients suffering OHCA 
of presumed cardiac aetiology, and when transport to ED is appropriate. It will aim to 
determine whether there is a subset of patients who are not included in existing UK 
ambulance service TOR guidelines and are currently transported to hospital 
following OHCA of presumed cardiac aetiology, for whom it can be said that 
transport to a receiving hospital with ongoing resuscitation is futile and that all further 
resuscitation can be terminated on scene. Specifically, the objectives of this research 
are: 
1. To evaluate critically the exiting validations of clinical decision rules 
(CDRs) relating to termination of resuscitation. 
2.  To derive a TOR CDR for adult OHCA of cardiac aetiology that is 
appropriate for use by pre-hospital clinicians, and which reduces the 
number of futile resuscitation attempts transported to hospital. 
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3.  To validate retrospectively the CDR against an independent data-set of 
out-of-hospital cardiac arrests 
4. To validate prospectively the CDR, to ensure that ambulance clinicians 
are able to apply the TOR CDR and identify those patients for who 
transport to hospital is futile. 
5.  To estimate the cost savings of introducing the TOR CDR. 
2.6 Value of this research 
This research is valuable for a number of reasons. The literature review will show 
whether TOR CDRs have been validated in pre-hospital care systems. In particular, 
it will aim to determine whether these rules are applicable to the UK ambulance 
Trusts, and whether the rules add to the TOR guideline currently in use, which allows 
for TOR of asystolic patients only.  
The subsequent empirical research is required to establish whether a termination of 
resuscitation guideline can be derived and validated, which accurately identifies 
those patients for whom further resuscitation and transport to hospital are futile, and 
whether ambulance clinicians are capable of identifying those patients in accordance 
with the guidelines. The RC(UK) states that, “In most patients where ROSC is not 
achieved on scene, despite appropriate ALS and treatment of any potentially 
reversible causes, little is to be gained from transferring these patients to hospital.” 4 
As shown above, the vast majority of these patients are presently transported to the 
emergency department (ED), which places an unnecessary burden on both the 
ambulance service and the receiving hospitals.  
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The question that needs to be answered is whether a decision rule can be 
established that identifies resuscitation attempts that are ultimately futile, and allows 
ambulance clinicians safely to terminate the attempt. This thesis will attempt to 
answer that question. Throughout this process, the figure of 1%, as proposed by 
Schneiderman and Jecker will be used to define futility. In the next chapter, the 
existing evidence will be reviewed and TOR guidelines that have been validated for 
use in practice will be discussed. 
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3. Chapter Three - Literature review  
In the previous chapter it was established that the majority of pre-hospital 
resuscitation attempts do not result in survival, despite transport to hospital. It was 
also established that it is possible to define futility in medical treatment scenarios. In 
this chapter, there will be a review of existing TOR CDRs that have been validated, 
and which purport to characterise futile resuscitation attempts. 
3.1 Search strategy 
A literature search was performed in January 2014. A preliminary search using the 
Web of Knowledge search engine confirmed that there was a large amount of 
research available on the subject of termination of resuscitation, with 476 results 
reported. However, the focus of this literature review is the validation of CDRs. 
Therefore an approach was taken that aimed to balance the need for high recall 
combined with high precision in the search strategy. To do this, the approach 
described by Hek and Langton was employed 136. First an initial search was 
conducted to capture any material that appeared to have a focus on the validation of 
CDRs for the termination of resuscitation. This ensured high recall. Then all 
remaining articles were appraised in order to filter less relevant ones. This ensured 
that only those studies that were concerned with the validation of TOR CDRs, rather 
than the derivation of them, were included for detailed review.  This process ensured 
high precision of the remaining articles.  
In order to formulate a search question for the initial search, the PICO (Population, 
Intervention, Comparator, and Outcome) format was used 137. Using this format, the 
question used was: 
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 “During adult cardiopulmonary resuscitation, can termination of resuscitation clinical 
decision rules predict futile resuscitations?” 
The search strategy included a search of three scholarly databases (Table 1) as well 
as direct searches of two academic and professional journals considered to have 
particular relevance (Table 2). No systematic reviews were found on the Cochrane 
database. Searches of Medline and the Web of Knowledge were conducted 
(Appendix 1). The titles of all articles found using this strategy were assessed for 
relevance. Where the content of an article was evidently unrelated to the validation 
of a CDR, it was discarded at this stage. Then the remaining articles were filtered 
following a review of their abstracts, leaving only those directly relevant to this study. 
Additionally, to support these searches and ensure full capture, a ‘snowball’ search 
as described by Maskrey and Greenhalgh138  was undertaken of the references cited 
by each of the papers already retrieved. This aimed to identify any potentially 
valuable literature that had not been captured, or had been rejected during the initial 
filter.  
Databases 
Cochrane Web of Knowledge 
Medline  
Table 1 - Databases searched 
Journals 
Resuscitation Circulation 
Table 2 - Professional journals searched 
 
3.2 Inclusion criteria 
All peer reviewed studies that were attempting to validate termination of resuscitation 
decision rules were included. 
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3.3 Exclusion criteria 
Studies and articles were excluded using the following filters: 
1. Abstract only studies, letters, editorials, conference information and non-peer-
reviewed articles. 
2. Studies where the termination of resuscitation rule was designed for 
paediatric patients. 
3. Non-English language articles were also excluded, as no reliable and 
accessible translation service is available for this thesis. 
3.4 Evidence appraisal 
Following the selection procedure, all remaining studies were reviewed in detail to 
assess methodological quality. There are various tools used to measure the quality 
of published research. Many of these are inconsistent in their classifications and 
subsequent recommendations 139. However, this thesis is concerned with the 
validation of a CDR, and specific requirements have been proposed to determine the 
methodological standards of these. A CDR  has be defined as “a clinical tool that 
quantifies the individual contributions that various components of the history, 
physical examination, and basic laboratory results make toward the diagnosis, 
prognosis, or likely response to treatment in an individual patient” 140. Once CDRs 
have been formally tested, they simplify clinical decision making. They also improve 
the accuracy and of a clinician’s diagnosis and prognosis. They are of particular use 
in complex decision making, such as in the practice of resuscitation. 
As with other areas of research numerous tools are available to evaluate the 
derivation and validation of CDRs 141-144. Although these vary in their detail, there are 
common elements. Firstly, the CDR should be derived as a result of clinical need. 
Any mathematical techniques used to derive the rule should be adequately defined. 
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Both the outcome and the predictor variables need to be defined, and the latter 
should be reliable. That is to say, they should be reproducible. Finally, and arguably 
most importantly, a rule should be validated.  
Validation ensures the CDR can be generalised to the patient population 140. It 
ensures that there is a causative association between the predictors and outcome 
and that they have not occurred by chance. It also ensures that the predictors are 
not due to peculiarities of the population or dataset from which the CDR was derived, 
or to other aspects of the study design. 
There are various strategies when performing a validation. In order of increasing 
rigor, these are temporal, geographical, and domain validations145. Temporal 
validations are often (though not necessarily) completed by the same investigators, 
in the same locations, but at a later date to the derivation of the guideline. 
Geographical validations, as the name implies, are ones which uses a population 
from a different location. A domain validation is the most rigorous, but difficult to 
achieve for out of hospital patients, as it requires a different setting (such as primary 
care vs. secondary care). 
McGinn, Guyatt, Wyer et al also define four levels of validation 141. Level 1 is the 
most robust and equates to a CDR that has undergone at least one prospective 
validation in a different population to the derivation, and one impact analysis. It must 
also demonstrate a change in clinician behaviour as well as beneficial 
consequences. A level 2 validation is one which has been proven in either one large 
prospective study or has been validated in several smaller studies, but within 
different settings. A level 3 validation is one that has utilised only one narrow, 
prospective sample. Finally a level 4 validation has used only split samples, large 
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retrospective databases, or statistical techniques. McGinn, Guyatt, Wyer et al argue 
that all but level 4 validations can result in a decision rule being implemented, with 
varying degrees of certainty. A level 4 validation, they contend, requires further 
validation before being implemented into practice. 
3.5 Search results 
In all, 86 articles were identified during the initial search (Appendix 2). An initial 
review of the titles, excluded 47 articles from further appraisal. The remaining 37 
appeared to address the research question. A further eight studies were included for 
review: Three of these were included following a review  of citations, and five were 
found as a result of alerts placed on searches, and were captured after the initial 
search was conducted.  
A review of the abstracts resulted in 14 studies being reviewed in detail. A summary 
of each study is provided in Appendix 3 (see also Tables 3-5).   An additional study 
was identified, which had performed a structured review of four CDRs146
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Table 3 – BLS TOR validations 
 
Rule Study Design Author Year EMS system 
Total 
Numbers 
TOR positive TOR Survivors 
Transport 
Rate 
CDR 
Criteria 
Level 
B
L
S
 T
O
R
 
Prospective, 
observational 
validation 
Morrison et 
al 
147
 
2006 EMT (AED) 1,240 62.6% (n=776) 0.51% (n=4) 35.60% 2 
R
e
tr
o
s
p
e
c
ti
v
e
 c
o
h
o
rt
 a
n
a
ly
s
is
 
Richman et 
al
148
 
2008 
EMT-Basics,EMT-Intermediates 
EMT-Paramedics 
2,180 n= 804 (adjusted) 0.12% (n=1) 46.80% 
C
D
R
 L
e
v
e
l 
4
 
Ong et al
110
 2006 BLS with AEDs 13,684 50.4%(n=6,908) 0.04%(n=3) 49.5%. 
Ong et  
al
149
 
2007 BLS with AEDs 2,269 68.7%(1,559) 0.38% (6) 31.30% 
Sasson et 
al
150
 
2008 Not specified 5,505 47.1%(n=2,592) 0.2% (n=5) 52.90% 
Morrison et 
al
128
 
2007 Paramedic 4,673 48% (n=2,263) Nil 51.6%. 
Morrison et 
al
151
 
2009 
Tiered:Police, Fire, defib-only 
EMTs, Paramedic 
2,415 54.3%(n=1,302) Nil 45.6%. 
Ruygrok
152
 2009 
Fire-based first responders 
providing BLS, including use of 
AEDs, and ALS paramedics 
715 32% (n=231) Nil(good neurological) 70.2%. 
Kajino et 
al
153
 
2013 
Emergency  Lifesaving 
Technicians 
151,152 74.9% (n=113,140) 
0.2%(n=193) (good 
neurological) 
25.10% 
Cheong et 
al
154
 
2016 
Intermediate life support service, 
including AED, laryngeal mask 
airways (LMAs), administration of 
IV adrenaline and a limited range 
of other medications. 
2,193 64.3%(n=1,411) 0.4% (n=5) 35.60% 
Chiang et 
al
155
 
2015 
Fire-based first responders 
providing BLS, including use of 
AEDs, and ALS paramedics 
1,727 62.5% (n=1,080) 1.7% (n=29) 37.50% 
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Table 4 – ALS TOR validations 
Rule Study Design Author Year EMS system 
Total 
Numbers 
TOR positive TOR Survivors 
Transport 
Rate 
CDR Criteria 
Level 
A
L
S
 T
O
R
 
R
e
tr
o
s
p
e
c
ti
v
e
 c
o
h
o
rt
 a
n
a
ly
s
is
 
Skrifvars et 
al
156
 
2010 
Nurses or paramedics and 
Emergency Medical Technicians 
20,705 26.4%(n=5,466) 0.04%(n=2) 73.60% 
C
D
R
 L
e
v
e
l 
4
 
Morrison et 
al
128 
2007 Paramedic 4,673 30% (n=1,425) Nil 69.9%. 
Sasson et 
al
150
 
2008 Not specified 5,505 21.7%(n=1,192) Nil 78.30% 
Morrison et 
al
151
 
2009 
Tiered:Police, Fire, defib-only 
EMTs, Paramedic 
2,415  31%(n=743) Nil 69.00% 
Ruygrok
152
 2009 
Fire-based first responders 
providing BLS, including use of 
AEDs, and ALS paramedics 
715 23% (n=162) Nil(good neurological) 77.30% 
Kajino et 
al
153
 
2013 
Emergency  Lifesaving 
Technicians 
137,986 27.1% (n=41,030) 0.1% (n=37) 70.30% 
Chiang et 
al
155
 
2015 
Fire-based first responders 
providing BLS, including use of 
AEDs, and ALS paramedics 
240 34.1%(n=82) 4.9% (n=4) 65.80% 
 Cheong et 
al 
154
 
2016 
Intermediate life support service, 
including AED, laryngeal mask 
airways (LMAs), administration of 
IV adrenaline and a limited range 
of other medications. 
2,193 27.3%(n=587) 0.2% (n=1) 73.20% 
Verhaert et 
al 
157
 
2016 Paramedic 598 6%(n = 35) Nil 94% 
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Table 5 – Remaining TOR validations 
Rule Study Design Author Year EMS system 
Total 
Numbers 
TOR positive TOR Survivors 
Transport 
Rate 
CDR Criteria 
Level 
Not EMS 
witnessed  
Not bystander 
witnessed Aged 78 
years or older,  or 
initial rhythm 
asystole 
R
e
tr
o
s
p
e
c
ti
v
e
 c
o
h
o
rt
 a
n
a
ly
s
is
 
Ruygrok
152
 2009 
Fire-based first responders 
providing BLS, including use of 
AEDs, and ALS paramedics 
715 5% (n=39) Nil(good neurological) 94.5%. 
C
D
R
 L
e
v
e
l 
4
 
Asystolic  arrests: 
Delay in 
ambulance 
exceeding 15min, 
No ROSC despite 
20min of ALS. 
Witnessed PEA: 
Delay in 
ambulance 
exceeding 
15min,No ROSC 
within 20min of 
ALS. 
Un-witnessed 
PEA:No ROSC 
within 10min of 
ALS 
Skrifvars et 
al 
156
 
2010 
Nurses or paramedics and 
Emergency Medical Technicians 
20,705 54.6%(n=1,1315)  0.5% (n=57)  45.30% 
Asystole and call 
time > 8 mins 
Ong et al
110
 2006 BLS with AEDs 13,684 9.4%(n=1,293) 0.08%(n=1) 90.60% 
Ong et  
al
149
 
2007 BLS with AEDs 2,269 31.6% (n=716) 0.28% (n=2) 68.40% 
no ROSC,  initial 
unshockable 
rhythm, and 
unwitnessed by 
bystanders 
Goto 
158
 2013 
Emergency  Lifesaving 
Technicians 
105,030 57.3% (n = 60,205) 
0.7% (n = 73) one 
month survival with 
CPC 1-2 
42.70% 
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3.6 Summary of evidence 
The majority of these validation studies considered only two individual CDRs. The 
first was developed by Verbeek, Marian, Vermeulen et al and was designed for BLS 
responders with AEDs, but subsequently validated against ALS providers as well 
(Table 3). This CDR recommends termination only where the arrest is not witnessed 
by EMS personnel, there was no defibrillation at any point during the arrest and there 
is no ROSC 111. For reference, this will be known as the BLS CDR from hereon in. 
The second is the ALS CDR, again developed by Morrison, Verbeek, Marian et al 
112. This model takes the BLS criteria, but adds the requirements that the arrest was 
not witnessed by by-standers, and that there was no by-stander CPR (Table 4).  
As can be seen in Table 3, the BLS CDR has been retrospectively validated ten 
times, and prospectively validated once. The numbers of patients in these studies 
varies greatly from 715 152 to 151,152 153. The guideline has also been tested against 
a variety of practitioners, from BLS trained staff to Paramedics. All but one of the 
studies shows numbers of unexpected survivors following application of the guideline 
as under 1 percent, and transport rates vary between 25.1%153 and 70.2%152.  
The ALS CDR has been validated nine times (Table 4). All of these are retrospective 
studies. Many of the datasets are the same as those of the BLS TOR, resulting in a 
similar spread of patient numbers and grades of practitioner. For the ALS CDR 
transport rates vary between 65.8% 155 and 94% 157. 
Other than these BLS and ALS CDRs, four other CDRs were found to have been 
validated (Table 5). One of these supports on-scene termination where the patient is 
asystolic and the response time is greater than eight minutes 110,149. This CDR will 
not be discussed further, as it so closely resembles the diagnosis of death available 
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to UK ambulance clinicians at the present time. As stated previously, the first stage 
of an assessment of a CDR is to establish that it is needed. From the perspective of 
a UK ambulance service that is able to terminate resuscitation attempts that result in 
asystole following 20 minutes of ALS, this guideline does not add clinical benefit.   
Two CDRs were designed to identify patient survival with good neurologic 
function152, 158. The first allows for termination, provided the following criteria are met: 
The arrest was not witnessed by either a bystander or EMS personnel; the patient is 
aged 78 years or older; or asystole was the initial arrest rhythm. The number of 
patients identified for termination of efforts under this guideline were 5% (n=39). The 
used no ROSC, an initial non-shockable rhythm and unwitnessed arrest as its 
variable158. This model was retrospectively validated on a cohort of 105,030 patients. 
It recommended TOR for 57.3% (n=60,205) of these, and there were 0.7% (n=73) 
unexpected survivors with good neurologic outcomes. 
The final model is based on response intervals, and is adjusted according to the 
patient’s presenting rhythm (PEA or asystole), and in the case of PEA, whether this 
was witnessed or not 156. This tool identified 54.6% (n=1,1315) potential TORs from 
a cohort of 20,705. There were 0.5% (n=57) survivors within this group. 
The quality of these validations can be assessed utilising the criteria noted above. 
The need for a TOR CDR has been discussed at length in previous chapters, so 
needs no further clarification. In order to assess the rigor of the initial derivation of 
the BLS CDR, a previous paper was examined 111. To identify the variables for the 
CDR the researchers used logistic regression analysis on a complete dataset of 662 
patients. All variables are defined. It is of note that only 13 (<2%) survived to hospital 
discharge, which is low and may be indicative of the particular EMS system, or the 
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selected population in this study. The impact of this low survival rate on the 
derivation is difficult to assess. It was also identified that only five variables were 
used in the regression model. No rationale was given as to why other variables were 
not included. 
Nevertheless, the CDR has been validated eleven times (varying both temporally 
and geographically), which suggests that despite any weaknesses in the derivation 
of the CDR, its results are reproducible to some extent. However, the marked 
variance in results, including one study for which unexpected survivors were greater 
than 1%, suggests that the CDR may not be universal. The BLS CDR is 
nevertheless the only TOR CDR to have been prospectively validated, though this 
was done by the same team that derived the guideline, which is not ideal.  
The ALS CDR was derived by different, and arguably more robust methods128. The 
derivation study used a large database of 4673 patients, for which there was a 5.1% 
survival to discharge. Fifteen variables, including response intervals and initial 
cardiac rhythm were assessed for their associated with survival. Selection was 
initially made by adding a single variable to ROSC (the key predictor variable of 
interest, as established by previous research) and assessing the effect of the 
combination. The second variable was retained for the final regression model if 
changed the parameter estimate for ROSC by more than 10%.  
Of note here is, the requirement that variables in a CDR should be adequately 
defined and reproducible 143. The ALS CDR uses bystander CPR as a variable. As 
discussed in Chapter 2, CPR is effective when performed correctly. The inclusion of 
bystander CPR does not account for present, but ineffective CPR. This may 
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therefore reduce the number of potentially futile attempts being classified for 
termination.  
Nine studies have sought to validate the ALS CDR. Again, all but one of these vary 
from the initial study both temporally and geographically. However, they suffer from 
the weakness that they are all retrospective studies. They also show a great 
difference in unexpected survivors (nil to 4.9%), which again suggests that the 
guideline may not be universal.  
The remaining three guidelines do not benefit from large numbers of validation 
studies. The validation performed by Ruygrok, Byyny and Haukoos, and based on 
good neurological outcomes, used a CDR derived by Haukoos, Lewis and Niemann 
86. The derivation of this rule differs from those previously discussed, as it did not 
utilise a regression model. Rather, a form of binary recursive partitioning known as 
Classification and Regression Tree (CART) analysis was used. The disadvantage of 
this method is that the combined effects of variables may not be established. On the 
other hand, this method prevents the model being over-fitted. However, one of the 
variables is age greater than 78 years. Whilst this can be established from 
retrospective datasets in many cases, it is less certain that it can be established at 
the scene of an OHCA, particularly if relatives or carers are not present to provide 
information. The validation by Ruygrok was also limited due to the small 
geographical area used to collect data. 
Skrifvars, Vayrynen, Kuisma et al validated the Helsinki ‘do not attempt to 
resuscitate’ guidelines, which were based on two studies by Vayrynen, Kuisma, 
Maatta, et al159, 160. The first of these considered the factors associated with short 
and long-term survival after asystolic out-of-hospital cardiac arrest, from a 
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prospectively gathered dataset of 1455 patients. They used both univariate and 
multivariate analysis to establish associations with survival. Although no CDR was 
created, the conclusion of the authors was that termination of resuscitation should be 
considered if the response interval was over 10 min or the ALS response time is over 
10 –15 min in bystander-witnessed arrests. The Helsinki rule also includes the 
element that if ROSC cannot be achieved despite 20min of ALS, then the attempt 
should be terminated, which whilst widely accepted, was not part of this study.  
The second element of the Helsinki guideline related to patients presenting with 
PEA. Again a study by Vayrynen et al was used as the basis for this element of the 
CDR. The study used logistic regression on 984 PEA arrests to establish 
associations with survival. As with the previously mentioned study, the study did not 
recommend a CDR, but concluded that prognosis is poor if the first response interval 
is over 15 min in bystander-witnessed arrests or if the duration of ALS exceeds 5.5 
min in EMS-witnessed arrests. The Helsinki guideline uses this conclusion as a 
basis, but increases the second interval. 
Despite its variation from the studies that derived it, the Helsinki guideline was 
validated by Skrifvars et al on  a large prospectively gathered cohort of 12107 
retrospective cases and found to be accurate at predicting survival with good 
neurologic outcomes, but less so for un-differentiated survival. However, whilst this 
dataset was temporally different to that of the derivation, it was geographically 
similar. It is also important to note that there was no data available to the 
researchers on how long resuscitation was attempted in cases where ROSC was not 
achieved. They therefore used the transport interval as a surrogate for this in their 
study, which may have influenced their results. 
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Goto, Maeda and Goto derived and validated their CDR158. The dataset of 495,607 
patients was divided into two. They performed logistic regression analyses including 
11 variables on one group to assess the association between them and one-month 
death or unfavourable neurological outcome. They validated the rule on the second 
group. The division was made by year, so there was a temporal difference between 
the two. It was noted, however, that the validation group had significantly higher one-
month survival and one-month with good neurology rates than the derivation group 
(survival: 4.34% vs. 3.81%; good neurology: 2.04% vs. 1.60%; all P < 0.0001). As 
well as a difference between the two, it is noted that these survival rates are low, 
suggesting that the rule may not be generalisable to locations with higher success 
rates. 
3.7 Discussion 
As discussed in the previous chapters, the question of TOR in OHCA has both 
ethical implications and operational impacts on the ambulance service. A balance 
needs to be made between maximising the chance of a patient surviving from 
OHCA, and the unnecessary allocation of scarce ambulance resources for 
transporting futile resuscitation attempts to already over-stretched emergency 
departments, as well as the hazards such transport entails.  
An important point to note, when comparing the various studies is the year from 
which they collected data. This is important, as the guidelines for resuscitation have 
undergone regular and significant changes over the years. In 1992, for example, the 
guidelines recommended that the ratio of compressions to ventilations should be 
15:2, with compressions provided at 80 per minute, and to a depth of 4-5 cm 161. In 
1998 the recommended rate of compressions was increased to 100 per minute, and 
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it was recommended that if two rescuers were present, a ratio of five compressions 
to one ventilation should be adopted 162. The guidelines from 2000 removed the 
variation for two responders, and recommended that the 15:2 ratio should be used 
no matter how many were in attendance 163. The guidelines were revised again in 
2005. These guidelines emphasised the importance of compressions, and 
recommended a ratio of thirty compressions to two ventilations as a result 164. The 
guidelines introduced in 2010 placed even more emphasis on the importance of 
good compressions and recommended an increased rate of 100-120 a minute, to a 
depth of 5-6 cm 165. The latest guidelines in 2015 did not adjust the 
recommendations on compressions 27. 
If one accepts the rationale of the latest guidelines that uninterrupted compressions 
are essential for improving outcomes, then arguably those studies that used data 
collected before 2010 were evaluating processes that were not maximising the 
potential for survival. Therefore it is questionable whether the results of earlier 
studies can safely be said to apply post 2010. Table 6 details each of the studies and 
indicates the guidelines that were used for each.  
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Study Study period Details of compressions 
Cheong et 
al 154 
2010 - 2012 
30:2 at 100 - 120 compressions per minute 5 – 6 cm 
Chiang et 
al155 
2008 - 2010 
Potentially 30:2 at 100 compressions per minute 4 – 5 
cm and 30:2 at 100 - 120 compressions per minute 5 – 
6 cm 
Goto et al 
158 
2007 -2010 
30:2 at 100 compressions per minute 4 – 5 cm 
Kajino et 
al153 
 
2005 - 2009 30:2 at 100 compressions per minute 4 – 5 cm 
Morrison et 
al128 
1998 -2003 Potentially 5:1 and 15:2 at 100 compressions per 
minute 4-5 cm, 
Morrison et 
al147 
2002 - 2004 15: 2 at 100 compressions per minute 4 – 5 cm 
Morrison et 
al151 
2006 - 2007 30:2 at 100 compressions per minute 4 – 5 cm 
Ong et al 
110 
1998 - 2003 Potentially 5:1 and 15:2 at 80 and 100 compressions 
per minute 4 – 5 cm 
Ong et  
al149 
2001 - 2004 15:2 at 100 compressions per minute 4 – 5 cm 
Richman et 
al148 
2004 - 2006 Potentially 15:2 and 30:2 at 100 compressions per 
minute 4 – 5 cm 
Ruygrok et 
al152 
2003 - 2004 15:2 at 100 compressions per minute 4 – 5 cm 
Sasson et 
al 150 
2004 - 2006 Potentially 15:2 at 100 compressions per minute 4 – 5 
cm, and 30:2 at 100 compressions per minute 4 – 5 cm 
Skrifvars et 
al156 
1990 - 2007 
Potentially 5:1 at 80 compressions per minute 4 - 5 cm, 
and 15:2 at 80 and 100 compressions per minute 4 – 5 
cm, and 30:2 at 100 compressions per minute 4 – 5 cm 
Verhaert et 
al 157 
2008 - 2011 
30:2 at 100 - 120 compressions per minute 5 – 6 cm 
Table 6 – Details of compressions from previous studies 
As well as differences in the resuscitation practice across the studies, it is apparent 
some variation also exists in relation to the reporting of the results of the studies. As 
predictive tests, TOR CDRs can be reported in one of two ways. Both would ideally 
have no survivors recommended for TOR, but how this is reported will vary 
depending on the approach. The first approach is to say that the test attempts to 
predict survival. In this case for the ideal test, which would recommend transport for 
all survivors, and both the sensitivity and the negative predictive value of the rule 
would be 100%.  The alternative approach is an attempt to predict death. In this case 
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the CDR aims primarily to recommend TOR for all futile resuscitations. It would still 
ideally result in all survivors being transported, but from this viewpoint, the perfect 
test would have specificity and a positive predictive value of 100%. Of the validation 
studies considered, five used survival or survival with good neurologic outcome as 
the positive outcome 110, 128, 149, 151, 152 nine used death or poor neurologic outcome 
as the positive outcome147, 148, 150, 153-158. Morrison, Bigham, Kiss et al have 
considered the two reporting options and proposed that the standard reporting of 
CDRs for TOR should recommend TOR for patients who will not survive to hospital 
discharge, rather than seeking to identify potential survivors 166. This is an important 
distinction, as a positive outcome from OHCA relies on a lot of factors out with the 
pre-hospital clinicians’ control. Differences in ED staffing and capability, as well as 
ongoing care in intensive care units all play a part in a successful outcome. 
Therefore attempting to predict survival becomes difficult.  Death however may be 
predicted earlier in the process and may be inevitable no matter what the ongoing 
care package consists of.  
Morrison, Bigham, Kiss et al suggest that as death should be the predicted outcome, 
all such studies should report on the specificity (or true negative rate), which will 
identify the CDR’s ability to identify potential survivors, and positive predictive value, 
which will demonstrate its recognition of futility. They also recommended that these 
studies should report the transport rate, as this is of particular operational importance 
to ambulance services. These recommendations are accepted as part of this thesis, 
as it is attempting to determine when the transport to ED of OHCA is futile and can 
therefore be terminated. It is not attempting to predict which patients would survive 
from an OHCA, though this group of patients will ideally be subject to transportation 
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as they do not fit the TOR criteria. This is the approach that will be adopted in later 
chapters.  
It is worthy of note, however, that whilst Morrison, Bigham, Kiss et al do not dwell on 
the importance of sensitivity (or true positive rate) in their paper, it is proposed here 
that it is of great importance. Whilst it is accepted that any CDR will result in patients 
being transported who ultimately die, it is important that there are as few of these 
cases as possible. When death is considered the positive outcome and the objective 
of the CDR is to limit the number of futile transports, then the sensitivity of the CDR 
will indicate how well that test recognises futility. Although it is important that the test 
should identify potential survivors, it should also minimise the number of futile 
transports to hospital. If one does not interrogate the sensitivity of a test, there is the 
potential that the rule recognises potential survivors, but at the cost of transporting 
undue numbers of futile attempts to hospital. By requiring the transport of greater 
numbers to ED, any CDR will inevitably capture more survivors. However, this alone 
does not maximise the identification of futile transport, and the ethical and 
operational burden that these entail. Sensitivity is an indicator of how well a TOR 
CDR captures these futile attempts. The aim of any TOR CDR should be to identify 
as many patients as possible, who would not benefit from continued resuscitation 
and transport, whilst allowing potential survivors the benefit of continued attempts. 
Inevitably, some of those identified for transport will not survive, and perhaps some 
of those identified for termination may be potential survivors, but unless the subset of 
transported non-survivors is reduced as much as possible, then the CDR is not 
achieving its maximum benefit. 
As well as the differences in statistical approach, there are other confounding 
factors, which prevent the results of the reviewed studies being compared directly. 
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Of the fourteen studies found, five were concerned with survival with good 
neurological outcome. Another study had good neurological outcome as a primary 
outcome, but also looked at survival as a secondary outcome154. All others 
considered only survival, irrespective of neurological outcome. The results of the 
former cannot therefore be compared directly with those of the latter.   
There are also differences in the patient cohort within the various studies. In the 
studies conducted by Morrison 147, Richman 148, Ong 110,149, Kajino153 Chiang 155 and 
Cheong 154 the EMS systems did not have any existing TOR guidelines in place at 
the time the data was collected. This means that that all OHCA patients were 
included in the study. This would include patients in an asystolic rhythm at the time 
the transport decision was made. Although the EMS system studied by Verhaerta 157 
did have the ability to terminate patients on scene, the design of the study  was such 
that all patients, whether terminated on scene or not, were included for analysis. The 
study by Skrifvars 167 was conducted in an EMS system that allowed for termination 
in cases of ongoing asystole despite 30 minutes of resuscitation. It is unclear 
whether these patients were included in the statistics for the study. However, this 
study included only those patients presenting with either asystole or PEA as an initial 
rhythm and included patients with an arrest of non-cardiac aetiology (excluding 
patients with either drowning or trauma). In two studies (Morrison 151 and  Ruygrok 
152) it appears that pre-hospital clinicians were able to apply existing CDRs at the 
time of the studies, in order to terminate resuscitation attempts, and that these 
patients were included in the statistics.  
In UK ambulance trusts, paramedics may already terminate resuscitation attempts 
following twenty minutes of ALS, where the patient is asystolic 68. Including this 
subset of patients in a TOR study produces exaggerated results for a CDR predicting 
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death, when compared with systems using such a rule, as the consensus is that 
these patients have a negligible chance of survival. By contrast, excluding this 
subset of patients from a study means that the proportion of unexpected survivors as 
a denominator of those expected to die is likely to increase.     
The type and training of responders varied across the studies as well (BLS with AED 
147,110,149, emergency life technicians 153, ILS paramedic 154, ALS paramedic 112,157, 
and multi-tiered responses148, 151, 152, 155). This may have had an effect on the survival 
of patients in each group, which may therefore prevent the results being generalised 
across other pre-hospital systems.  
All but one of the validation studies that were reviewed reported survival rates 
following a positive TOR that were within the accepted definition of futility (ranging 
from zero to 0.51%) and so all appear to be able to identify futile transportation to 
hospital. However, the study by Chiang, Ko, Chang et al retrospectively validated 
both the BLS and ALS CDRs and found that 1.9–4.9% of patients who survived were 
misclassified as non-survivors 155. The authors suggest two possible reasons for this. 
Firstly, the high number and density of tertiary hospitals in Taipei may have had an 
influence on the increased numbers of survivors. Secondly, they suggest there may 
have been selection bias within their study cohort. They report anecdotally that some 
families refused transport of the patient if the patient was either old or was 
bedridden. This may have led to a reduction of TOR-positive non-survivors. 
However, they go on to say that even if all 1534 of these cases were added to as 
TOR-positive, the number of unexpected survivors was still higher than 1%. This is 
important, as it emphasises that TOR CDRs need to be validated in the population to 
which they are to be applied, as variances in response model, treatment options or 
population may have an impact on their application. That a CDR has been validated 
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in one healthcare system does not automatically validate it in terms of all other 
healthcare systems. 
There is perhaps an expectation that as the number of false positive terminations 
(unexpected survivors) approaches zero, the frequency of recommended transport 
increases. Unless the sensitivity of a CDR is high, then this will necessarily be the 
case. By reducing the number of patients who are potentially TOR-positive and 
thereby transporting greater numbers to hospital, one would anticipate the number of 
unexpected survivors to decrease, at a cost of transporting more futile attempts. 
However, if the CDR has higher sensitivity, then a reduction in the number of false 
positives should be achieved without an increase in transportation. There has been 
extensive study of both the BLS CDR criteria and the ALS CDR criteria and they 
have both been shown to identify correctly those patients who will not benefit by 
transportation to hospital. However, transport rates using both CDRs have been 
shown to vary considerably between systems and populations. The BLS CDR has 
shown transport rates of 25.1% to 70.2% and the ALS TOR 65.8% to 94%. The 
lowest transport rate for the ALS CDR found in this review was recorded by a study 
looking at good neurological outcomes, so the outcomes cannot be compared with 
other studies. However, the lowest reported transport rate over all used the BLS 
CDR as a decision tool, and reported transportation rates of only 25.1% 153. 
However, this study was based in Japan, where no existing TOR guideline exists. 
This means that these results also capture resuscitations that would be terminated 
following current ‘asystole guidelines’ present in the UK. As noted previously, this 
may artificially reduce the numbers of transports, when compared with systems that 
already exclude this group of patients under existing TOR CDRs. On the data 
provided, the effects of removing this cohort of patients from the final figures could 
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not be achieved. Therefore the results of the CDR on only those patients not already 
captured by the ‘asystole guidelines’ could not be established. The highest reported 
transport rate among these studies was 94.5%, and again measured good neurology 
as an outcome 168.  This guideline resulted in only 5.5% of patients proving TOR 
positive and was the most restrictive in terms of criteria for TOR. Nevertheless the 
highest transport rate measuring survival was for the ALS CDR (94%)157. 
The proportion of patients transported to hospital is of particular importance to 
ambulance operations, as it is this figure that determines the operational impact on 
the service, as opposed to the clinical impact of the CDR. Nevertheless, a TOR 
CDR, however promising both clinically and operationally, is limited in its application 
if the validation process used is low level. In order for a prognostic tool to be 
implemented into clinical practice, it needs to be validated in such a way that it, that it 
is shown to work satisfactorily for patients other than those from whose data it was 
derived 145. 
 All but one of these validations are of level four, as defined by McGinn, et al 141. The 
only validation which is level two, and therefore robust enough to be implemented, 
was tested only in an environment where responders were BLS and AED trained147. 
This view is supported by Sherbino, whose appraisal of available literature in 2010 
concluded that “In the setting of OHCA receiving exclusive basic life support with 
AED, only the BLS-TOR rule has been prospectively validated in a rigorous fashion 
to warrant widespread use” (p84)146.  Although subsequent validation suggests the 
BLS-TOR guideline may be applicable to ALS scenarios112, this was only validated 
as a level four retrospective study. A second study collected data prospectively, but 
the CDR was applied retrospectively, rather than by the attending clinicians, and so 
this is also a retrospective validation 151.  
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As already noted, it is important to recognise that the BLS and ALS CDRs are 
designed to be applied to all adult cardiac arrests of cardiac aetiology. By contrast, 
the Trust already employs a TOR CDR. This allows for TOR where ALS results in 
asystole after twenty minutes of ALS, and is irrespective of any presenting rhythm, 
rhythm changes throughout the arrest, or involvement of by-standers. Any TOR CDR 
derived using patients within the area of the Trust will therefore apply only to those 
patients who do not fulfil the criteria presently in use, and who are consequently 
transported to hospital. So any patient fulfilling the present TOR criteria will not be 
included in the analysis. Therefore, excluded from the patient group will be any 
patient whose resuscitation attempt results in asystole. Those currently taken to 
hospital by the Trust will therefore be those patients who have either a PEA or a 
persistent VF/ pVT rhythm, following ALS.  
As with any literature review, this study may be limited by the factors inherent to any 
such search, including publication and selection bias. In particular, language 
restrictions prevented the inclusion of non-English language studies when searching 
the clinical databases. Another limitation is that the search strategy used and 
ensuing manual screening may have been fallible and some relevant studies may 
have been omitted. However, all due care was taken to ensure that the impact of this 
was reduced as much as possible. Moreover, the search terms were retained and 
alerts enabled, so that articles published subsequently could still be reviewed and 
included here, when appropriate. 
3.8 The need for further research 
Girija, Sudha, Cauvery et al have discussed the efficacy of partaking in new research 
169. Although concerned with the social sciences, their suggested requirements are 
equally fitting to health research. They maintain that research should be novel, and 
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even if touched by other research, must be an area in need of further investigation. 
As evidenced from the review of the literature, there are thirteen published reports, 
which purport to validate TOR CDRs. However, only one of these is anything other 
than a data-based retrospective study, and that was validated in a pre-hospital 
system utilising BLS with AEDs, unlike the ALS system used in the UK. Moreover, 
none of the studies were conducted under the current guidelines for resuscitation, 
and the majority were assessed in pre-hospital systems that did not have the existing 
termination rules that are available to UK ambulance Trusts. All of this means that 
the results cannot be generalised to the population of patients of interest to this 
thesis. Certainly there is a paucity of evidence to support change without further 
study.  
This view is supported by the Resuscitation Council (UK), who in their latest 
guidelines, state that “The decision about when to stop a cardiac arrest where 
pulseless electrical activity (PEA) persists is less clear and is not currently within the 
UK Ambulance Service Clinical Practice Guidelines (2013)...There is limited 
evidence to support when one should terminate a PEA cardiac arrest…” 170.  This 
highlights the need for more research aimed specifically at the patient group of 
interest. Without further research to establish whether and when PEA rhythms are 
futile, then this group of patients will continue to be transported to hospital. 
Girija, Sudha, Cauvery et al go on to suggest that research should be up to date and 
relevant, and should come out with pragmatic solutions to the issue. It has been 
shown in previous chapters that the majority of resuscitation attempts that are 
transported to hospital do not result in the patient’s survival, despite the existence of 
TOR guidelines for asystolic patients, which already reduce the number of patients 
who undergo transport. It has also been shown that there is support for the position 
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that futile medical interventions are unethical. This literature review has shown that 
there are nevertheless tools available to establish when a resuscitation attempt 
should be terminated, due to its futility, but that none of these tools were either 
derived or validated in a pre-hospital system similar to that of the UK Trust in 
question. Nor were they designed to complement the present TOR guidelines 
currently in place in the Trust. Research is needed to establish whether a similar tool 
can be derived and validated for the population served by the Trust, or if the 
previously validated TOR CDRs are appropriate for identifying patients presently 
transported and for who transport to hospital is futile. The introduction of such a tool 
would potentially reduce the number of adult OHCA patients transported to hospital, 
and the risks associated with that transport, whilst still protecting those patients for 
who continued efforts may be successful. Not only could such a tool address the 
ethical issues of futile treatment for the appropriate patients, but may also benefit the 
wider health economy, due to the resulting increase in available resources to attend 
and treat other patients both in the pre-hospital environment and within hospitals.  
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4. Chapter Four – Methodology and methods 
4.1 Qualitative vs quantitative 
In the previous chapter, it was concluded that whilst various CDRs have been 
derived for TOR, the CDRs do not necessarily produce similar results across 
different populations and pre-hospital systems, and the existing research is not 
robust enough to consider changing the practice in a UK ambulance Trust when 
critiqued using the criteria defined by McGinn, Guyatt, Wyer et al 141. Furthermore, 
the populations used to validate these existing CDRs are different from those 
relevant to the Trust, as they include those patients already suitable for termination 
under existing rules available for the termination of asystolic rhythms. Therefore, 
having established the need for further research, this chapter will discuss the various 
methodologies available to researchers and propose the most appropriate one for 
this project. It will then give an overview of the methods used in subsequent chapters 
to gather and analyse data.  
Methodology may be defined as the general principle or approach that guides a 
research project171. In its broadest terms all research is the search for new 
knowledge. However, in order to be able to inform future practice, it must be 
performed in a way that allows others to follow the methods and assess the 
robustness of its results 172. Research methodology provides the structure for 
research. A methodology provides the overall approach to the research and offers a 
framework for answering questions as to constraints, dilemmas and ethical choices 
that may present themselves 171. There are different ways to classify research, and 
one of the most common classifications is into either qualitative or quantitative 
research. The former, which is often, though not exclusively, associated with the 
social sciences, explores experiences, behaviour and attitudes through methods 
   74 
 
such as focus groups, interviews or facilitation. Qualitative research does not aim to 
produce quantifiable answers to a particular research question, but rather seeks to 
produce insights on social interactions 173. The methods employed by qualitative 
research tend to focus on fewer participants, but the contact interval with them is 
usually longer. The precise methods used will depend on the exact methodology 
chosen for the research and there is no single approach 174. So, for example, 
ethnography, which evolved from the study of anthropology, may rely heavily on 
fieldwork, where the researcher participates in a group’s activities and observes its 
interactions and behaviour. By contrast, action research works with a closed group of 
participants and aims to facilitate change by working through defined stages of 
planning, acting, observing and reflecting. Grounded theory is another qualitative 
methodology, which allows a theory to emerge from gathered data. Through a series 
of interviews or focus groups, grounded theory gathers information from an 
unspecified number of participants, until such time as no new information is being 
obtained. Once this point of saturation is reached, a theory or idea may emerge, 
which was previously unconsidered.  
Quantitative methodology is more associated with the natural sciences, and differs 
from qualitative in that in that it is concerned primarily with statistics, gathered using 
a variety of means and depending on the methods chosen. One of the  tenants of 
quantitative methodology is that it is objective and value-free in its investigation of a 
material reality 175. This has its basis in the theories of positivism, which purports that 
scientific statements are based only upon empirical observations, and the logical 
inferences based on them 176. Although this is an over-simplified view of the 
methodology, it does emphasise the difference in approach to qualitative study. 
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Nevertheless, this view of the scientific approach has been criticised in recent years; 
not least by Stephen Hawking, who notes that; 
 “Up until now, most scientists have been too occupied with the development of new 
theories that describe what the universe is to ask the question why” (pp174) 177. 
Despite the apparent dichotomy between the two methodologies, it is possible to 
conduct mixed-methods studies. These studies will have different methods of data 
collection that include qualitative data such as surveys, combined with qualitative 
data such as interviews. The relative merits and shortcomings of the different 
methodologies are beyond the scope of this thesis. However, to determine which 
methodology to use for this research, it was necessary to focus on the aim of the 
thesis. For example, if the focus was on the decision-making process relating to 
termination of resuscitation, then a grounded approach would allow one to develop 
theories from the ideas and experiences of clinicians who have experienced this, by 
means of interviews or focus groups. Similarly, an ethnographical approach would 
allow for observations in the field to establish how decisions were made by different 
levels of clinician when presented with difficult decisions about termination of 
resuscitation.  Although these approaches would certainly add to the knowledge of 
decision-making in the field, the aim of this thesis is to determine whether there are 
key objective determinants, which can be used to classify a resuscitation attempt as 
futile, and which would otherwise result in transport. Some of the motivations behind 
this research do have qualitative features; such as the effect on clinicians and family 
member when they are required to continue resuscitation on patients for whom they 
believe their efforts are futile. However, the primary aim was to produce evidence, 
which could be used to change current practice. Qualitative studies, along with 
descriptive studies, opinion leaders and patient preference  are all valid tools in 
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modern evidence-based practice 178. Nevertheless, as the previous chapter showed, 
in other pre-hospital emergency systems and populations, it has been possible to 
determine objectively when a resuscitation attempt is likely to prove futile. This was 
done by obtaining objective data on cardiac arrests and analysing it using statistical 
methods to determine which independent factors were associated with poor 
outcomes. This approach directed the study firmly towards a quantitative 
methodology. 
4.2 Methods 
Having established that this research would follow a quantitative methodology, a 
research design was required to answer the research question. This section gives an 
overview of the methods used in subsequent chapters. It provides an understanding 
of why certain methods were used. More detail on the decisions made at each stage 
of the study is provided in following chapters.  
The second objective of this thesis, given in chapter two was:  
To derive a TOR CDR for adult OHCA of cardiac aetiology that is appropriate for use 
by pre-hospital clinicians, and which reduces the number of futile resuscitation 
attempts transported to hospital. 
The third and fourth objectives were to validate this rule, first retrospectively and then 
prospectively. This then led to the hypothesis that there are objective characteristics 
that can determine when an adult patient suffering an OHCA of cardiac cause will 
not survive a cardiac arrest despite ongoing resuscitation attempts and transport to 
ED. This is a causal hypothesis, as it not only describes a relationship between two 
or more variables, but also implies that a change in one of those variables will lead to 
changes in the other 175. By generating this hypothesis it was now possible to aim to 
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design a study that would lead to predictions based on observation, and in particular 
towards the outcome of resuscitation attempts. In deciding how to design this study, 
it was important to consider generalisation. Generalisation is the concept that results 
will be applicable to situations similar to those studied. The notion of generalisation 
has led to several commentators developing hierarchies of evidence 139, 179, as 
discussed in chapter three. The hierarchies are used to show the increasing risk of 
bias, and reduced generalisation that results from different research designs. 
Although these hierarchies vary, they are generally consistent in that they rate 
systematic reviews or meta-analysis of randomised controlled trials as the ‘gold 
standard’ of primary research 180. Next are randomised controlled trials (RCTs), 
which allow for rigorous evaluation of a single variable and are designed to eradicate 
bias by comparing identical groups 181. However, the complexity of resuscitation 
practice and the posed clinical question make an RCT impractical due to the number 
of influencing variables. Even if possible, an RCT would raise ethical issues about 
randomising patients for resuscitation that would be difficult, if not impossible to 
justify. Furthermore, one could not randomly terminate a resuscitation attempt at 
scene and determine whether that patient would survive to hospital discharge due to 
clinical equipoise. 
Therefore, the components of the TOR CDR were established by performing a 
retrospective cohort study using OHCA data collected by the Trust. This data was 
refined to include only those adult patients who presented with an OHCA of 
presumed cardiac aetiology, and who were transported to hospital. Cohort studies 
are a ‘nonexperimental’ research design, as participants are not allocated randomly. 
They are therefore ranked lower in the hierarchy of evidence than RCTs. They do, 
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however, provide evidence of the factors influencing outcomes and in population 
studies they are the only type of study that can accurately identify risk factors 182.  
The aim was to review the variables collected by a single ambulance trust on all pre-
hospital cardiac arrests and determine whether certain variables were associated 
with and predictive of death for adult OHCA of presumed cardiac aetiology. In this 
way, statistical methods were used to develop a model that would predict future 
observations. It was decided that an initial retrospective study could be validated 
prospectively, once the model had been developed and refined if necessary.  This 
approach was considered to be important to improve the rigour of the CDR. As 
Altman and Royston have argued; a statistically validated model, which passes all 
the appropriate statistical tests, has no clinical value unless it can be shown 
successfully to predict outcome 145. In order to do this the performance of a model 
must be tested using data other than that used for the model development, and 
ideally in a clinical setting. 
4.3 Population 
The data for this study were taken from a large United Kingdom Ambulance Trust 
(the Trust), covering both large urban centres and remote rural areas. The Trust 
covers a geographical area of approximately 5,400 square miles, with a population of 
approximately seven million people. The Trust responds to over one million medical 
incidents per year. It operates approximately 700 response vehicles, being a mixture 
of single crewed rapid response cars and double crewed ambulances. It has a 
combined technician (BLS) and paramedic (ALS) staff, with some crews being 
exclusively one or the other, whilst other crews are mixed. This variation is the result 
of rostering practicalities, and local requirements, rather than universal design. The 
Trust also utilises a system of community first responders, who respond via pager to 
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a number of incidents, including adult OHCA and who are equipped with AEDs. The 
Trust supports a scheme of public access defibrillators, which allows for by-standers 
to collect an AED, if it is within a reasonable distance of the scene. The Trust 
currently operates a TOR guideline, in line with the majority of UK ambulance 
services, which allows for termination only if, following 20 minutes of ALS, the patient 
is in an asystolic rhythm. Therefore, whilst BLS staff may occasionally be the only 
attending response to an arrest, only ALS responders are permitted to terminate an 
arrest attempt. Ambulance clinicians of all grades are also not required to initiate 
CPR where there are obvious signs of death, or where there has been no effective 
BLS for more than fifteen minutes since collapse, and the patient is in an asystolic 
rhythm. 
4.4 Study design 
Having decided on an initial retrospective cohort study, there was a need to 
determine which statistical model to use for this. There is a variety of opinion on 
which statistical model to use for different tasks, and much of that opinion is based 
on personal preference of the researcher, rather than any hard and fast rules 183. 
Lehmann quotes A. P. Dawid as saying: 
“In general, the theoretician is happy to accept that his abstract probability triple (Ω, 
A, P) was found under a gooseberry bush, while the applied statistician’s model ‘just 
growed’.” 184 
As the aim was to predict an outcome variable from several predictor variables, 
multiple regression was chosen as the tool. However, linear regression assumes 
linear relationships between variables. When the dependent variable is categorical 
this assumption is violated.  The dependent variable for this study was dichotomous: 
death vs survival to hospital discharge (survival), so binominal logistic regression 
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was chosen to overcome this problem of violating the linearity assumption. Binominal 
logistic regression enables one to predict the likelihood that a subject will fall into one 
of two possible outcomes, given a set of dependent variables.  Binomial logistic 
regression (often called simply logistic regression) models a relationship between 
multiple independent variables and a single dependent variable. However, a 
transformation is applied so rather than directly predicting the category of the 
binomial logistic regression, the logit of the dependent variable is predicted. This 
makes the form of the relationship between independent and dependent variables 
linear, but leaves the relationship itself non-linear. To do this, the logistic regression 
model first takes the odds of the dependent variable happening following variations 
to each independent variable. It then takes the ratio of those odds and then the 
logarithm of that ratio in order to transform the dependent variable into a continuous 
criterion. So, whilst the dependent variable is binomial, the regression is conducted 
on the logit, which is the continuous criterion 185. The predicted value of the logit is 
then converted back into predicted odds using the inverse of the logarithm. 
Therefore, whilst the observed dependent variable in logistic regression is 
dichotomous, logistic regression is able to estimate the odds as a continuous 
variable. Categorical prediction can then be based on the computed odds of a 
success. 
For example, if four independent variables are "X1 to X4" and the probability of the 
dependent variable is "Y", binomial logistic regression produces the model: 
P(Y) = 1/  1 + e -(β0 + β1X1 + β2X2 + β3X3 + β4X4+ εi) 
Where β0 is the constant, β1, β2, β3, and β4 are the coefficients for X1, X2, X3, and X4 
respectively and ε is a residual term 186. A point to note here is that the relationship 
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between any independent variable and the dependent variable depends on the 
values of the other variables in the model. So, for example, in a simple model with 
age and sex as independent variables, the sex (male/female) is different across 
ages.  It must also be noted that as with all statistical modelling, there are inherent 
dangers, such as the model being over fitted, resulting in false positive associations, 
or predictions that are too extreme, so results must be viewed with caution. As one 
of the great statisticians, George Box commented “All models are wrong, but some 
are useful” 187. This was borne in mind as variables were selected for inclusion at 
each stage of the CDR development.  
This process was applied in three stages. First, all potential variables were assessed 
for their association with the outcome (survival). Arguably, by doing this there was 
the potential of excluding the possibility of detecting the effect of small combined 
differences across the factors 183. However, it was decided that at this stage the 
effects of small combined differences could be sacrificed in order to produce a 
simplified CDR, which would be applicable in the field. Having established which 
independent variables may be associated with outcomes for pre-hospital cardiac 
arrest, a decision was taken not to include certain variables into the subsequent 
calculations to determine the CDR. This was an done by excluding those variables 
which could be excluded on ethical grounds, as well as those that could not be 
established with any degree of certainty by clinicians at the scene of an arrest. As it 
is ambulance clinicians who would be expected to implement the CDR, only 
variables that could be established with accuracy on scene were considered for 
further analysis. This would ensure that the CDR was clinically applicable, rather 
than being a purely academic exercise. The remaining variables were then included 
in the regression model. The final selection of variables to include in the CDR was 
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then considered. Full details of that process are explained in detail in chapter 5, and 
include the selection of variables to be included in the regression process and how 
these were refined for inclusion in the CDR. 
Whilst there are inherent statistical tests that attempt to measure how well the model 
fits the data, such as the Nagelkerke R2, it was decided early on that the model 
would be validated as cohort studies against subsequent data sets of actual cardiac 
arrest events. In this way, there is some assurance of generalisability of the CDR 
that had been created from the original data set. It was decided that both 
retrospective and prospective cohort studies would be used as the methods for 
validation. This would satisfy McGinn’s requirements for implementing a CDR into 
clinical practice 141. The retrospective validation was chosen as it could utilise data 
already gathered by the Trust.  This would provide a substantial data set, without the 
requirement for data gathering from the Trust’s clinicians. Any problems identified at 
this stage could then be rectified easily. The second, prospective cohort study 
required significant operational input from the Trust’s clinicians, which is described in 
detail in chapter 7.  
Both the retrospective and prospective cohort studies aimed to determine sensitivity 
and positive predictive value of the established decision rule, as well as the 
specificity and negative predictive values.  These values are determined, as with 
other diagnostic tests, by reporting the results using a 2×2 diagnostic test results 
table (Table 7). It is important to note here that as the rule is aiming to determine 
futile resuscitations, the positive outcome is death. This will be discussed further in 
later chapters. 
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TOR Guideline Died Survived Total 
Terminate  a b a=b 
Transport  c d c+d 
Total a+c b+d a+b+c+d 
Table 7 – 2x2 table of results 
The 2x2 table identifies the following subsets of patients:  
(a) True positives, which are those patients for whom the rule predicted death and 
did in fact die;  
(b) False positives, where the rule predicted death, but the patient survived;  
(c) False negatives, where the rule predicted survival but the patient died;  
(d) True negatives, where the rule predicted survival and the patient survived.  
From these results, one can determine the sensitivity and specificity of the test. The 
sensitivity of a test denotes its ability to identify correctly those patients whose 
resuscitation should be terminated due to the futility of onward transport (as the CDR 
is designed to determine futile attempts, rather than survival). This is established by 
the equation: 
Sensitivity = True positives / (True positives + False negatives) 
The specificity of this test refers to its ability to identify those patients who should be 
transported (due to not fulfilling the criteria of the termination rule) and who go on to 
survive. This is established by the equation: 
Specificity = True negatives / (True negatives + False positives) 
One can also use these results to establish the positive predictive value (PPV) of the 
test. That is, how likely it is at a patient will not survive, when the rule recommends 
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termination. As such, PPV has more real world meaning than sensitivity or 
specificity. It is established by the equation: 
Positive Predictive Value = True positives/ (True positives + False positives) 
The negative predictive value (NPV) determines how likely it is that a patient will 
survive when the decision rule recommends transport. This is established by the 
equation: 
Negative Predictive Value = True negatives/ (True negatives + False negatives) 
Although the number of expected survivors in any population of OHCA patients is 
likely to be low, the NPV is a good indicator for the effectiveness of any CDR that is 
produced. Although not designed to determine survivors, a high NPV would indicate 
that fewer futile attempts have be classified as survivable. A high PPV, on the other 
hand, will indicate that there are few unexpected survivors in the group predicted to 
die, which is also a good indicator of an effective CDR in these circumstances. 
It was apparent that in order to justify the development of a new CDR, it should be 
compared against those already validated: the BLS and ALS CDRs discussed 
previously. Therefore at each stage of the process, both of these CDRs were applied 
to the patient population and evaluated against the TOR CDR that had been derived. 
As any effective TOR CDR would require the number of false negatives (unexpected 
survivors) to be less than 1%, a high specificity (ideally 100%) was expected for all 
three of the CDRs. This would indicate that fewer potential survivors were classified 
in the futile group of OHCA patients. Therefore it was predicted that the specificity of 
the three CDRs would be broadly similar – they should all recommend transport for 
potential survivors. On the other hand, whilst the test is aimed to identify futile 
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resuscitations, it is not expected that sensitivity will be as high in any of the CDRs. 
This is because there were still expected to be a number of patients transported to 
hospital, who do not survive (false negatives). By assessing the comparative 
sensitivity of the three CDRs, their ability to predict death was established. 
The result of a higher sensitivity will be fewer futile resuscitations being transported 
to hospital. As discussed earlier, if the only goal is to identify potential survivors, then 
transporting all OHCA patients to hospital would achieve this. However, this does not 
alleviate the issues of finite resources or the ethical dilemma of continuing 
resuscitation attempts when they are ultimately futile. Therefore all decisions relating 
to TOR must balance the need to reduce unexpected survivors to an acceptable 
number, but at the same time minimise the number of futile transports. A comparison 
of the sensitivity of each rule addresses this latter point. 
Furthermore, the efficacy of the three CDRs was also assessed by means of their 
receiver operating characteristic (ROC).  The ROC space is a graph, which plots the 
performance of a binary classifier system by plotting the true positive rate 
(sensitivity) on the y axis against the false-positive rate (calculated as 1 − specificity) 
on the x axis. Analysis of the ROC space helps to identify possibly optimal models. 
The optimum prediction method (also called a perfect classification) would result in a 
point in the top left corner of the ROC space, which represents 100% sensitivity (no 
false negatives) and 100% specificity (no false positives). A diagonal line divides the 
ROC space. A point above this line indicates a result that is better than random, 
whereas a point below the line indicates a worse than random result.   
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4.5 Cost savings 
The final element of this research involves an estimate of cost savings following the 
introduction of the TOR CDR.  Although the concept of futility is heavily bound with 
issues of ethics, as previously discussed, there are also distinct economic factors, 
which need to be considered. As emphasised in previous chapters, all resources in 
terms of pre-hospital and ED staff, time and facilities are limited, and increasingly 
under pressure, both due to economics and capacity. Increasingly, there are 
pressures within the NHS to reduce cost, whilst maintaining efficiency. The NHS Five 
Year Forward View emphasised the need to drive efficiency in order to maximise 
resources 188. This document emphasised that with no additional annual efficiencies, 
and flat real terms funding, the continued growth in demand on NHS resources could 
produce a deficit of almost £30 billion a year by 2020/21. It highlighted an ambition 
for the NHS to attain 2% net efficiency gains each year for the rest of the decade, 
and the possibly that this could increase to 3% over time.  This was supported by the 
Association of Ambulance Chief Executives, whose vision for the future of the 
ambulance service acknowledged the need for financial savings, whilst maintaining 
patient care 189. Although this latter document was aimed primarily at urgent, rather 
than emergency care provision, its underlying message is that too many patients are 
transported to ED, when other options may be available to ambulance clinicians. It 
suggests that reducing transportation plays a pivotal role in improving cost 
efficiencies. Similarly, the National Institute for Health Research discussed the cost-
effectiveness of ambulance service practices 190. Although this paper considered 
OHCA, it did not comment on the appropriateness of transportation, but rather at 
interventions on scene. Nevertheless, it emphasised throughout the need for 
ambulance clinicians to deliver care solutions on scene, when appropriate, as 
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opposed to transporting patients to hospital. The NHS Confederation have also 
stressed that whilst emergency care pressures are most visible in the emergency 
department, they result from systemic issues, including those of the ambulance 
service 191. They emphasised that reducing avoidable emergency admissions is one 
of the key issues in reducing unnecessary cost. Therefore, in order to understand the 
impact of any proposed CDR, it is important to understand the economic impact they 
will have on healthcare system as a whole. 
The characteristics that define an economic analysis are a comparison of choices 
and the relative costs and consequences of those competing choices. However, 
there is no standard method of economic evaluation.  An economic analysis may 
take different forms, depending on the measurements, costs and consequences that 
are considered. Therefore the choice of method used depends on the answer to two 
questions. Firstly, whether there are comparisons being made between two or more 
alternative options, and secondly, whether both costs and consequences are being 
compared. If one examines both the costs and consequences of two or more 
alternatives, then this is considered to be a full economic evaluation. Within this 
group of methods, there are three potential techniques that can be employed. For 
example, if one was comparing different interventions, but measuring a common 
effect, which may vary between the two, then a cost-effectiveness analysis may be 
undertaken. A cost-utility analysis takes a broader measure of benefit and makes 
adjustments for quality of life, whilst providing comparisons of a generic outcome 
measure. A third method, the cost-benefit analysis, translates the various 
components of an effect (e.g. quality-adjusted life-years (QALYs) gained, 
complications or disability days avoided) into a monetary value and seeks to 
establish the net benefit or loss of one option over another. Other forms of economic 
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analysis are available, which do not necessarily consider all the elements required 
for a full economic evaluation. Drummond, Sculpher, Torrance et al consider these 
partial evaluation techniques, which may not consider two or more alternatives, or 
which may not examine both the costs and consequences of the examined 
alternatives 192.  
There are difficulties in applying a full economic evaluation to the application of a 
TOR CDR. First and foremost, the CDR is not designed to affect patient outcomes. 
Rather, a TOR CDR aims to identify patients who will not survive, and to allow 
termination on scene. The outcome for the individual patient does not change. 
Potential benefits of reducing the number of futile transportations can be anticipated. 
However, these do not relate to the individual patient being transported. Rather they 
are implicit benefits. They include the availability of both ambulance and hospital 
resources that could otherwise be utilised, if not allocated to an ultimately futile 
resuscitation attempt. For the ambulance resource, this could include their 
availability for other emergency incidents. In-hospital benefits could include the 
availability of clinical staff to attend other patients, and the availability of beds to 
accommodate other patients. These benefits, although real, cannot easily be 
quantified. 
The approach taken was therefore to determine the cost savings of implementing the 
CDR from an acute care perspective. This was done by reviewing the possible 
locations at which a futile resuscitation attempt could be terminated.  The cost of 
each alternative was made on the basis of assumptions, which will be discussed 
further in Chapter 8. However, it is important to note that these assumptions were 
made on the basis that they deliberately under-estimated the full costs. This was 
done so as not to over-emphasise any financial benefits of implementing a CDR. The 
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data from phase 3 were used to calculate the costs. The costs were established for 
the current situation, where all patients are transported, and repeated for the TOR 
CDR, as well as the BLS CDR and ALS CDR. From this, the cost savings were 
compared. 
4.6 Approval and ethics 
Before this study was initiated, approval was sought to ensure the methodology was 
appropriate for the study; the methods selected were valid and that the participants 
were appropriately safeguarded. Approval was sought from three organisations, due 
to the nature of the study. A proposal was presented to Northumbria University for 
academic approval and a subsequent application was made to and approved by the 
Faculty Ethics Review Panel. As the research was to be conducted using data, 
patients and personnel from a UK Ambulance Trust, a submission was also made to 
and approved by the Trust’s Research and Development team. As the study required 
the creation and maintenance of a database relating to OHCA, approval was also 
sought and approved by the National Health Service Heath Research Authority 
(Appendix 4).  
4.7 Conclusion 
In his chapter methodology and methods employed in subsequent chapters were 
discussed. The use of a quantitative methodology has been justified and then an 
overview of the methods employed to establish and validate the TOR CDR were 
given. The following chapters will look in turn at the derivation of the CDR and then 
its validation, both retrospectively and prospectively. Finally the cost savings will be 
discussed in detail. Each of these chapters will discuss in more detail the methods 
relevant to that chapter.  
   90 
 
5. Chapter Five - Derivation of a clinical decision rule (Phase 1) 
In previous chapters a definition of futility has been established and it has been 
confirmed that TOR CDRs may be able to predict those adult OHCA of cardiac 
aetiology that will not have a successful outcome, despite transport to hospital. In 
this chapter, phase 1 of the study will be discussed. This phase addresses the 
second objective of the thesis: To derive a TOR CDR for adult OHCA of cardiac 
aetiology that is appropriate for use by pre-hospital clinicians. Therefore the aim was 
to develop a TOR CDR that could be used by pre-hospital clinicians to determine 
when a resuscitation attempt that is currently transported to hospital under existing 
guidelines could safely be terminated at scene, without the need for transport. The 
creation of such a CDR required the identification of certain characteristics, or 
combination of characteristics, which could be used to identify futile resuscitation 
attempts that under current practice would result in transportation of the patient. 
Since 1991, the “Utstein style” of defining and reporting on out-of-hospital 
resuscitation has been internationally accepted. This consensus, reached following 
an international multidisciplinary meeting held at the Utstein Abbey, Norway, in June 
1990 was aimed at providing uniformity in reporting OHCA and resuscitation 
attempts 193. The Utstein templates have subsequently been updated, with the latest 
version announced in 2014 194. Wherever possible, the Utstein definitions are used 
throughout this and subsequent chapters. However, the Utsein reporting method was 
designed to provide a uniform tool for reporting survival from cardiac arrest and to 
compare survival rates across different systems. Utstein reporting therefore 
compares those arrests, which are thought to be of cardiac aetiology, are by-stander 
witnessed and present in a shockable rhythm. However, this study is seeking to 
derive a universal TOR CDR, and the Utstein template itself is inappropriate for use 
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in these circumstances, as it would exclude certain subsets of cardiac arrest that are 
of interest to this study (e.g. those presenting with PEA or asystole and unwitnessed 
OHCA). 
5.1 Study design 
Phase 1 was a retrospective cohort study that reviewed all consecutive cases of 
OHCA that were treated by clinicians within the Trust during a single 26-month 
period. From this pre-existing dataset adult patients were identified whose OHCA 
was of presumed cardiac aetiology and who were also transported to hospital. These 
data were collected by the Trust Governance Department from patient report forms 
(PRFs) that are completed by ambulance crews following every patient contact. The 
dataset included patient characteristics as well as any treatment provided and 
pertinent ambulance intervals. These variables included: patient age and sex; 
response interval (time of call to the first response stopping on- scene); ambulance 
interval (time of call to the first ambulance arriving on scene); treatment interval 
(interval between ambulance arrival and initiation of transport to hospital), travel 
interval (interval from scene to hospital); presence of witnesses to the arrest 
(whether bystander or ambulance crew); presence of bystander CPR; whether the 
initial cardiac rhythm was shockable (VF/pVT); whether defibrillation was 
administered at any time during the resuscitation; and presence of any return of 
spontaneous circulation (ROSC). The data also identified those patients who 
survived to discharge and those that died before discharge. These patient outcomes 
were collected from hospital records. The Trust transports OHCA patients to 33 main 
hospitals, from which two do not share survival data. Additionally, patients were 
transported or transferred to three hospitals outside of the Trust’s geographical 
footprint. There is no agreement to share data with these hospitals.  
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The process of determining which variables to include in the final CDR involved 
several stages. First all variables were examined that were found in previous 
research to have an association with outcome 111, 112, 149, 195, 196.  These variables 
were then independently assessed for association with death. Arguably, by doing 
this there was the potential that the effect of small combined differences across the 
factors would be missed183. However, it was decided that that at this stage that it was 
important to understand how each variable was associated with outcome and that 
the effects of small combined differences could be sacrificed in order to produce a 
simplified CDR, which would be clinically meaningful and applicable in the field.  
Once associations with outcomes had been established, the implications of including 
the variables into a CDR were considered. At this stage the aim was to exclude any 
variables that would be unethical to include, as well as any variables that could not 
easily be established at the time of the incident.  
Regression was then performed on the remaining variables, having first addressed 
the assumptions of the regression model. Finally, variables that were found to be 
positively associated with outcome were considered for the development of a TOR 
guideline. At this stage the aim was to simplify the potential CDR, whist retaining its 
effectiveness. This required the developing of hypotheses, which could be adjusted 
at a later stage, if required. 
Once a CDR was established by this method, it was retrospectively applied to the full 
dataset of transported, adult OHCA of presumed cardiac cause. This was done to 
establish whether the false positives (unexpected survivors) remained under the 
threshold of futility (defined previously as < 1%). It also enabled examination of the 
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unexpected survivors to decide whether any of the variables excluded during the 
earlier stages may have improved the results.  
 Finally, the newly derived CDR was compared with the results of applying the 
existing BLS and ALS CDRs to the same dataset. The aim here was to determine 
which rule resulted in fewer futile resuscitations being transported to hospital.  
5.2 Study setting and population 
All OHCA resuscitation attempts that occurred between 1 April 2011 and 29 June 
2013, and which were transported to hospital were reviewed. Patients were excluded 
from the study if no resuscitation was attempted (i.e. death was diagnosed due to 
presence of rigor mortis, decomposition, massive cranial and cerebral destruction, 
hemicorporectomy, incineration, hypostasis, or where a do not attempt CPR order 
was in place, in accordance with present Trust guidelines); they were under 18 years 
old; if the arrest was not presumed to have been of cardiac origin (i.e. the arrest was 
due to trauma, drowning, drug overdose, or some other medical cause); if the 
resuscitation attempt was terminated under current TOR guidelines (asystolic rhythm 
following twenty minutes of ALS); or if their outcome was unknown (Some hospitals 
did not provide follow up data).  
5.3 Data analysis 
Statistical analysis was performed using IBM SPSS Statistics 22. For the purposes 
of analysing the data, death was considered as the positive outcome. Rather than 
predict survival, this approach attempts to determine when transport to ED is futile. It 
should also be noted that death was defined as any patient who was not discharged 
alive from hospital. No distinction was made between neurological outcomes of 
survivors, as this is beyond the scope of this thesis.  
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5.4 Patient disposition 
Between 1 April 2011 and 29 June 2013, 8316 arrests were attended by ambulance 
crews in the Trust. Of these, 173 were under 18 years of age; 808 were not 
presumed to have been of cardiac origin (180 trauma, 26 submersion, 483 
respiratory, 104 other and 14 unknown); 1268 resuscitations were terminated under 
the existing Trust policy; 704 were taken to hospitals who did not share survival data 
and 493 had no data available on survival.  
A total of 4,870 patients met the inclusion criteria for the study. Table 8 describes the 
out-of-hospital characteristics of all eligible patients according to follow-up status. 
The mean age for the patient group was 71.5 (sd 15.1) years, and 3033 (62.3%) 
were male.  The mean response interval for the first response (Public access 
defibrillator, community first responder, rapid response vehicle etc.) was 6.67 
minutes (sd 5.843). The mean response interval from ambulance activation to 
arriving on scene was 10.24 minutes (sd 7.72). The mean interval on scene was 
28.72 minutes (sd 11.57) and the mean transport to hospital interval was 9.05 
minutes (sd 6.78). 
Of the 4870 patients with complete follow-up 4354 (89.4%) died and 516 (10.6%) 
survived to hospital discharge. In 4859 (99.8%) cases, it was recorded whether or 
not the arrest was witnessed. 2383 (48.9%) patents had an arrest witnessed by a 
bystander and 646 (13.3%) witnessed by an ambulance crew. In 100 (5.5%) of 1830 
unwitnessed arrests the patients survived to discharge.  Of the 2383 witnessed by a 
bystander, 276 (11.6%) survived. This compares to 140 (21.7%) of the 646 patients 
whose arrest was witnessed by ambulance crews.  The presence of bystander CPR 
was recorded for 4836 (99.3%) of patients. Of the 2893 (59.8%) who received 
bystander CPR, 335 (11.6%) patients survived. In 1943 (40.2%) cases, bystander 
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CPR was recorded as not being present. 180 (9.3%) of these patients survived. In 34 
(0.7%) cases, bystander CPR was not recorded. Of the 4870 patients, 4650 (95.5%) 
had a presenting cardiac rhythm recorded. Of these, 1383 (28.4%) presented with a 
shockable rhythm (1335 (27.4%) ventricular fibrillation and 48 (1%) ventricular 
tachycardia), 1667 (34.2%) presented with asystole and 1600 (32.9%) presented in 
PEA. 183 (3.8%) were recorded as other. For the purposes of analysis, this last 
group were listed as ‘unknown’. 1833 (37.6%) patients were defibrillated during the 
resuscitation, so can be assumed to have had a shockable rhythm at some stage. 
3035 (62.3%) were not defibrillated. ROSC was achieved at some point in the field 
for 1778 (36.5%). 3092 (63.5%) patients failed to achieve ROSC. Figure 1 illustrates 
the disposition of all OHCA patients utilised in this study. 
 
 
Characteristic Present 
Unwitnessed 1830 (37.7%) 
Bystander witnessed 2383 (48.9%) 
Crew witnessed 646 (13.3%) 
Bystander CPR 2893 (59.8%) 
No Bystander CPR 1943 (40.2%) 
Shockable rhythm 1383 (28.4%) 
Non-shockable rhythm 3267 (67.1%) 
Defibrillated 1833 (37.6%) 
Not defibrillated 3035 (62.3%) 
ROSC 1778 (36.5%) 
No ROSC 3092 (63.5%) 
 
Table 8 - Characteristics of cardiac arrests  
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Figure 1 - Disposition of cardiac arrest patients 
5.5 Test for association 
The first step in assessing which variables to include in the CDR was to consider the 
variables that have been shown to have an association with patient outcome, 
following findings of previous research 111, 112, 149, 195, 196. These were patient age and 
sex; response interval; ambulance interval; treatment interval; travel interval; 
presence of witnesses to the arrest (bystander or ambulance clinician); presence of 
bystander CPR; Whether the initial cardiac rhythm was shockable (VF/pVT); whether 
defibrillation was administered at any time during the resuscitation; and presence of 
ROSC. 
Total Cardiac Arrest Cases 
8316 
 
Under 18 years old 
173 
Excluded 
3445 
Included 
4870 
Bystander Witnessed 
2383 
Crew Witnessed 
646 
Unwitnessed 
1830 
Non Cardiac Aetiology 
808 
848 
No Follow Up 
1197 
Bystander CPR 
2893 
No Bystander CPR 
1943 
Shockable Rhythm 
1383 
Non-Shockable Rhythm 
3267 
ROSC 
1778 
No ROSC 
3092 
Terminated on Scene 
1268 
Discharged 
516 
Died in Hospital 
4354 
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These variables were then independently assessed in order to establish odds ratios 
(ORs) and 95% confidence intervals (95% CIs) for the association of that 
independent variable with survival outcomes. Tests of association among the 
categorical variables were conducted using chi square test, and continuous data 
were analysed using the independent samples t test or Mann-Whitney U test, as 
appropriate. All comparisons were based on two-tailed tests. Categorical data 
included the patient’s sex, whether the initial cardiac rhythm was shockable 
(VF/pVT), whether the arrest was witnessed by a bystander or by ambulance 
clinician, whether bystander CPR was performed, and whether the initial rhythm was 
shockable.  
The chi-square test relies on two assumptions; firstly that each entity contributes to 
only one cell of the contingency table; and secondly that all cell frequencies should 
be greater than 5 185. In each of the comparisons, these assumptions were met: No 
individual patient characteristic contributed to more than one cell and all cell 
frequencies were greater than 5. There was a statistically significant association 
between sex and outcome χ2(1) = 32.617, p <0.05; between bystander CPR and 
outcome χ2(1) = 6.550, p =0.01; between crew witnessed arrests and outcome χ2(1) 
= 95.885, p <0.05; between initial shockable rhythm and outcome χ2(1) = 620.401, p 
<0.05; between defibrillation and outcome χ2(1) = 389.034, p <0.05; between by-
stander witnessed arrests and outcome χ2(1) = 4.565, p =0.33; and between ROSC 
and outcome χ2(1) = 862.018, p <0.05.  
The effects size for this categorical data was measured by using the odds ratio. The 
odds of survival for each significant variable were calculated, and then the odds of 
survival, if that variable was not present. The odds ratio was then calculated by 
dividing the first figure by the latter. Results are: ROSC (OR 48.9; 95% CI: 32.3 to 
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74.1); shockable rhythm (OR 13.8; 95% CI: 10.7 to 17.8); Defibrillated (OR 7.0; 95% 
CI: 5.6 to 8.7); Crew witnessed (OR 2.8; 95% CI: 2.3 to 3.5); Bystander witnessed 
(OR 1.2; 95% CI: 1.0 to 1.5); Male gender (OR 1.8; 95% CI: 1.5 to 2.2); Bystander 
CPR ( OR 1.2; 95% CI: 1.1 to 1.6);  
For the continuous variables, the independent-samples t-test was considered to 
determine whether the difference between these two independent outcome groups 
was statistically significant. However, the independent-samples t-test has six 
assumptions that first needed to be considered. The first three of these assumptions 
were met: (i) the presence of a continuous dependent variable; (ii) a dichotamous 
independent variable; and (iii) independent observations. The remaining three 
assumptions required testing: (iv) that there are no significant outliers within the two 
groups of independent variable in terms of the dependent variable; (v) that the 
dependent variable should be normally distributed for each of the independent 
variable groups; and (vi) That the variance is equal in each group of independent 
variables. 
Outliers were found in all three groups of continuous data. The outliers appeared to 
be plausible and did not appear to be as a result of data entry errors and could not 
be assessed for accuracy of measurement, due to ethical restrictions of assessing 
data in any format other than that provided to the researcher. The outliers were 
therefore assumed to be genuine, and so there was no good reason to reject them 
as invalid. Rather than replace the values at this stage of data analysis, it was 
decided to run the non-parametric Mann-Whitney U test, as this is not affected by 
outliers to the same extent as the independent-samples t-test. The Mann-Whitney U 
test (also called the Wilcoxon-Mann-Whitney test) is a nonparametric rank-based 
test that determines if there are differences between two groups on a continuous 
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dependent variable. As with other tests, the Mann-Whitney U test, is subject to 
certain assumptions, which must be met before the test is run. These are: (i) There 
must be one dependent variable that is continuous or ordinal; (ii) There must be one 
independent dichotomous variable; (iii) There should be independence of 
observations; (iv) The distribution shape of scores for both scores of independent 
variables must be determined to have either the same or different shape. Where they 
are the same shape, the Mann-Whitney U test can be used to determine if there are 
differences in the medians of the two groups. If the two distributions are shown to 
have a different shape, the Mann-Whitney U test can be used to establish if there are 
differences in the distributions of the two groups.  
Mann-Whitney U tests were run to determine if there were differences in age, 
response interval, ambulance interval, on-scene interval and travel interval between 
survivors and non-survivors. In each of the five tests distributions for both survival 
and non-survival groups were similar, as assessed by visual inspection.The median 
age was statistically significantly higher for non-survivors (75.16) than for survivors 
(63.79), U = 537,549, z = -12.751, p < .001. The median response interval was 
statistically lower for survivors (5 minutes) than for non-survivors (6 minutes), U = 
965,192.5, z = -5.246, p < .001. The median ambulance response interval was 
statistically lower for survivors than for non-survivors, U = 1,052,974, z = -2.327, p = 
.02. The median on scene time was significantly lower for survivors (23 minutes) 
than for non-survivors (29 minutes) , U = 771,253, z = -11.645, p < .001. The median 
transport interval was significantly higher for survivors (8 minutes) than for non-
survivors (7 minutes), U = 1,217,107.5, z = 4.091, p < .001. 
This stage of the anlysis concluded that the independent variables age, sex, 
response interval, ambulance interval, on-scene interval, transport interval, 
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bystander witnessed, crew witnessed, shockable rhythm, defibrillation and ROSC 
may be associated with outcomes for adult pre-hospital cardiac arrest of assumed 
cardiac aetiology. 
5.6 Variable selection for regression 
Having established which independent variables may be associated with outcomes 
for pre-hospital cardiac arrest; it was decided which of these to include in 
subsequent calculations to determine the CDR. At this stage the clinical application, 
as well as the operational and ethical implications of any variable was given priority. 
Both age and sex were shown to have an association with outcome. However, it is 
arguable that these two variables are potentially markers for unobserved 
comorbidities, so were considered inappropriate for use in the CDR. Additionally, 
age is a variable that may be difficult to establish on scene, particularly when there 
are no reliable bystanders to provide that information. Moreover, it was deemed 
ethically inappropriate to formulate a TOR CDR based on either of these patient 
characteristics. Intervals were also shown to have an association with outcome. 
Although these may well have a part to play in clinical decision-making on scene, 
their use in formulating the formal CDR was considered, but rejected at this stage.  
There were also practical limitations to the use of response times in a CDR. Although 
response and ambulance intervals are currently used to assess whether a 
resuscitation attempt should be initiated 68, it was thought that once the decision had 
been made to start a resuscitation, the response interval would be inappropriate to 
determine whether continued efforts were futile. Also, whilst the on scene interval 
was associated with survival, the interval spent on scene has a lot to do with the 
logistics and procedures surrounding the process of resuscitation and could not be 
seen as a causative indicator, without having an understanding of those other 
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factors. Travel interval cannot be assessed accurately whilst on scene and so was 
excluded from further consideration. It was accepted that these variables may have 
an interaction with the other variables, so to include them in any subsequent analysis 
may have unduly influenced the model, so were not included. Excluding these 
factors was consistent with the approach of Gold, Fahrenbruch, Rea, et al, discussed 
previously, which  concluded that models should incorporate only physiological 
changes following cardiac arrests as a more accurate way to ascertain survival 121. 
5.7 Binominal logistic regression 
The next stage of evaluation was to perform regression on the remaining variables. 
As the dependent variable (survival) was dichotomous (i.e. a nominal variable with 
only two categories) and there was more than one independent variable, binomial 
logistic regression was required as the predictive model. Logistic regression is 
similar to multiple regression, but is used where the outcome variable is a categorical 
dichotomy, and where the predictor variables are categorical or continuous 185.  
Unlike linear regression, logistic regression does not attempt to determine the 
predicted value of the dependent variable, but rather the probability of a case being 
in a particular group of the dependent variable having regard to the independent 
variables. This tool therefore enabled determination of whether the variables were 
predictors of a patient’s outcome.  
Like other statistical techniques, binary logistic regression carries certain 
assumptions, which need to be met in order to generalise the results of the test to 
the universal population. The first five assumptions relate to the study design and 
are: 
1. There is a dichotomous dependent variable.  
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2. There are two or more independent variables, which can be either continuous or 
nominal. 
3. There should be independence of observations.  
4. The categories of the dichotomous dependent variable and all the nominal 
independent variables should be mutually exclusive and exhaustive. 
5. There should be, in general, a minimum of 15 cases per independent variable 
These assumptions were met with this dataset. The dependent variable was 
dichotomous (Death or survival); all independent variables were dichotomous; the 
observations were independent as patients could be categorised as ‘yes’ or ‘no’ for 
each of the independent and the dependent variable: They could not be both.  
The last three assumptions relate to the nature of the data. These are: 
1. That there is no multicollinearity. i.e. that no independent variables in the model 
are approximately predicted by a linear combination of any other independent 
variables in the model. 
2. There is a linear relationship between the continuous independent variables and 
the logit transformation of the dependent variable. 
3. That there are no significant outliers. 
 
Having established the first five assumptions, the predictor variables were assessed 
for multicollinearity. Multicollinearity refers to an approximate linear relationship 
between two or more independent variables. A tolerance of less than 0.2 or a 
Variance Inflation Factor (VIF) of greater than 5 were taken to indicate a 
multicollinearity problem 197. Using these indicators, none of the predictor variables 
showed multicollinearity. There were no continuous independent variables, so the 
assumption of a linear relationship was not an issue.  
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Binominal logistic regression was then performed to determine whether survival 
could be predicted, based on bystander witnessed, bystander CPR, crew witnessed, 
initial shockable rhythm, defibrillation and ROSC. The binominal logistic model is 
used to quantify the effect of a predictor as an odds ratio or log odds ratio.  
The baseline analysis showed that without any independent variables, the 'best 
guess' will assume that no participants would survive. This assumption would 
correctly classify 90.6% of cases (Table 9). This figure is high, but not unexpected, 
as the number of survivors over all is low. 
Observed 
Predicted Percentage 
correct Died Survived 
Died 4170 0 100% 
Survived 435 0 0 
Overall Percentage 90.6% 
Table 9 – Baseline analysis 
 
 B S.E. Sig. Exp(B) 
95% C.I.for 
EXP(B) 
95% C.I.for 
EXP(B) 
Lower Lower 
Bystander CPR -.079 .137 .566 .924 .707 1.209 
Bystander 
witnessed 
.300 .157 .057 1.349 .992 1.836 
Crew witnessed 1.232 .198 .000 3.430 2.327 5.054 
Shockable 2.368 .244 .000 10.676 6.619 17.220 
Defibrillated .208 .250 .405 1.231 .754 2.010 
ROSC 3.692 .226 .000 40.110 25.749 62.483 
Constant -6.537 .273 .000 .001   
 
Table 10 - Logistic regression predicting survival 
 
The coefficients for the associations between OHCA characteristics and survival are 
shown in Table 10.The regression model explained 51.1% (Nagelkerke R2) of the 
variance in survival and correctly classified 91.8% of all cases. From the perspective 
of death as a positive outcome 166, sensitivity was 99.3%, specificity was 20.0%, 
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positive predictive value was 92.30% (95% CI; 91.49% to 93.06%) and negative 
predictive value was 73.73 % (95% CI; 64.83% to 81.40%). The low specificity at this 
stage was not unexpected. With only 10.6% survival to discharge, it was unlikely that 
this model would be able to identify these patients, without including any non-
survivors. However, the process did identify the predictor variables likely to be of use 
for creating the CDR. Of the six predictor variables three were statistically significant. 
These were shockable rhythm, ROSC and crew witnessed. 
 
5.8 Selecting TOR CDR criteria 
Having established the variables with a strong association to outcomes, each 
variable was further assessed for inclusion in the final TOR CDR. Bystander 
witnessed, bystander CPR defibrillation at any time were not significantly associated 
with outcome, so were excluded from the CDR.  Three variables were shown to have 
have a strong negative association with death; ROSC (OR = 40.1; 95% CI: 25.7% to 
62.5%), initial shockable rhythm (OR = 10.7; 95% CI: 6.6% to 17.2%), and crew-
witnessed (OR = 3.4; 95% CI: 2.3% to 5.0%). Independently, ROSC had a specificity 
of 95.4% (95% CI: 93.2% to 97%); a sensitivity of 70.5% (95% CI: 69.1% to 71.8%); 
PPV of 99.2% (95% CI: 98.9% to 99.5%) and NPV of 27.7% (95% CI: 26.7 to 28.7). 
A presenting shockable rhythm had a specificity of 81.7% (95% CI: 77.7% to 85.2%); 
a sensitivity of 75.6% (95% CI: 74.3% to 76.9%); PPV of 97.6% (95% CI: 97% to 
98%); and NPV of 25.7% (95% CI: 24.4% to 27.1%). The variable ‘crew witnessed 
arrest’ had a specificity of 27.1% (95% CI: 23.3% to 31.2%); a sensitivity of 88.4% 
(95%CI: 87.4% to 89.3%); PPV of 91.1% (95% CI: 90.6% to 91.5%); and NPV 21.7% 
(95% CI: 19% to 24.6%).  
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This analysis suggests that the variables with the strongest association with outcome 
were ROSC and initial shockable rhythm. By itself, a lack of ROSC predicted death 
in all but 24 (0.8%) cases. Consideration was given to utilising the absence of ROSC 
as the sole predictor of death. However, whilst 0.8% is within the predetermined 
definition of futility, there was a potential that this may increase beyond 1% when 
applied to a different dataset. Therefore it was decided not to use ROSC as a 
predictor in isolation at this stage, but would nevertheless be reviewed at later 
phases of the study. Crew witnessed arrests showed similar sensitivity, but much 
lower specificity than the other two variables. This is due in part to the low numbers 
of patients who suffer a crew witnessed arrest, so the majority of survivors are not 
witnessed by crews. Nevertheless, a large proportion of patients who had a crew 
witnessed arrest went on to survive (21.7%). However, it was postulated that the 
variable of crew witnessed arrest may be interacting with the variable relating to the 
cardiac rhythm the patient presents with. As discussed earlier, VF arrests are the 
most common initial rhythm 39, and VF respond well to early defibrillation 57. 
Therefore, a patient who arrests in the presence of a responder with a defibrillator at 
hand may be likely to have definitive treatment very quickly after that arrest occurs. If 
this hypothesis is correct, then it is the fact that a patient has presented in a 
shockable rhythm in the presence of a responder that is important, rather than the 
proximity of the responder per se.  
To examine this further those patients who had a crew-witnessed cardiac arrest were 
selected. A chi-square test for association was conducted between initial shockable 
rhythm and survival. All expected cell frequencies were greater than five. There was 
a statistically significant association between initial shockable rhythm and survival, 
χ2(1) = 178.251, p < .0001. Of the 549 patients suffering a crew-witnessed cardiac 
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arrest, for whom all appropriate data was available, 172 (31.3%) had an initial 
shockable rhythm. Of these, 91 (52.9%) survived. Of the remaining 377 (68.7%) who 
suffered a non-shockable arrest, 16 (4.3%) survived (Figure 2) 
 
Figure 2 – Outcomes vs rhythm (crew witnessed only)  
These results suggest that the presence of a shockable rhythm interacts with the 
association between crew-witnessed arrests and survival. It was therefore decided 
not to include the variable ‘crew-witnessed arrest’ in the CDR at this point. This 
would be reconsidered later.  
Consequently only initial shockable rhythm and ROSC were considered for inclusion 
in the proposed TOR CDR. As a result, the TOR CDR proposes TOR for adult 
OHCA of suspected cardiac aetiology, in addition to existing guidelines on asystolic 
patients, where the presenting rhythm is not a shockable rhythm, and where no 
ROSC is achieved before transport.  Patients not within this group would be 
transported to hospital. Retrospective application of this CDR to the original sample 
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(Figure 3) showed that all but 5 patients suffering OHCA who survived to discharge 
were within the group identified as requiring onward transport (positive predictive 
value = 99.8%; 95% CI: 99.5% to 99.9%, specificity = 99.0%; 95% CI: 97.7% to 
99.7%). The sensitivity and negative predictive values of this TOR CDR are also of 
note (53.1%, 95% CI: 51.6% to 54.6%, and 20.3%, 95% CI: 19.8% to 20.9%). The 
study aimed to determine which resuscitation attempts would not benefit from 
transport to ED.  Although it is not possible to determine who will survive an OHCA, 
the sensitivity of the test indicates how effective it is at ensuring that only those 
patients likely to survive are transported to hospital. A lower sensitivity suggests that 
greater numbers of futile attempts are recommended for transport. 
 
Figure 3 – Application of TOR CDR 
Application of the TOR CDR would have resulted in five unexpected survivors, which 
equates to 0.2% of those categorised as futile (Figure 4 and Table 11). This is below 
the threshold of 1% for futile interventions 198. The CDR also recommended 
termination of resuscitation for 2264 (47.6%) of 4761 patients (taking into account 
missing data), or a transport rate of 52.4%. This compares favourably with those 
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validations reported in previous chapters, where the mean transport rate was 59.5% 
(lowest 25.1%, highest 94.5%). It should be remembered however that the transport 
rates reported in the previous studies include all patients with OHCA of presumed 
cardiac aetiology. The transport rates reported here refer only to those patients 
currently transported, so do not include those who end up in an asystolic rhythm. As 
previously noted, some 1268 OHCAs were already terminated under existing TOR 
guidelines.  As these patients were excluded from the present study, they are not 
included in the total figures for transport rate. This results in a higher overall 
transport rate than would be the case if all OHCAs of cardiac aetiology are 
calculated. However, the purpose of this study was to identify futile transport from 
those patients currently transported to hospital. Despite this, the TOR CDR 
compares favourably with the other CDRs in terms of transport rate.  
 
 
 
 
 
 
 
 
 
Figure 4 - Derivation of TOR - Disposition of cardiac arrest patients 
 
Adult, Primary Cardiac Arrest Cases 
4870 
 
Shockable rhythm 
1383 
ROSC 
1778 
No presenting shockable or ROSC 
2259 
Transported to hospital 
2502 
Survived to discharge 
509 
Survived to discharge 
5 
Not recorded 
109 
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TOR Guideline Died Survived Total 
Terminate  2259 5 2264 
Transport  1993 509 2502 
Total 4252 514 4766 
Table 11 - Table of results 
5.9 Comparison with other CDRs 
In order to determine the efficacy of the CDR in relation to the BLS and ALS CDRs, 
they were also applied to the data. The BLS CDR criteria derived by Verbeek, 
Vermeulen, Fahim et al included crew-witnessed arrest, defibrillation at any time or 
ROSC at any time 199, 200.  Although this CDR appears at first to be very similar to the 
TOR CDR derived here, there are some important differences. The inclusion of crew-
witnessed arrests has already been discussed. The other difference is the use of 
defibrillation as a variable. Whereas the TOR CDR created here uses an initial 
shockable rhythm as a component, the BLS TOR uses defibrillation at any time. This 
would capture all patients within the group presenting with shockable rhythm, but 
would also include patients who were initially presenting in an asystolic, or PEA 
rhythm, and subsequently developed fibrillation. This is potentially a much wider 
group of patients. 
Applying the BLS CDR to the dataset resulted in 3067 patients being recommended 
for transport, of whom 513 (16.7%) survived. 1797 patients were recommended for 
termination, and 3 (0.2%) survived. This equates to a specificity of 99.4% (95% CI: 
98.1% to 99.8%), a positive predictive value of 99.8% (95% CI: 99.5% to 100%), 
sensitivity of 41.2% (95% CI: 39.8% to 42.7%) and a negative predictive value of 
16.7% (95% CI: 15.4% to 18.1%). This would have resulted in a transport rate of 
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63.1%. Figure 5 illustrates the increased number of transported patients resulting 
from the BLS CDR. 
Figure 5 - Comparison of BLS CDR with the derived CDR. 
 
The ALS guideline derived by Morrison, Verbeek, Vermeulen et al recommends 
termination for patients where the arrest was not witnessed by either bystanders, or 
ambulance clinicians, there was no bystander CPR, no defibrillation at any point and 
no ROSC 112. The inclusion of bystander witnessed and bystander CPR into the 
CDR greatly increases the number of potentially futile attempts that are transported 
to hospital. Applying these criteria to the dataset resulted in 478 patients 
recommended for termination; with 2 (0.4%) of these surviving. 4379 patients were 
recommended for transport. Of these 513 (11.7%) survived. This equates to a 
specificity of 99.6% (95% CI: 98.4% to 99.9%); a positive predictive value of 99.6% 
(95% CI: 98.3 to 99.9%); sensitivity of 11.0% (95% CI: 10.0% to 11.9%); and a 
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negative predictive value of 11.7% (95% CI: 10.8% to 12.7%). The transport rate, 
when applying this CDR is 90.2% (Figure 6 and Table 12).   
 
Figure 6 - Comparison of ALS CDR with the derived CDR. 
Against this retrospective cohort of patients, both the BLS and ALS CDRs result in 
fewer unexpected survivors (3 and 2 survivors respectively). However, this is at the 
cost of increased transport rates (63.1% and 90.2% respectively), which reduced the 
sensitivity of the tests from 53.1% to 41.2% and 11.0% respectively. When plotted on 
a ROC space (sensitivity vs (1 − specificity) plot) (Figure 7), the TOR CDR clearly 
shows the best predictive power, when compared to either the BLS CDR or the ALS 
CDR (The closer a result is to the upper left corner, the better it predicts, and the 
distance from the random guess line indicates how much predictive power a method 
has).  
 
   112 
 
 TOR CDR BLS CDR ALS CDR 
Specificity 99.0% 
(95%CI: 97.7% to 99.7%) 
99.4%  
(95% CI: 98.1% to 99.8%) 
99.6%  
(95% CI: 98.4% to 99.9%) 
Sensitivity 53.1% 
(95% CI: 51.6% to 54.6%) 
41.2%  
(95% CI: 39.8% to 42.7%) 
11.0%  
(95% CI: 10.0% to 11.9%) 
PPV 99.8%  
(95% CI: 99.5% to 99.9%) 
99.8%  
(95% CI: 99.5% to 100%) 
99.6%  
(95% CI: 98.3 to 99.9%) 
NPV 20.3%  
(95% CI: 19.8% to 20.9%) 
16.7%  
(95% CI: 15.4% to 18.1%) 
11.7%  
(95% CI: 10.8% to 12.7%) 
Transport 
rate 
52.4% 63.1% 90.2% 
Table 12 – Characteristics of CDRs 
 
Figure 7 – ROC space comparing three CDRs 
5.10 Unexpected survivors 
Retrospective application of the TOR CDR resulted in 5 unexpected survivors. Of 
these, one was recorded as an 85 year old female, who had an unwitnessed cardiac 
arrest in a public place. The patient is reported to have been in an asystolic cardiac 
arrest, albeit with bystander CPR, for eight minutes until the ambulance arrived. 
         Random guess 
Perfect classification 
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Following 26 minutes of treatment on scene and a further ten minutes transport 
interval to hospital and without being defibrillated at any point, or regaining ROSC, 
she is reported to have been intubated, but cannulation was failed and no 
medications administered. She is reported to have survived to discharge. The 
second was a 64 year old male. He is reported to have had an unwitnessed cardiac 
arrest in a place of residence. He was asystolic and received no bystander CPR, 
though the response interval was only three minutes. This patient was intubated, 
cannulated and received 1mg of adrenaline. He was defibrillated twice and although 
not reported as regaining ROSC for the duration of 22 minutes of treatment on scene 
and 54 minutes transport interval. The third was a 70 year old male. He is reported to 
have had an unwitnessed cardiac arrest in a place of residence.  He received no 
bystander CPR and was in a PEA rhythm on arrival of the first response, which 
arrived three minutes from the time of the call.  He was intubated and cannulated, 
but did not achieve ROSC before transport. He is reported to have survived to 
discharge. The fourth was a 20 year old female. She is reported to have had an 
unwitnessed cardiac arrest in a place of residence. There was bystander CPR and      
she was in asystole on arrival of the first response after three minutes. She was 
intubated and cannulated and received adrenaline as part of ALS protocol. She was 
also reported to have been defibrillated three times. She is reported not to have 
achieved ROSC before transport. She was treated on scene for 27 minutes and the 
transport interval was 16 minutes. The last unexpected survivor was an 89 year old 
male. He is reported to have had an unwitnessed cardiac arrest in a place of 
residence. There was no bystander CPR and his presenting rhythm was PEA on 
arrival of the first response after one minute. He was cannulated and administered 
adrenaline, but the intubation attempt is reported to have failed. He was treated on 
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scene for 31 minutes and the transport interval was eight minutes. He did not 
achieve ROSC at any point during this interval, but reportedly survived to discharge. 
Of these unexpected survivors, 3 (60%) were male. The mean age was 67.57 (sd 
27.25). The mean response interval was 3.2 minutes (sd 2.95), ambulance interval 
9.4 minutes (sd 2.97), on scene interval 30.4 minutes (sd 9.29), and transport 
interval 17 minutes (sd 20.92). None were witnessed arrests (either by bystander or 
crew). Two (40%) received bystander CPR. Two (40%) were in an initial PEA rhythm 
and three (60%) were in asystolic rhythms. Two (40%) received defibrillation at some 
point during the resuscitation. None of the survivors were witnessed arrests. Whilst 
the BLS CDR excludes from termination those patients with crew-witnessed arrests 
and the ALS CDR also excludes those with bystander-witnessed arrests, the 
decision was made not to include witnessed arrest as part of the CDR, for the 
reasons discussed earlier.  The exclusion of this variable from the CDR did not result 
in unexpected survivors. Although two unexpected survivors received bystander 
CPR, to include this as a variable requiring transport would have resulted in marginal 
improvement to specificity (99.4%; 95% CI: 98.3% to 99.9%), it would have reduced 
sensitivity (22.5%; 95% CI: 21.3% to 23.8%). Moreover would have increased the 
transport rate from 52.4% to 79.9%. Similarly, both the BLS and ALS CDRs included 
defibrillation at any point during the arrest as a variable requiring transport. To 
include this would have captured two of the unexpected survivors. However, this 
would also have resulted in a marginal improvement to specificity (99.4%; 95% CI: 
98.3% to 99.9%), it would have reduced sensitivity (46.3%; 95% CI: 44.8% to 47.8%) 
and resulted in another 305 patients being transported to hospital, increasing the 
transport rate to 58.6%.  
   115 
 
The data gained from these unexpected survivors did not therefore suggest that the 
derived CDR should be adjusted before further validation. However, the details of 
each of these events did raise an element of doubt about the veracity of the original 
dataset. On the face of it, it does appear improbable that some, if not all of these 
unexpected survivors actually survived to discharge, if the data surrounding the 
conditions of their cardiac arrests are correct. For example, the second unexpected 
survivor appears to have survived an unwitnessed OHCA despite being found in an 
asystolic rhythm, receiving no bystander CPR, and not achieving ROSC for the full 
66 minutes of the event. Although this is a possibility, it does appear unlikely on the 
face of it. However, due to the ethical restrictions on accessing anything other than 
the original dataset, it could not be ascertained whether there had been a clerical 
error in determining survival, whether the surrounding circumstances were annotated 
incorrectly, or whether this was, in fact, an unexpected survival. In the interests of 
transparency, this and the other cases were retained in the dataset.  
5.11 Strengths and limitations 
This phase of the study was able to consider 4870 consecutive OHCA incidents, 
which is a large number of incidents, all of which were collected independently. 
Nevertheless, there are several limitations to this study, which must be mentioned. 
Firstly, our study utilised a register of OHCA, maintained by the Trust, and collected 
by auditors from data presented by crews on PRFs. This team are highly trained as 
auditors and there are systems in place to corroborate evidence if required, which 
include the information from ambulance control centres and reviews of local press 
reports. However, the auditors are non-clinicians and so there is the potential that 
interpretation may be lost in the audit process. Also, whilst using this register 
ensures a high degree of external validity, it does mean that the study was 
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observational by nature. Because the database was examined through a secondary 
analysis of the TOR CDR rather than prospectively, data integrity and validity are 
potential limitations. This has been highlighted in the previous section. Furthermore, 
this database was a ‘convenience sample’, in that the data was not collected for the 
purposes of determining futility of resuscitation attempts. The dangers of using such 
‘convenience samples’ were highlighted by Harrell and include the following: study 
subjects may not be representative of the population; important predictors may not 
have been collected; key variables may not be present for large numbers of subjects 
183. That the dataset collected all resuscitation attempts performed by Trust clinicians 
over the given period negates the first point, but the second element is of note. 
However, the comprehensive nature of the data gathered, due its inclusion in 
national reporting, make that unlikely. The final point does need to be emphasised, 
nevertheless.  As a case-control study, this study suffered from a limitation common 
to all such studies: missing data could not be retrieved retrospectively. Several of the 
receiving hospitals in the Trust’s locality did not share data on survival, and a further 
72 (1.5%) of cases did not record either initial cardiac rhythm or ROSC, so were 
excluded from the study. The ROSC variable used in this study includes the 
occurrence of ROSC at arrival in the emergency department as well as in the pre-
hospital setting, and it was not possible to distinguish momentary ROSC events and 
those which persisted for longer intervals. This may inflate the accuracy of the CDR, 
which should include only ROSC which persists long enough for a decision to be 
made to transport the patient.  
During the analysis of data, no account was taken of the qualifications of the crew(s) 
involved with each cardiac arrest. As technician crews cannot terminate 
resuscitations under the present TOR guidelines, there is the potential that 
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resuscitations deemed futile under the present guidelines were transported to 
hospital, as the efforts were not permitted to be terminated on scene. This may have 
exaggerated the effect of the CDR being derived, as these patients would not have 
been included, had the efforts been terminated by Paramedics on scene under 
existing guidelines. It is of note, however, that none of the five CDR-positive 
survivors were attended by technician crews. The retrospective nature of the study 
failed to determine whether Paramedics in the field would be able to apply the rule 
correctly. However, as Paramedics within the Trust have been successfully applying 
a different TOR decision rule for over ten years, and regularly follow clinical decision 
rules relating to other conditions, this is not considered to be prohibitive. Also, the 
study was limited to a single ambulance Trust. Although, as a large Trust, covering 
both densely urban and sparsely rural areas, the population is not heterogeneous; 
any results may not be transferable to other localities and emergency systems. 
It should also be mentioned at this stage that whilst the derived TOR CDR appears 
be worthy of further study, advances in resuscitation science and post-resuscitation 
care could quickly invalidate any specific decision rule 114. As noted previously, there 
is some potential that measuring ETCO2 may prove a useful predictor for futility. 
However, the data collected for this study did not include ETCO2, so could not 
assessed as a variable. 
Having derived the TOR CDR it was important that the rule was also validated. The 
following chapter discuss the validation of the rule against a separate retrospectively 
collected dataset. 
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6. Chapter six - Retrospective validation (Phase 2) 
In the previous chapter a TOR CDR was derived, which appeared to show that it was 
possible to determine the futility of transporting an adult suffering an OHCA of 
cardiac aetiology to hospital if the patient did not present initially with a VF/pVT 
arrest and did not achieve ROSC on scene. This chapter aims to provide initial 
validation of the rule by applying it to a second cohort of patients, from a 
retrospectively collected dataset. Both the BLS and ALS CDRs will also be applied to 
the cohort to compare the results. Application of the rule to a retrospective cohort will 
provide assurance at  level 4 in the validation hierarchy, meaning that it is validated, 
but not to the extent that it is clinically applicable at this stage 141. It was decided that 
rather than moving directly to a prospective validation, which would be time-
consuming and require a lot of organisational coordination, it was important to 
ensure that the CDR was first tested against a second data set of OHCA patients, 
and in particular to compare it with the other CDRS in terms of identifying futile 
transportation. Any adjustments to the CDR that this may highlight could then be 
made before the prospective validation process was undertaken in a subsequent 
phase. 
6.1 Study design  
Phase 2 was a retrospective cohort study. It was conducted in order to validate the 
TOR CDR established in phase 1 against an independent data set of patients and to 
compare the results with the application of existing CDRs. The TOR CDR sought to 
find those variables that could be used to identify futile resuscitation attempts 
amongst adult patients currently transported to hospital with continuing resuscitation. 
As for phase 1, this phase included all patients aged 18 years of age or older who 
were treated for an OHCA of suspected cardiac aetiology and who were 
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subsequently transported to hospital. Patients were enrolled between 1 April, 2014, 
and 31 March 2015.  
6.2 Study setting and population 
As for phase 1, this phase of the study was a multi-centre design, using data from 
the Trust that covers a population of over seven million people, and which attends 
over one million emergencies per year.  The study population was made up of 
consecutively enrolled adult patients who were treated for OHCA by the Trust’s 
clinicians (Paramedics and technicians) between 1 April 2014 and 31 March 2015. 
These data were collected as in phase 1 by the Trust Governance Department’s 
trained auditors from PRFs completed by clinicians during or immediately after each 
patient contact, as well as survival outcomes from hospital records. Patients were 
excluded from the phase 2 if they were under 18 years old; if no resuscitation was 
attempted (i.e. death was diagnosed before resuscitation was attempted);  if the 
arrest was not presumed to have been of cardiac origin (i.e. their arrest was due to 
trauma, drowning, drug overdose, or other non-cardiac cause); if the resuscitation 
attempt was terminated under current TOR rules (i.e. asystole after 20 minutes of 
Advanced Life Support (ALS)); or if their outcome was unknown (Some hospitals did 
not provide follow up data). 
Data for each resuscitation event included all elements gathered at phase 1: patient 
age and gender; response interval; ambulance interval; treatment interval; transport 
interval; presence of witnesses to the arrest (bystander or ambulance crew); 
presenting cardiac rhythm; presence of bystander CPR; whether defibrillation was 
attempted at any point during the resuscitation attempt; and presence of ROSC. 
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6.3 Outcome measures 
The primary outcome measure was survival to hospital discharge. The aim was to 
determine whether the TOR CDR could accurately predict those patients who would 
not survive to discharge, and how it compared to existing CDRs in the identification 
of futile transportation. The TOR CDR, established in phase 1 recommends 
termination of resuscitation where the initial presenting rhythm is not shockable (i.e. 
is PEA/asystole), and where there is no ROSC before transport to hospital. 
 The test characteristics for each of the three CDRs included in this phase were 
sensitivity, specificity, and positive and negative predictive values.  Ideally a CDR 
would recommend termination for all those patients who will not survive to hospital 
discharge, as the aim of the CDR is to reduce futile transportation. As such the 
sensitivity of the rule (the probability that the CDR will recommend termination when 
transport is futile) is an important characteristic. This will indicate how effective the 
rule is at reducing the number of futile transportations. To support it, the 
transportation rates were also determined. These were based on the number of 
patients that the CDR recommended for transport to ED. Survival amongst the group 
was also calculated. It is also important that any CDR should not recommend TOR if 
there was a potential for the patient to survive. The specificity of the rule (the 
probability that the CDR will recommend transport when the patient survived) and 
the positive predictive value (the probability that the patient would die if the rule 
recommends TOR) were the key test characteristics to assess this.  
6.4 Statistical analysis 
The Statistical analysis was performed using SPSS for Windows (SPSS ver. 22, 
Chicago, IL). For the purposes of analysing the data, death was considered as the 
positive outcome.  
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6.5 Results 
Between 1 April 2014 and 31 March 2015, a total of 3920 OHCAs were attended by 
ambulance crews in the Trust. The disposition of these patients is shown in figure 8.  
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Figure 8 – Retrospective validation - Disposition of cardiac arrest patients 
 
Of the 3920 patients, 93 (2.4%) were excluded as they were under 18 years of age. 
Of the remainder, 653 (17.1%) cardiac arrests were not of cardiac origin (123 
trauma; 8 submersion; 373 respiratory; 40 asphyxiation; 40 hanging; 67 drug 
overdose; and 2 unknown). Another 748 (19.5%) were terminated under the existing 
Trust TOR guidelines; and 287 (7.5%) had no data available on survival outcomes. 
Therefore a total of 2139 patients met the inclusion criteria for the study. The mean 
age for the patient group was 69.6 (sd 15.7) years, with the youngest being 18 years 
and the oldest 102 years. 1373 (64.2%) were male.  The mean response interval for 
Total Cardiac Arrest Cases 
3920 
 
Under 18 years old 
93 
Excluded 
1781 
Included 
2139 
Shockable Rhythm 
704 
Non-Shockable Rhythm 
1383 
Missing 
25 
 
 
Non Cardiac Aetiology 
653 
No ROSC 
1132 
ROSC 
1007 
Terminated on Scene 
748 
No Follow Up 
287 DIED 
1784 
SURVIVED 
331 
   122 
 
the first response (Community first responder, rapid response vehicle, or ambulance) 
was 8 minutes 8 seconds (sd 7:02). The mean on-scene interval was 38 minutes 27 
seconds minutes (sd 14:32) and the mean transport interval from the scene to 
hospital was 10 minutes 34 seconds (sd 11:04). 
Characteristic Present % of total 
Shockable rhythm 704  32.9% 
Non-shockable rhythm 1383  67.3% 
ROSC 1007  47.1% 
No ROSC 1132  52.9% 
Survival to discharge 331 15.4% 
Table 13 – Selected characteristics of cardiac arrests included in the phase 2 
 
Table 13 shows the relevant characteristics of all patients included in this phase of 
the study. Of 2139 patients, who met the inclusion criteria for the study, 704 (32.9%) 
presented with an initial shockable rhythm; 665 (31.1%) presented with asystole; 700 
(32.7%)  presented in PEA; 2 (1.4%) were reported as bradycardic; 16 (0.7%) were 
recorded as ‘other’; and 25 (1.2%) had missing data. 1007 (47.1%) achieved ROSC 
at some point and 1132 (52.9%) did not. 331 (15.4%) patients survived to hospital 
discharge (233 (10.9%) with unknown neurological deficit, 5 (0.2%) with known 
neurologic deficit, and 93 (4.3%) with no neurologic deficit). 1808 (84.5%) died in 
hospital (1560 (72.9%) died within 24 hours, and 248 (11.6%) died after 24 hours). 
The TOR CDR derived in phase 1 recommended termination for 832 (38.9%) and 
transportation for 1283 (60.0%) of the patients currently transported in Phase 2. 24 
(1.1%) could not be classified due to missing data. Of the 832 patients that the TOR 
CDR recommended termination, 3 (0.4%) survived to hospital discharge. The 
remaining 328 survivors were recommended for transport (Figure 9). 
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Figure 9 - Retrospective validation – Results 
Observed 
TOR CDR 
Transport Terminate 
Died 
% within CDR 
% within total  
955 
74.4% 
45.2% 
829 
99.6% 
39.2% 
Survived 
% within CDR 
% within total 
328 
25.6% 
15.5% 
3 
0.4% 
0.1% 
Total 1283 832 
 
Table 14 - Retrospective validation – Table of results 
Table 14 shows the results of applying the TOR CDR in phase 2. The TOR CDR 
recommended termination for 829 (46.5%) of the 1784 patients who died (sensitivity 
= 46.5%; 95% CI: 44.1% to 48.8%). Of the 832 patients for whom the TOR CDR 
recommended termination, 829 (99.6%) died and three (0.4%) survived. This 
represents a positive predictive value of 99.6% (95%CI; 99.0% to 99.9%) and 
specificity of 99.1% (95% CI:  97.4% to 99.8%). Transportation was recommended 
Adult, Primary Cardiac Arrest Cases 
2139 
Shockable rhythm 
704 
ROSC 
1007 
No presenting shockable or ROSC 
832 
Transported to hospital 
1283 
Survived to discharge 
328 
Survived to discharge 
3 
Transported to hospital 
832 
Not recorded 
70 
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for 1283 (60.7%) patients. Of these 328 survived. This results in a negative 
predictive value of 25.6% (95%CI; 23.2% to 28.1 %). The transportation rate using 
the TOR CDR was 60.7%. 
6.6 Comparison with other CDRs 
As with the derivation of the CDR in phase 1, the existing BLS and ALS CDRs were 
applied to the data to compare results. Applying the BLS TOR to the dataset resulted 
in 1557 patients being recommended for transport, of whom 331 (21.3%) survived. 
582 (27.1%) patients were recommended for termination, and all of these survived. 
This equates to a specificity of 100% (95% CI: 98.9% to 100%), a positive predictive 
value of 100% (95% CI: 99.3% to 100%), sensitivity of 24.4% (95% CI: 22.6% to 
26.1%) and a negative predictive value of 15.5% (95% CI: 14.0% to 17.1%). This 
would have resulted in a transport rate of 72.8%. 
Applying the ALS TOR criteria to the dataset resulted in 102 (4.8%) patients 
recommended for termination; with none of these surviving. 2026 (95.2%) patients 
were recommended for transport. Of these 331 (16.3%) survived. This equates to a 
specificity of 100% (95% CI: 98.6% to 100%); a positive predictive value of 100% 
(95% CI: 95.5% to 100%); sensitivity of 4.7% (95% CI: 3.9% to 5.8%); and a 
negative predictive value of 14.0% (95% CI: 12.7% to 15.5%). The transport rate, 
when applying this CDR is 95.2%. 
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 TOR CDR BLS CDR ALS CDR 
Specificity 99.1%  
(95% CI: 97.4% to 99.8%) 
100%  
(95% CI: 98.9% to 100%) 
100%  
(95% CI: 98.6% to 100%) 
Sensitivity 46.5% 
(95% CI: 44.1% to 48.8%) 
24.4%  
(95% CI: 22.6% to 26.1%) 
4.7%  
(95% CI: 3.9% to 5.8%) 
PPV 99.6%  
(95%CI; 99.0% to 99.9%) 
100%  
(95% CI: 99.3% to 100%) 
100%  
(95% CI: 95.5% to 100%) 
NPV 25.6%  
(95%CI; 23.2% to 28.1 %) 
15.5%  
(95% CI: 14.0% to 17.1%) 
14.0%  
(95% CI: 12.7% to 15.5%) 
Transport 
rate 
60.7% 72.8% 95.2% 
Table 15 – Characteristics of CDRs in phase 2 
6.7 Discussion 
There were fewer patients in this phase of the study, when compared to the previous 
phase (2139 vs 4870). However the mean ages were broadly comparable (69.6 (sd 
15.7) vs 71.5 (sd 15.1)), as was the percentage of male patients (64.2% vs 62.3%). 
A Mann-Whitney U test was run to determine if there were differences in median 
response intervals, on scene intervals and transport intervals between the validation 
and derivation studies. Distributions of all intervals between the datasets were 
similar, as assessed by visual inspection. All intervals were found to be statistically 
significantly higher in the validation dataset than in the derivation dataset (p < .001). 
Despite these increased intervals, proportionately more patients survived in this 
phase of the study (15.5%), than the previous (10.6%) Again this is statistically 
significant (p < .001).  However, proportionately more presented with an initial 
shockable rhythm (32.9% vs 28.4%; p< .001), which may account for some of the 
increased survival. Also, whereas 36.3% achieved ROSC in the derivation phase, 
this increased to 47.1% during this phase (p < .001). That the Trust saw an increase 
in ROSC during the validation period is not unexpected. Mandatory training for all 
staff during that period included a session on effective compressions and a 
procedure was introduced whereby at least four responders, including where 
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possible a senior clinical lead, were sent to all OHCA incidents. Both these 
procedures were aimed at improving OHCA outcomes, though whether they had a 
direct influence on the increase in ROSC cannot be confirmed. Nevertheless, with 
increased numbers of ROSC, and increased incidence of initial VF/pVT, it is not 
surprising that the transport rate increased during this stage of the study from 52.5% 
to 60.7%. Despite this increase in transport rate, the percentage of unexpected 
survivors increased from 0.2% to 0.4%, resulting in a reduced PPV of 99.6% from 
99.8% and specificity of 99.1% from 99.8%.  
Following discussions from phase 1, it was considered whether the presence of 
ROSC would in and of itself be a good indicator of survival, and if so, whether the 
lack of ROSC could be used as an indicator of futility. However, in this sample the 12 
patients survived despite no presence of ROSC. This equates to 1.1% of the total 
number without ROSC (n = 1132), which is outside the acceptable limits for futility, 
as discussed earlier. This confirmed the inclusion of presenting shockable rhythm as 
an essential element of the TOR CDR at this stage. 
The TOR CDR compared favourably with the pre-existing CDRs. Applying the BLS 
and ALS CDRs to this patient cohort demonstrated both increased transport rates 
(+12.1% for the BLS CDR and +34.5% for the ALS CDR). As part of our second 
objective was to reduce the number of futile transportations to hospital, the sensitivity 
of each CDR is of particular importance. The TOR CDR was able to identify more 
futile resuscitations than either of the other CDRs (829 vs 582 and 102 respectively), 
which would result in fewer unnecessary transports. Neither the BLS or ALS CDRs 
had any unexpected survivors, but this was at the expense of identifying far fewer 
futile transports (331 (21.3%) and 102 (4.8%) vs 829 (46.5%)).It was not an 
expectation that the TOR CDR would result in all potential survivors being identified, 
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which is why the limits of futility were agreed as 1% and not zero. The aim was to 
reduce, as far as practicable, the number of futile transports, whilst remaining within 
the 1% definition of futility for unexpected survivors. In this retrospective cohort, the 
CDR achieves this, and does so with a lower transportation rate than either the BLS 
or ALS CDRs. 
When plotted on a ROC space (sensitivity vs (1 − specificity) plot) (Figure 10), the 
TOR CDR clearly shows the best predictive power, when compared to either the 
BLS CDR or the ALS CDR 
 
Figure 10 – ROC space comparing three CDRs 
6.8 Unexpected survivors 
Application of the TOR CDR resulted in three unexpected survivors. The first was a 
43 year old male, who had a bystander witnessed cardiac arrest in a public place. He 
received no bystander CPR and the first response on scene arrived one minute from 
Perfect classification 
BLS CDR 
         Random guess 
ALS CDR 
TOR CDR 
   128 
 
the collapse. The treatment interval was 17 minutes and the travel interval was 16 
minutes. The first monitored rhythm was asystole, though he did receive one shock 
from a defibrillator, suggesting that at some point he was in a VF/pVT rhythm. The 
patient was treated with a supraglotic airway and although cannulation was 
successful, it is recorded that he received no adrenaline. This is inconsistent with 
guidelines for a patient in cardiac arrest, but the data collected does not explain why 
this should be the case. 
The second patient was a 64 year old male. The call to scene interval for this patient 
was nine minutes, the on scene interval was 57 minutes and the travel interval was 
seven minutes. This patient suffered an unwitnessed cardiac arrest at home. 
Bystander CPR was performed. The patient is reported to be asystolic on arrival of 
the ambulance crew. He received endotracheal intubation, intravenous access and 
adrenaline. He was defibrillated three times, the first being reported as 26 minutes 
after the ambulance arrived on scene, but was reported not to gain ROSC on scene. 
The final unexpected survivor was a 63 year old female, who suffered a crew-
witnessed cardiac arrest in the ambulance. The presenting rhythm was PEA. The 
patient was intubated and cannulated. She received adrenaline, but was not 
defibrillated at any point.  The data for this patient records the cause of arrest as 
presumed cardiac. However there are notes attached to ‘presenting complaint’ that 
say “fitting/cardiac arrest”. No other details of this patient are available. 
In the light of these unexpected survivors it was considered whether other variables 
should be added into the TOR CDR. In particular was considered the inclusion of 
crew-witnessed arrests, as this is included in the BLS CDR and had a significant 
association with outcome in the original model. However, whilst inclusion of this 
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variable would have reduced the number of unexpected survivors in this cohort to 
two, it would also increase the number futile transports from 955 (53.5%) to 1105 
(77.1%), taking into account missing data. The resulting CDR would equate to a 
specificity of 99.4% (95% CI: 97.8% to 99.9%); a positive predictive value of 99.7% 
(95% CI: 98.9% to 99.9%); sensitivity of 38.6% (95% CI: 36.4% to 40.9%); and a 
negative predictive value of 22.9% (95% CI: 22.3% to 23.6%). After consideration it 
was decided that the impact on transport rates did not justify the inclusion of this 
variable into the CDR. 
The inclusion of bystander witnessed arrests and defibrillation were also considered 
for inclusion in the CDR. Neither of these variables were significant in the original 
model, but were considered here for the purposes of transparency. Like the crew-
witnessed variable, the bystander-witnessed variable would have reduced the 
unexpected survivors to two in this cohort of patients. However, this would have 
been at the cost of 1674 transports (391 more than the TOR CDR). This equates to a 
specificity of 99.4% (95% CI: 97.8% to 99.9%); a positive predictive value of 99.6% 
(95% CI: 98.4% to 100%); sensitivity of 24.6% (95% CI: 22.6% to 26.7%); and a 
negative predictive value of 19.7% (95% CI: 17.8% to 21.6%). The transport rate, 
when adding this variable to the CDR is 79.1%. The inclusion of defibrillation at any 
time would have reduced the number of unexpected survivors in this cohort to one. 
As before, this is at the expense of increased transportation and equates to a 
specificity of 99.7% (95% CI: 98.3% to 100%); a positive predictive value of 99.9% 
(95% CI: 98.3% to 100%); sensitivity of 38.5% (95% CI: 36.3% to 40.8%); and a 
negative predictive value of 23.1% (95% CI: 20.9% to 25.4%). The transport rate, 
when applying this to the CDR is 67.5%. Although this variable appeared to be the 
most favourable to add to the CDR at this stage, in phase 1 of this study defibrillation 
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did not show a strong association with outcome (OR = 1.231; 95% CI: 0.754% to 
2.010%). Therefore it was decided not to add it to the CDR at this stage. 
6.9 Strengths and limitations 
It is important to validate any predictive model before it is implemented 145. By 
evaluating the performance of the CDR against this separate cohort of patients, it 
was shown that the CDR was not data-dependant at phase 1, and that it works 
satisfactorily for patients other than those from whose data it was derived. 
Nevertheless, this phase of the study, like the previous, used a pre-existing dataset 
compiled by Trust auditors. As such, it suffers from many of the limitations described 
for phase 1 of this thesis. It retains a high degree of external validity, as the data was 
collected independently of the investigators, but data integrity and validity are 
potential limitations. This was highlighted when the data concerning the three 
unexpected survivors were reviewed. There were some inconsistencies with the 
reported information, such as the lack of administration of adrenaline for the first 
patient, despite apparent ongoing resuscitation efforts. This in itself suggests that 
ROSC was achieved; negating the need for adrenaline, but this is not evident in the 
information available to this study. Similarly, there were potential inconsistencies in 
the recording of the cause of the cardiac arrest for the third patient, as discussed 
earlier.  
As with phase 1, the data was provided as a single dataset and missing data could 
not be retrieved retrospectively. As a result there was relevant data was missing for 
70 patients, who could not therefore be designated as either termination or transport 
under the rules of the TOR CDR, so were excluded from the final results.  
The most fundamental limitation of this phase was that it was retrospective in nature, 
so failed to determine whether Paramedics in the field would be able to apply the 
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rule correctly. As noted previously, this was accepted before phase 2 was started, 
but was seen as a necessary step before a prospective cohort study was undertaken 
in phase 3. 
Having now completed the retrospective validation and confirmed that the TOR CDR 
retained its validity on an independent data set of patients, the next chapter reports 
on the subsequent prospective validation of the rule. 
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7. Chapter Seven - Prospective validation (Phase 3) 
7.1 Study design 
Previous chapters have discussed the derivation and subsequent retrospective 
validation of a TOR CDR. Phase 3 took the form of a prospective cohort study and 
was conducted to validate the same CDR. This was seen as an essential step to 
take in the validation process. As Altman and Royston have noted, the reason for 
validating a prognostic model is to establish that the model works acceptably for 
patients other than those from whose data the model was derived 145. This was 
achieved in phase 2. However, they go on to make the distinction between 
statistically validated and clinically validated models. This is akin to the categories 
defined by McGinn Guyatt, Wyer et al and discussed earlier that require at least one 
prospective validation study and a change in clinical behaviour in order for a CDR to 
be considered a level 1 validation.  As Burstein noted, “Any classification system… 
should be proved to be a workable tool before it is used in a discriminatory or 
predictive manner” 201. During this phase of the study the TOR CDR could not be 
used as a tool to decide patient outcomes, but rather it was intended to show that 
ambulance clinicians were able to apply it prospectively, and that it was able to 
predict patient outcome satisfactorily.  
Before the start of the study, all Paramedics and EMTs within the Trust were 
informed of the prediction rule via emails and Trust bulletins. During the course of 
the study reminders were published in the Trust’s clinical newsletter (CLEAR Vision) 
and via the Trust’s in-house social network site. Also emails were sent to all the 
Trust’s Advanced and Senior Paramedics (clinical leads) informing them of the study 
and requesting them to highlight the study to clinicians, encourage completion of the 
data collection forms and to collect completed forms and forward them to the 
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investigator. Twenty volunteers were also recruited throughout the Trust. They were 
tasked with ensuring that clinicians continued to complete the data collection forms 
throughout the study period. In order to ensure availability, electronic data collection 
forms were emailed to staff and paper copies were also left on ambulance stations.  
7.2 Study setting and population 
Before the study was initiated, the location of the study was considered. Three 
options were reviewed. The first was to limit the study to a small selection of 
clinicians within the Trust. The Trust has a cadre of Senior and Advanced 
Paramedics, numbering approximately 250 clinicians. Limiting the study to this 
cohort would ensure increased compliance with completing the CDR. However, 
whilst the Trust endeavours to send a clinical lead to each OHCA, this cannot be 
guaranteed. This would result in a limited number of OHCAs attended and could 
result in low study numbers. The second option was to limit the study to a single area 
of the Trust. Again, this would ensure maximum data capture within the selected 
area, as the investigator would have had a smaller area on which to concentrate 
their efforts for data capture. However, with the relatively low number of OHCA within 
the Trust, it was determined that to limit the area would require the study to run for a 
longer interval, which was prohibited by the timescales of this thesis. This method 
could also introduce limitations to the generalisability of the study, in that it would 
contain results from only a small population, with a limited number of receiving 
hospitals. The final option was to include all clinicians within the Trust, and aim to 
capture a greater number of OHCA, over a shorter interval. This method would 
create results that could be generalised across the Trust. However, it increased the 
risk that data would be lost, due to the investigator having to gather data from a 
much wider area, and including greater numbers of clinicians. Nevertheless, it was 
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decided to continue with this method in order to gather the most data in the time 
frame available. The risk of lost data was mitigated by the use of regular information 
being passed to clinicians and the use of champions throughout the Trust to ensure 
maximum data capture.  
Next, it was necessary to determine the minimum number of OHCA required to 
provide statistical power to prove the CDR. A balance needed to be established 
between obtaining enough data and the efforts required to collect the data from 
across a large geographical area, whilst maintaining clinicians’ reliability in 
completing the data collection forms. To establish a minimum number, a sample size 
calculator that assesses a  dichotomous endpoint for two independent sample study 
was utilised 202. To do this the CDR was equated to a treatment, with survival as the 
primary endpoint. The previous phases showed a survival rate of 10.6% and 15.5%. 
The mean of these (13.1%) was taken as the incidence of expected survival within 
the transport group. Survivors within the termination groups were 0.2% and 0.4% for 
the previous phases. Again the mean of these (0.3%) was taken to represent the 
expected incidence of survivors within the termination group. An alpha of 0.05 was 
used. This represents the probability of a type-I error, or finding a difference when a 
difference does not exist. Using 0.05 indicates a 5% chance that a significant 
difference is actually due to chance and is not a true difference. A beta value 
represents the probability of a type-II error, which occurs when it is believed there is 
no effect, when in reality there is.  It has been suggested that the maximum 
acceptable probability of a type-II error should be 0.2 (or 20%) 185. This means that in 
a population of 100 in which an effect does exist, that effect would be missed in 20 
cases (i.e. 1 in 5 genuine effects would be missed). In order to reduce that 
possibility, a beta value of 0.1% was used here. Beta is directly related to study 
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power (Power = 1 - Beta). Using a beta cut-off of 10% (0.1) indicates a 10% chance 
that a significant difference is missed. Applying these figures meant that a minimum 
sample size of 78 was required in each group. The previous phases of this study 
suggested a mean of 182 suitable OHCA per month. With approximately 13.1% 
survival, this equates to approximately 23 survivors per month. Therefore it was 
concluded that 3.4 months of data were required to ensure 78 survivors. However, 
as there was a risk of lost data, it was decided that a five month period of data 
collection would be used. 
The study population was made up of adult patients (persons 18 years of age or 
older) who were treated for an out-of-hospital cardiac arrest, which was of presumed 
cardiac cause between August 2015, and December 2015 in the geographical area 
of the Trust. The Trust had a policy in place at the time of the study that aimed to 
ensure at least four rescue personnel were mobilised to each resuscitation event. At 
least one of these should be an ALS provider. Ideally, at least one should also be a 
clinical lead. All patients who were under 18 years of age and any who were thought 
to be pregnant were excluded, as well as those patients who had an arrest 
presumed to be of non-cardiac origin (e.g., trauma or asphyxia). Pre-hospital care 
was documented with the use of a standard PRF used by ambulance personnel 
throughout the Trust. 
All statistical analysis was performed with SPSS for Windows (SPSS ver. 22, 
Chicago, IL). The TOR CDR was evaluated as a diagnostic test, and test 
characteristics were calculated. The test characteristics included sensitivity, 
specificity, as well as positive and negative predictive values. An ideal test would 
recommend termination for all patients who did not subsequently survive to hospital 
discharge. The sensitivity of the rule would indicate how well the CDR recognised 
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these futile attempts. Additionally, the PPV of the test will show how likely it is at a 
patient will not survive, when the CDR recommends termination. In addition to this, 
the CDR should not recommend termination if the patient could potentially survive 
OHCA. This is indicated by the specificity of the rule.  The NPV will determine how 
likely it is that a patient will survive when the decision rule recommends transport.  
Finally, the transport rate was determined, as this has particular relevance for 
ambulance operations, as it gives an indication of the impact on ambulance 
resources of implementing the CDR.  
7.3 Study protocol 
Data collection forms were made available to all NWAS clinicians, both in paper and 
electronic format. Each form included all relevant elements of the CDR in the form of 
a flow chart and tables, and a final section that indicated either ‘termination’ or 
‘transport’ (Appendix 6). Both the preceding literature and the form itself highlighted 
that the information was for study purposes only and should not affect any decisions 
relating to the patient’s ongoing care or transport, which would be decided on 
existing Trust guidance and policy. Following any OHCA, where the patient was 
transported to hospital, the ambulance clinicians were asked to complete one of 
these forms. Patients were subsequently categorised by the attending clinician 
according to the recommendations of the CDR (termination or transport). For 
patients who did not achieve ROSC before they were transported to the hospital, and 
whose initial presenting rhythm was non-shockable (PEA / Asystole), the rule 
recommended the termination of resuscitation. For patients who did have ROSC 
before transport was initiated, or who presented initially with a shockable rhythm (VF/ 
pVT), the prediction rule recommended transport. Data were identified by date and 
incident number only. No patient identifiable information was collected or recorded at 
   137 
 
any point in the study, in accordance with the requirements of ethical approval for the 
project. Because of the clinical setting and that the patients in this study were 
suffering an OHCA, the standard requirement of written informed consent by patients 
was waived. However, all clinicians were made aware that they were under no 
obligation to complete the forms for this study. 
The clinical leads and volunteers at each ambulance station reviewed the data 
collection forms for accuracy.  Once checked, the forms were sent via Trust internal 
mail, or scanned and emailed using the Trust’s secure email system, to the 
investigator. The data were then collected using a spread sheet program (Excel 
2010, Microsoft Corp., Redmond, WA) and statistical analyses performed with SPSS 
for Windows (SPSS ver. 22, Chicago, IL). Problems relating to missing data were 
resolved by requesting additional information from the clinical leads at each site, or 
contacting the attending clinicians personally either by telephone or email. Other 
data required for the study was collected by reviewing the anonymised copy of the 
PRFs that were completed for each incident. These copies of the PRF are used for 
audit purposes by the Trust and contain all relevant clinical data, but have all patient 
details obscured. 
7.4 Outcome 
The investigator was able to obtain information on the patients’ outcomes from 
hospitals, via the Trust’s audit team. The data received included the date, incident 
number and patient outcome, including neurologic status if this was known. The data 
was received six to eight weeks after the cardiac arrest event. Not all receiving 
hospitals were willing to share data with the Trust, so the outcomes of some patients 
remained unknown. Outcomes were categorised as: survived to hospital discharge 
(neurological deficit unknown); survived to hospital discharge (with neurological 
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deficit); survived to hospital discharge (no neurological deficit); Died in Hospital (<24 
hrs); Died in Hospital (>24hrs). For the purposes of this study the outcomes were 
analysed as a binary measure of “survived” (the first three outcomes) or “died” (the 
last two outcomes). 
7.5 Results 
Between 1st August 2015 and 31st December 2015, a total of 832 CDR forms were 
received from ambulance clinicians. Of these, 17 (2%) related to patients who were 
less than 18 years old, so were excluded from the study. A further 78 (9.6%) 
recorded OHCA as non-cardiac aetiology, so were also excluded. Of the remaining 
737, there were no outcome results provided by the receiving hospitals for 23 
(3.1%). Of the 656 included patients the mean age was 70.3 years (sd 14.9) and 431 
(65.7%) were male. The mean response time for these incidents was 8 minutes (sd 
16), the mean on scene interval was 40 minutes (sd 16), and the mean travel interval 
was 11 minutes (sd 8).  
Of 656 patients, who met the inclusion criteria for the study, 244 (37.2%) presented 
with an initial shockable rhythm,  425 (64.8%) achieved ROSC. 104 (15.9%) patients 
survived to hospital discharge (75 (11.4%) with unknown neurological deficit, 3 
(0.5%) with known neurologic deficit, and 26 (4%) with no neurologic deficit). 552 
(84.1%) died in hospital (454 (69.2%) died within 24 hours, and 98 (14.9%) died after 
24 hours). 
The TOR CDR recommended termination for 162 (24.7%) and transportation for 494 
(75.3%) of the patients currently transported into hospital. Of the 162 patients that 
the TOR CDR recommended termination, none survived to hospital discharge. All 
104 survivors in this phase of the study were recommended for transport by the 
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CDR. This equates to a positive predictive value of 100% (95%CI; 97.1% to 100%), 
specificity of 100% (95% CI:  95.6% to 100%), a negative predictive value of 21.1% 
(95%CI; 17.6% to 25.0%), and a sensitivity of 29.3% (95% CI: 25.6% to 33.4%). The 
transportation rate indicated during the prospective validation was 75.3%. 
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Figure 11 – Prospective validation - Disposition of cardiac arrest patients 
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Figure 12 - Prospective validation - results 
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Table 16 - Prospective validation – table of results 
  
7.6 Comparison with other CDRs   
In order to determine how he CDR fared when compared with existing CDRs, the 
BLS and ALS CDRs were applied to the data. Applying the BLS TOR to the dataset 
resulted in 570 patients being recommended for transport, 104 (18.2%) of whom 
survived. 85 (13.0%) patients were recommended for termination, and none 
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0 
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survived. This equates to a specificity of 100% (95% CI: 95.6% to 100%), a positive 
predictive value of 100% (95% CI: 94.6% to 100%), sensitivity of 15.4% (95% CI: 
12.6% to 18.8%) and a negative predictive value of 18.2% (95% CI: 15.2% to 
21.7%). This would have resulted in a transport rate of 87.0%. 
Applying the ALS TOR criteria to the dataset resulted in 10 patients recommended 
for termination; with none of these surviving. 645 (98.2%) patients were 
recommended for transport. Of these 104 (16.1%) survived. This equates to a 
specificity of 100% (95% CI: 95.6% to 100%); a positive predictive value of 100% 
(95% CI: 65.5% to 100%); sensitivity of 1.8% (95% CI: 0.9% to 3.4%); and a 
negative predictive value of 16.1% (95% CI: 13.4% to 19.2%). The transport rate, 
when applying this CDR is 98.2%. As in the previous phases of this study, these 
results show that the TOR CDR has the potential to reduce the number of futile 
transportations, when compared to either the BLS or ALS CDRs. 
 TOR CDR BLS CDR ALS CDR 
Specificity 100%  
(95% CI: 95.6% to 100%) 
100%  
(95% CI: 95.6% to 100%) 
100%  
(95% CI: 95.6% to 100%) 
Sensitivity 29.3%  
(95% CI: 25.6% to 33.4%) 
15.4%  
(95% CI: 12.6% to 18.8%) 
1.8%  
(95% CI: 0.9% to 3.4%) 
PPV 100%  
(95%CI; 97.1% to 100%) 
100%  
(95% CI: 94.6% to 100%) 
100%  
(95% CI: 65.5% to 100%) 
NPV 21.1%  
(95%CI; 17.6% to 25.0%) 
18.2%  
(95% CI: 15.2% to 21.7%) 
16.1%  
(95% CI: 13.4% to 19.2%) 
Transport rate 75.3% 87.0% 98.2% 
Table 17 – Characteristics of CDRs in phase 3 
As with previous phases of this study, when plotted on a ROC space (Figure 13), the 
TOR CDR shows the best predictive power, when compared to either the BLS CDR 
or the ALS CDR. 
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Figure 13 – ROC space comparing three CDRs 
7.7 Discussion    
The aim of this phase of the thesis was to validate prospectively the CDR, to ensure 
that ambulance clinicians are able to apply the TOR CDR and identify those patients 
for who transport to hospital is futile. It has already been discussed how the issue of 
TOR in OHCA is complex and requires the balance between the need to achieve 
survival wherever possible against the unnecessary use of limited medical resources 
for transporting patients to hospital who have no chance of survival. Despite the 
potential complexities, any rule aimed at achieving this must be useable by 
ambulance clinicians in the field, where decisions need to be made quickly and with 
limited availability of senior clinical advice. As previously discussed, various TOR 
guidelines for OHCA have been validated and implemented in several Countries 203, 
204, 205. However, these guidelines were produced for different EMS systems and 
models. Whilst current practice within the Trust allows for TOR in very limited 
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circumstances, large numbers of patients are transported to hospital, the majority of 
who do not go on to survive the event. This phase has prospectively validated a TOR 
CDR that can be applied successfully by ambulance clinicians to that subset of 
patients currently required to be transported. It recommends termination for adult 
patients suffering OHCA of presumed cardiac aetiology who neither presented in a 
shockable rhythm nor achieved ROSC before transport. Of the 162 patients for 
whom the prediction rule recommended TOR, none survived to hospital discharge. 
The TOR CDR therefore successfully identified patients with OHCA for who transport 
was ultimately futile. However, the increase in the percentage of reported primary 
shockable rhythms when compared to previous phases (64.8% vs 36.5% and 47.1% 
respectively) as well as an increase in reported ROSC (64.8% vs 36.5% and 47.1% 
respectively) resulted in a higher than expected transport rate (74.6% vs 41.5% and 
60.7% respectively). However, along with the increase in recommended 
transportation, there was also an increase in the proportion of survivors within the 
entire patient group when compared to previous phases (15.9% vs 10.6% and 15.4% 
respectively). The proportion of survivors within those recommended for transport 
increased from the phase 1 figure of  20.3%  to 21.1%,  although this was lower than 
that of phase 2 (25.6%).  
Despite having prospectively validated the TOR CDR during this phase of the study, 
there are some caveats that must be mentioned. Firstly, as part of this study, the 
completion of TOR CDR forms was not mandatory. Forms were completed 
voluntarily by ambulance clinicians. There was an extensive information campaign 
as well as the enrolment of senior clinicians and other advocates to assist with the 
data gathering and the retrieval of missing data. Nevertheless, not all OHCA events 
were captured by this study over the course of the study period. Subsequent audit by 
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the Trust indicates that 1122 OHCA events were transported to hospital during the 
study period, of which 1080 were for patients 18 years of age or over; 935 were of 
presumed cardiac aetiology; and 669 had outcome data available. This equates to 
the capture of 98% of all possible events for this phase. Although this is high, there is 
the possibility that all of the missing events were survivors who fulfilled the TOR 
criteria. This leads to the second caveat, which is one of selection bias. There is the 
possibility that clinicians chose not to complete forms that did not appear to result in 
the perceived ‘correct’ outcome for the patient. The researcher has no evidence that 
this is the case, but is aware that this is a possibility. This may account for the 
previously discussed increase in transportation rate from this phase (74.6%), which 
is markedly higher than those of both the derivation phase (41.5%) and the 
retrospective validation phase (60.7%). As noted before, this increase is due to both 
an increase in the reported number of primary shockable rhythms (37.2% vs 28.4% 
and 32.9% respectively) as well as an increase in reported ROSC (64.8% vs 36.5% 
and 47.1% respectively). It should be noted, however, that the data used for the 
previous phases, as collected by the Trust record “ROSC at any time” and “ROSC at 
hospital”. It was pointed out in Chapter 5 that for the purposes of the derivation and 
retrospective validation phases, these figures were combined, in order to capture all 
patients with ROSC. For this phase of the study the question asked clinicians “Was 
ROSC achieved before transport?” This difference in question may be the cause for 
the variation, though selection bias by individual clinicians cannot be ruled out at this 
stage.   
Finally, there is the possibility that the awareness of this study may have affected the 
actions of clinicians on scene. Ultimately, the decision as to whether or not to 
transport a patient to hospital following OHCA lies with the clinicians on scene. 
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Despite policies, procedures and guidelines that attempt to regulate behaviour, 
compliance with these cannot be guaranteed in all circumstances. Therefore it is 
possible that when clinicians were making decisions at the time of the event, that 
their decisions were affected by CDR, despite the explicit direction on both the data-
gathering documentation and the various awareness media that this should not be 
the case. 
Having identified, and being aware of the potential limitations of this phase of the 
study, further work was done to determine whether the CDR could be improved 
using the prospectively captured data. It was therefore decided first to establish 
whether either primary shockable rhythm or ROSC could have been used alone as a 
CDR for TOR. This phase of the study was not intended for this purpose, but it was 
seen as appropriate, due to the increased incidence of both ROSC and primary 
shockable rhythm within the cohort. Both were therefore independently assessed for 
association with outcome using the Pearson’s chi-square test. There was an 
association between initial shockable rhythm and survival, as expected: χ2(1) = 
96.071. p < .001. However, as a single predictor, this would have resulted in 21 
(5.1%) unexpected survivors. ROSC is considered to have the strongest association 
with survival 112. In this sample, the association was confirmed: χ2(1) = 63.292, p < 
.001. However, as a single predictor, this would have resulted in 1 (0.4%) 
unexpected survival. This is below the previously discussed definition of futility and 
could, in this sample, have been used as a predictor of survival. However, the 
inclusion of initial shockable rhythm improves both the positive predictive value and 
specificity of the CDR in this sample, by capturing that single survivor.  
The increase in initial shockable rhythm and achievement of ROSC may be due 
selection bias, as noted above. However, the increase in ROSC may also be due to 
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the change in operational systems that were discussed in phase 2. During phase 3, 
461 (64.8%) incidents had a minimum of four clinicians on scene during the 
resuscitation attempt. During phase 2, only 22% of incidents were attended by four 
or more clinicians, and whilst crew numbers were not recorded for the majority of 
incidents at phase 1, of the 981 cases where these data were recorded, 134 (13.6%) 
were attended by 4 or more clinicians. The RC(UK) recommend that a minimum of 
four trained staff are required to deliver high quality resuscitation for OHCA4. This 
was examined further by performing a Pearson’s chi-square test to determine 
whether there was a relationship between the number of clinicians and survival. As 
one of the assumptions of the chi-square test is that the expected frequencies should 
be greater than 5, and this assumption was not met in all cases, the numbers were 
combined to include less than four and four or more clinicians. These groups were 
compared against both ROSC and survival, to determine if there is a significant 
association with either outcome. There was a significant association between the 
number of clinicians being four or more, and survival (χ2(1) = 8.964, p = .003). 
However, this appears to represent the fact that based on the odds ratio, fewer than 
four clinicians were 1.9 times more likely to result in survival. Although at first this 
appears counter-intuitive, it is perhaps not unexpected. One would expect patients 
who are more likely to survive an OHCA to achieve ROSC early in the resuscitation 
process. The consensus is that the patient group most likely to survive from an 
OHCA are those patients having a VF arrest, and who are defibrillated early 27. 
Therefore, provided a single response with the ability to defibrillate arrives in a timely 
manner to these patients then, at least in theory, and provided ROSC is achieved, 
further resources may not be required on scene, as the patient is no longer in 
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cardiac arrest. So, it is only in the more difficult arrest scenarios, which have a 
reduced chance of success that extra resources will arrive on scene.   
Similarly, it may be hypothesised that the attendance of a senior clinician at an 
OHCA may improve the chances of survival, as there is the assumption that this 
group of clinicians bring with them some advanced skills, as well as experience and 
improved clinical decision making. However, there was no significant association 
between the attendance of a senior clinician (either a Senior or Advanced 
Paramedic) and ROSC ( χ2(1)  = .252, p =  .616, or survival χ2(1) = .009, p = .923). 
Whether this was due to the selection bias mentioned earlier, or the result of some 
other factor is of interest and worthy of further study. However, it is beyond the scope 
of this thesis to look into this further. 
The purpose of phase 3 was to complete the fourth objective of this thesis. That was, 
to validate prospectively the clinical decision rule, to ensure that ambulance 
clinicians are able to apply the TOR CDR and identify those patients for whom 
transport to hospital is futile. This sample of 656 cases has shown that ambulance 
clinicians are able to apply the TOR CDR and in doing so have identified patients 
who would not benefit from transport to hospital, with a positive predictive value and 
specificity of 100%. However, while this study has successfully validated the TOR 
CDR, it must also be recognised that these conclusions remain valid only as long as 
resuscitation practice and procedures within the Trust and the wider healthcare 
system remain consistent. If radically different procedures or techniques are 
introduced, then the TOR CDR would need to be re-considered against these. 
Although the high-impact initiatives such as quick response and early defibrillation 
are seen as important for improved survival, novel treatments and procedures may 
affect success rates for OHCA in such a way that those patients, for whom continued 
   148 
 
resuscitation is presently considered futile, become potential survivors. In recent 
years, for example, it was thought that that therapeutic hypothermia may have been 
such a treatment 206,207. Although subsequent work has suggested that this is not the 
silver bullet resuscitation practitioners have been looking for, the use of targeted 
temperature management has become part of the recommended treatment for post 
cardiac arrest patients 27. Also, procedures such as percutaneous coronary 
intervention and extracorporal membrane oxygenation during cardiac arrest may see 
positive results 208. The latter is a technique whereby blood is diverted from the heart 
and artificially oxygenated outside of the body, allowing for CPR to be stopped, and 
other therapeutic techniques to be employed. Percutaneous coronary intervention is 
a technique used to open occluded blood vessels around the heart. Although these 
techniques were not in place at the time of this study, that is not to say that in time 
the same or different procedures will not require a revalidation of all existing TOR 
CDRs, including this one.  
Similarly, recent work has suggested that futile resuscitations may be determined by 
use of end tidal capnometry (ETCO2). ETCO2 measures the partial pressure of 
carbon dioxide at the end of an exhaled breath. It is an indication of both the 
patient’s cardiac output and their pulmonary blood flow, as carbon dioxide is 
transported to the right atrium of the heart and then to the lungs by the right ventricle. 
Currently, ETCO2 is used by Paramedics to determine correct placement of 
endotracheal tubes in the trachea 60, and as a result of this, is a tool available to all 
pre-hospital clinicians who perform advanced airway techniques. Ahrens, Schallom, 
Bettorf et al found that in 127 patients, all but one with ETCO2 of less than 10 mmHg 
died before discharge 131. This is supported by the recent work of Ozturk, Parlak, 
Yolcu et al has suggested that if ETCO2 remains under 10 mmHg during CPR, it is 
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likely that ROSC will not occur 130. However, this study was small (n = 50), and there 
was one patient who survived, despite ETCO2 of under 5 mmHg. ILCOR considered 
the prognostic value of ETCO2 and recommended against using ETCO2 cut-off 
values alone as a predictor of mortality or for deciding when to terminate a 
resuscitation attempt 209. Nevertheless, developments in this area may prove the 
prognostic value of ETCO2, and may therefore affect the efficacy of any pre-existing 
TOR CDR. 
Another area of study which may affect TOR decisions is the use of ultrasound as a 
prognostic tool.  A review of the literature by Brooke, Walton, Scutt, et al found that 
there was evidence that with the right education, paramedic cohorts could be taught 
to use and interpret the results of ultrasound in the prehospital environment 210. 
Further work by the same team found that advanced paramedics could acquire the 
knowledge and skills over a two-day course to acquire diagnostic quality ultrasound 
images to identify the presence or absence of pneumothoraces 211. Although no 
studies could be found to indicate that paramedics are able to use ultrasound to 
assist with decisions on TOR, it is possible that protocols could be established for 
the assessment of myocardial contractility for presumed PEA, and so incorporated 
into a TOR CDR. The current expense of the equipment probably prohibits its 
introduction to all front-line clinicians at the present time, but there is some potential 
for future on-scene decision-making by senior paramedic clinicians. 
As well as the impact of specific procedures to any TOR CDR, it is important to 
recognise organisational changes that may affect their validity. Work by Schober, 
Holzer, Hochrieser, et al. has found variation in survival between hospitals, which 
raises the question as to whether specialist resuscitation hospitals may result in 
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improved outcomes 212. System changes such as this would require wholesale re-
evaluation of pre-hospital TOR. 
Nevertheless, until further work is progressed on novel treatments and procedures 
such as those mentioned, the validity of TOR CDRs based on the characteristics of 
the cardiac arrest remain valid. This validation has shown that paramedic clinicians 
are able to utilise a CDR that accurately identities those patients for who transport to 
ED is futile. In order for this to be put into practice, however, it would need to be 
combined with the existing TOR guidelines to ensure that clinicians understood how 
the two elements interact, as well as ensuring that aggressive resuscitation is 
continued up until the point it is decided to terminate the attempt. Such guidance 
would need to include a minimum interval for which the attempt should be continued, 
as well as ensuring any reversible causes are addressed before a decision is made.  
Having prospectively validated the CDR, the next chapter attempts to determine the 
economic impact of this decision-making on the ambulance service and the wider 
health economy. 
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8. Chapter eight – Estimate of cost savings 
Previous chapters have reported on a retrospective cohort study that derived a TOR 
CDR. They then reported on the subsequent retrospective and prospective cohort 
studies that validated this CDR. At each stage the results of this CDR were 
compared with the previously derived BLS and ALS CDRs to evaluate its 
effectiveness at recognising futile transportation following adult OHCA of suspected 
cardiac aetiology.  
The aim of this chapter is to compare the costs to the NHS of introducing the various 
CDRs against current practice. As discussed previously, the NHS is under pressure 
to reduce spending, whilst improving standards and efficiency 188.  This relentless 
pressure to deliver more and better healthcare for less understandably means there 
is an emphasis on establishing ways to reduce expenditure. Early decisions, which 
reduce the need for unnecessary, futile care are in great demand. Previous chapters 
have shown that the TOR CDR can effectively identify futile transportation and that 
clinicians are able to use the CDR in practice. If the application of the CDR can be 
shown also to have positive financial implications, then the case for introducing it is 
strengthened. Although only explicit cost will be considered here, it is anticipated that 
there will be resource and cost implications for the Trust and the wider healthcare 
economy, which are implicit and cannot easily be measured.  They include the 
availability of the transporting ambulances to attend other emergency calls, and the 
attending staff at hospital being able to concentrate on other patients and tasks. 
However, these effects are beyond the scope of this thesis and further research 
would be needed to quantify them. 
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8.1 Literature search 
Before estimating the cost savings, a literature search was performed to determine if 
evidence existed on the cost of TOR for adult OHCA patients in the field and in 
hospital. It was found that there is limited evidence available that addresses the cost 
of OHCA in the UK. Furthermore, difficulties in quantifying the cost of these futile 
transports are evident in the literature. In 1993, Bonnin, Pepe, Kimball et al 
estimated that transporting patients to the hospital for “continued but futile” 
resuscitation cost between $2000 to $3000 per patient 126. In 2000, Cheung, 
Morrison and Verbeek compared the costs of TOR in the pre-hospital environment to 
the costs of transporting patients to hospital for TOR in a single Canadian hospital 
213. They analysed data from 20 patients subject to TOR by ambulance staff and 
matched these to 20 patients subject to TOR in the ED. They found that the total 
cost of TOR in the ED was $45.35 higher than the cost of TOR in the field (p < 
0.001), with Paramedic TOR costing approximately $159.41 against hospital TOR 
costing $204.76 overall. 
However, in addition to ambulance costs, the greatest costs are associated with 
hospital interventions, particularly when patients survive long enough to be 
transferred to intensive care units (ICU). The data available at the time of writing 
does not allow a detailed analysis of these costs, but they nevertheless become 
important to the overall cost of treating OHCA. In order to make an overall 
assessment of the cost impact to the NHS of introducing a prehospital TOR CDR, 
ideally the hospital costs of treatment leading to the discharge of survivors as well as 
costs relating to non-survivors must be taken into account. 
In 1991 Gray, Capone and Most evaluated the costs of continued hospital 
resuscitation for 185 patients suffering OHCA and transported to a Rhode Island 
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hospital, of whom 16 (9%) survived to admission from ED, and none survived to 
discharge 214. They concluded that the mean stay in hospital for the 16 patients who 
survived to be admitted from ED was 12.6 days, with a mean stay in ICU of 2.3 days. 
This resulted in a cost of hospitalisation of $180,908, with a mean cost per patient of 
$11,307.  
In 1996 Dhar, Ostryzniuk, Roberts et al retrospectively reviewed 285 consecutive 
admissions to a university hospital ICU following resuscitation to determine long-term 
outcome, length of stay, and resource consumption 215. This study involved both in-
hospital and OHCA patients and not all patients suffered an arrest of cardiac origin, 
so these results may not be generalised to a purely OHCA cohort who suffered an 
arrest of cardiac aetiology. However, they found that overall the 94 survivors spent a 
total of 2589 hospital days in hospital, whereas the 191 non-survivors spent 1076 
days in hospital. The non-survivors had statistically higher (p < 0.01) mean and 
median daily costs in ICU (mean $175; median $143) than survivors (mean $145; 
median $140). 
Swor, Lucia, McQueen et al compared the cost of treating OHCA patients with  
patients treated with ST-segment acute myocardial infarction (heart attack) 216. This 
work, from 2010 in USA, suggests that the median length of stay in hospital of all 
OHCA patients was 4 days. The study however looked only at patients who survived 
OHCA to discharge, and even then may have excluded those who were resuscitated 
fully in the prehospital phase and entered the hospital without on-going resuscitation. 
Due to the methods employed in this study, and its emphasis on revenue gained 
from each patient encounter, any costs it concluded cannot be generalised to the UK 
system. 
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In 2002, Gage, Kenward, Hodgetts et al reported on health system resources used 
to treat OHCA in a British district general hospital, following a prospective 
observational study 217. They found that based on costs for the financial year 1999-
2000, the average variable cost per resuscitation attempt was £195.66.  The mean 
fixed cost per resuscitation attempt, which included provision and maintenance of 
capital equipment, and the training of clinicians in resuscitation skills, was £928.81. 
They calculated an overall average cost of £1165.48 per resuscitation attempt, and 
£8278.65 per survivor, where the survival rate was 13.6%. 
Naess and Steen studied long-term survival and estimated the costs per year of 
survival after OHCA of cardiac origin, treated by an ambulance, staffed by a doctor, 
in Oslo from January 1971 to June 1992 218. During this study 9.5% of patients with 
OHCA of cardiac origin and who had fully available documentation survived to 
discharge. They included costs of EMS, hospital treatment, rehabilitation, nursing 
homes and psychiatric institutions after discharge. They concluded that the cost per 
patient discharged alive was €40,642 or €6,632 per life year gained, with 4.4% of the 
total costs being spent on patients who did not survive to hospital, 35.6% on patients 
who died in hospital and 60% on those who were discharged from hospital alive. 
This study highlights the difference in costs between prehospital TOR and in-hospital 
TOR. However, whilst 57.6% of resuscitations were terminated before ROSC 
(combined pre-hospital and ED TOR), there is no indication of how many of these 
patients were actually transported to ED.  
The costs of ICU stays for patients suffering OHCA were again studied by Graf, 
Mühlhoff, Doig et al in 2008 219. This study was aimed at investigating the cost per 
life-year gained from data gathered at a single German ICU for any patient suffering 
OHCA, whatever the cause. It nevertheless established the cost per survivor, by 
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dividing the total healthcare costs (including ICU, hospital and post-hospital 
discharge) by the number of patients who survived to hospital discharge. The costs 
per hospital survivor were found to be €49,952 (total hospital costs = €7,492,771, 
divided by 150 hospital discharge survivors). Although specific costs were attributed 
to each individual patient in this study, these are not individually quantified in the final 
analysis. Therefore, whilst this study is of interest, it does not relate purely to OHCA 
of cardiac aetiology and so cannot be generalised to this group of patients 
specifically. 
The most recent study by Petrie, Easton, Naik et al in 2015 was a single centre 
retrospective review of in-hospital costs of patients admitted to the ICU following 
ROSC after OHCA 220. This study reviewed successive patients admitted over an 18-
month period, and established costs, which were defined as the sum of money 
allocated to each patient episode, as generated using the UK payment by results 
(PbR) system. This methodology was comprehensive and accounted for hotel 
services, medical, nursing and other clinical staff costs, treatments, ward 
consumables, medicines, blood and blood products, medical and surgical 
equipment, and any diagnostics undertaken while the patient was in the ICU. A total 
of 68 patients who required ICU admission following OHCA were included in the 
study. A further 101 OHCA patients were excluded as they were not admitted to ICU. 
This study found that the average overall hospital cost per patient, including non-
survivors admitted to ICU was £20,000. The overall hospital cost per survivor was 
£51,000 (£1,698,000/33). The cost per ICU day was calculated to be £1700. 
Although this study reviewed all OHCA patients, irrespective of aetiology, the 
majority (78%) of arrests were of cardiac origin.  In contrast to the previously 
mentioned studies, this study utilises reasonably current data from 2011–2012, and 
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includes the latest treatments for cardiac arrest patients, including targeted 
temperature management and primary percutaneous intervention. Inevitably, there 
are time dependant inflationary changes and other economic factors, such as 
variations in purchasing power, which mean the figures quoted here will not correlate 
exactly to the costs relating to the patient group of interest to this thesis. Moreover, 
the treatment options for patients will vary depending on the receiving hospital. 
However, as the most recent and thorough UK study, it does give a good indication 
of the costs involved. 
8.2 Methods 
In order to estimate the cost savings of the three service options (TOR CDR; BLS 
CDR; and ALS CDR) against current practice, a retrospective review of the patients 
from phase 3 who were eligible for TOR under each of the CDRs, was conducted. 
This was done in order to identify and compare the costs of each CDR with those of 
current practice, where all of the patients are transported to hospital and TOR occurs 
there.  The analysis was performed from an acute care perspective, determining only 
those costs associated with treatment up to the point of TOR. The aim was to 
determine the cost savings from adult OHCA of cardiac aetiology, as a result of early 
TOR for non-survivors. It was hypothesised that prehospital TOR would be 
associated with lower costs than transport and TOR in hospital and that the CDR 
established in this thesis would be associated with lower costs than either the BLS or 
ALS CDRs. 
To establish the cost of interventions, first the patient pathways associated with 
OHCA were established (Figure 14).  
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Figure 14 - Schematic diagram of patient pathways 
Patients all enter the pathway as OHCA. On arrival of the ambulance, they may be 
diagnosed as dead at this point, or resuscitation may be attempted. If attempted, the 
resuscitation may be terminated on scene, or the patient is transported to ED. Once 
in ED, the resuscitation attempt may be terminated, or continued. The schematic 
shows that the stage at which the patient is resuscitated successfully may vary 
(though this is not affected by the CDR). If resuscitated in the pre-hospital 
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environment, the patient will still require transport to the ED, though this may not 
necessitate ICU admission. Similarly, successful resuscitation in the ED may, or may 
not require ICU admission. The end-state for patients within this pathway is not 
changed by the implementation of any of the CDRs: patient survival is not affected 
by the application of the CDR. However; the stage at which patients are identified as 
being irreversibly dead is affected. This stage may either be by ambulance clinicians 
in the pre-hospital phase; by emergency physicians in the ED; or by intensivists in 
the ICU.  
 
8.3 Estimation of costs used within the model 
The prospective cohort study used to validate the CDR consisted of 656 patents. Of 
these, the TOR CDR recommended prehospital TOR for 162 patients. The approach 
taken was to look at the reduction in cost that would result from the implementation 
of each of the CDRs, by calculating estimated costs for each non-survivor that was 
transported to ED and then estimating the effect on that cost under the newly-
established CDR as well as under the BLS and ALS CDRs. 
In order to complete an estimate of cost savings, relevant costs needed to be 
established, or assumed. For each patient, only limited data were available from the 
Trust’s records: number of clinicians on scene; treatment interval; travel interval; 
survival outcome; and if the patient died, whether this was before or after 24 hours. 
Several assumptions therefore needed to be made in terms of treatment and the 
costs of that treatment. The approach taken here was to minimise the assumed 
costs for both the ambulance and subsequent hospital treatment for all patients. In 
that way, any savings as a result of implementing the CDR will not be over-
estimated.  
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The first assumptions are in terms of ambulance costs.  It was assumed that all 
ambulance interventions on scene would not be affected by implementing the CDR. 
All ALS procedures would be performed according to RC(UK) guidelines, whether or 
not the CDRs are used, and so use of equipment and medicines were presumed to 
be equivalent throughout. It was therefore assumed that no extra costs for 
equipment or medicines were incurred by the ambulance Trust when transporting a 
patient to hospital. 
Once a crew has completed at an incident, that crew must spend time completing 
paperwork, re-packing response bags from their vehicle stocks, debriefing the 
incident etc. It was assumed that whether this is done on scene or at hospital, the 
time spent doing this would be equivalent throughout. Leading on from those 
previous assumptions, the only added expense is the time spent in transit with the 
patient. These data were available as a travel interval for each incident. 
Although there may have been more than one ambulance on scene, it was assumed 
that during transport, only a single crew (two clinicians) attended the patient; one to 
drive and the other to treat the patient. It was therefore assumed that any other 
clinicians remain at scene and are available for further incidents. Although this is not 
always the case, and a second attending clinician may travel with the patient in the 
ambulance, this assumption was again made so as not to over-estimate any cost 
implications of implementing the CDRs.  
The only data available relating to hospital expenditure was whether the patient 
survived and, if they died, whether this occurred before or after 24 hours. Again 
several assumptions needed to be made here. Firstly, it was assumed that if the 
patient survived less than 24 hours, that they were taken into ED and that twenty 
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minutes of ALS was performed before resuscitation was terminated. It is accepted 
that on occasion, the attempt may be terminated almost upon arrival at ED, once the 
attending doctor has been told the details of the arrest, the intervals involved and the 
treatment already provided. Alternatively, other patients may achieve ROSC and 
require further interventions. However, it is reasonable to assume that for the 
majority of patients, twenty minutes of ALS is performed before termination in the 
ED. Further assumptions needed to be made in terms of attending staff at the 
hospital. All EDs to which OHCAs are taken receive a pre-alert from the Trust. This 
pre-alert is a telephone call that gives brief details of the patient, the history of the 
incident and treatment provided, as well as an estimated time of arrival at the ED. 
Therefore it can be assumed that the ED would have a minimum clinical response 
available for each OHCA. This was assumed to be one ED registrar, one 
anaesthetics registrar and two band 5 nurses. This assumption is based on the need 
for at least two persons to continue CPR, an ED lead and an airway management 
specialist. Although there is the potential for more, or higher grade staff to be in 
attendance, these numbers and grades were again used so as not to over-estimate 
costs. 
If a patient was known to have survived over 24 hours, it was assumed that they 
were taken to intensive care. As the actual length of stay in intensive was not 
available, each intensive care stay was assumed to have been no longer than 24 
hours for this analysis. Again, this assumption ensured that there was no 
exaggeration of hospital costs. In fact, they may greatly underestimate costs. 
However, it was decided that a large underestimation of cost benefit of introducing a 
CDR was preferential to even a small overestimation of that benefit, so as not to 
unreasonably raise expectation. 
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The Personal Social Services Research Unit publishes figures on the estimated unit 
costs of NHS staff and services 221. These data were used to calculate costs of ED 
staff (registrar = £41 per hour; Band 5 nurse = £35 per hour). However, whist this 
data estimates the costs of ambulance attendances, these are calculated per 
incident and are not calculated per hour. Therefore Trust data was used to calculate 
the cost of travel intervals. The Trust currently equates the cost of a double crewed 
ambulance to £72 per hour (np- see appendix 7) (This value is specific to the Trust 
and may not equate to all ambulance trusts throughout the UK). For ICU costs, the 
work of Petrie, Easton, Naikcost et al was used. This work  calculated that the cost 
per ICU day for a patient following cardiac arrest was £1700 220. 
Costs Value (2015) Source 
Double crewed ambulance £72 per hour Trust data (np – see appendix 7) 
ED registrar £41 per hour Personal Social Services Research Unit 221 
Anaesthetic registrar £41 per hour Personal Social Services Research Unit 221 
Band 5 nurse £35 per hour Personal Social Services Research Unit 221 
ICU £1700 per day Petrie, Easton, Naikcost et al 220 
Table 18 – Costs used in the model 
8.4 Results 
This section reports the results of the costs for the three alternative termination rules 
that have been identified, compared with current practice.  
A cost identification analysis was first performed on existing processes. 737 patients 
were transported to hospital during phase 3. Of these, survival data was available for 
656 patients. The total travel interval for these patients was 120 hours 53 minutes. 
However, of these, 104 survived, accounting for 25 hours of travel. Therefore 95 
hours and 53 minutes of travel was spent on non-survivors. Of the 552 non-
survivors, 454 died within 24 hours, and 98 died over 24 hours after arrival. 
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Number of Patients Intervention Unit Cost Total cost 
552 transport £72 per hour £6,903.6 
552 2 x Registrar £41 per hour each £15,088 
552 2 x Band 5 nurse £35 per hour each £12,880 
98 ICU £1,700 per 24 hours £166,600 
 £201,471.6 
Table 19 – Cost identification of current processes 
 
A cost identification analysis was then performed on the results of the phase 3 TOR 
CDR figures, as if those patients recommended for TOR had not been transported to 
ED.  
 
Applying the TOR CDR to the patients for whom outcome is known, would have 
resulted in 494 patients being transported to hospital during phase 3. The total travel 
interval for these patients was 92 hours 47 minutes. However, of these, 104 
survived, accounting for 25 hours of travel. Therefore 67 hours and 47 minutes of 
travel was spent on non-survivors. Of the 390 non-survivors, 299 died within 24 
hours, and 91 died over 24 hours after arrival.  
 
Number of Patients Intervention  Unit Cost Total cost 
390 transport £72 per hour £4,880.4 
390 2 x Registrar £41 per hour each £10,659.18 
390 2 x Band 5 nurse £35 per hour each £9,099.3 
91 ICU £1,700 per 24 hours £154,700 
 £179,338.88 
Table 20 – Cost identification of TOR CDR 
 
Applying the BLS CDR to the patients for whom outcome is known, would have 
resulted in 570 patients being transported to hospital during phase 3. The total travel 
interval for these patients was 107 hours 3 minutes. Removing the 104 survivors (25 
hours of travel), leaves 82 hours and 3 minutes of travel spent on non-survivors. Of 
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the 466 non-survivors, 371 died within 24 hours, and 95 died over 24 hours after 
arrival.  
Number of 
Patients 
Intervention  Unit Cost Total cost 
466 transport £72 per hour £5,907.6 
466 2 x Registrar £41 per hour each £12,737.88 
466 2 x Band 5 nurse £35 per hour each £10,873.8 
95 ICU £1,700 per 24 hrs £161,500 
 £191,019.28 
Table 21 – Cost identification of BLS CDR 
 
Applying the ALS CDR to the patients for whom outcome is known, would have 
resulted in 645 patients being transported to hospital during phase 3. The total travel 
interval for these patients was 119 hours 10 minutes. Removing the 104 survivors 
(25 hours of travel), leaves 94 hours and 10 minutes of travel spent on non-
survivors. The total cost of this transfer interval (@ £72 per hour) is therefore £6,768 
Of the 541 non-survivors, 443 died within 24 hours, and 98 died over 24 hours after 
arrival.  
Number of 
Patients 
Intervention  Unit Cost Total cost 
541 transport £72 per hour £6,768 
541 2 x Registrar £41 per hour each £14787.88 
541 2 x Band 5 nurse £35 per hour each £12,623.8 
98 ICU £1,700 per 24 hrs £166,600 
 £200,779.68 
Table 22 – Cost identification of ALS CDR 
 
From the costings above, it is possible to establish the total additional cost per non-
survivor, by dividing the total cost by the number of patients who did not survive to 
discharge (including those terminated on scene). The total saving per 1,000 patients 
currently transported to hospital can then be calculated (Table 23). 
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Clinical Decision 
Rule 
Cost Cost per 
patient 
Cost per 1000 
patients 
Cost-saving per 1000 
patients 
Present position £201,471.6 £307.12 £307,121  
TOR CDR £179,338.88 £273.38 £273,382 £33,739 
BLS CDR £191,019.28 £291.19 £291,188 £15,933 
ALS TOR £200,779.68 £306.07 £306,067 £1,054 
Table 23 – Total cost savings per 1,000 patients currently transported 
 
8.5 Discussion    
Utilising the figures above, the current minimum cost of transporting 1,000 patients 
who do not survive is £307,121. Applying any of the three CDRs results in a 
reduction of cost: £1,054 for the ALS CDR; £15,933 for the BLS CDR; and £33,739 
for the TOR CDR. Due to the assumptions that were made, this is the minimum 
saving. The calculation did not include any cost connected to time spent by ED staff  
in matters indirectly related the OHCA patient, such as time spent with members of 
the deceased’s family, supporting any family members who may have attended the 
hospital, contacting the coroner, or the completion of documentation, removal of the 
deceased etc. Yet, all of these activities are important as they detract from the time 
available to ED staff to care for other patients.  Nevertheless, this demonstrates that 
the TOR CDR has the potential to contribute to financial savings by conserving the 
limited resources available to the healthcare system, and the financial impact of this.  
Also, the impact of transporting fewer patients to hospital cannot be quantified in 
terms of the effect on other patients attending that hospital at the same time. This 
impact may include the availability of staff, beds and other facilities that would 
otherwise be needed to treat the OHCA patient. Assumptions were made that four 
members of hospital staff would be required to attend each OHCA patient brought 
into the ward and would be attended for twenty minutes. As explained earlier, these 
figures are deliberately conservative. They do not account for the time spent waiting 
for an ambulance to arrive at ED once the hospital has been alerted that an OHCA is 
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expected on the ward, nor the time required for the appropriate staff to leave their 
current location to attend the ED. All of this removes hospital clinicians from their 
ongoing work, which will impact on other patients. Future evaluations should 
incorporate the impact of this resource allocation on the wider population. 
The generalisability of any research findings are an important consideration.  In order 
to assess this, one must consider not only the quality of research, but also its 
applicability to different health settings and their impact on different patient groups 
180. Although this study was conducted over a large geographical area, which 
includes both densely urbanised and sparsely rural areas, and also considered a 
large population base, there are certain elements that may affect its generalisability 
to other areas. Firstly, all the clinicians were from a single ambulance trust and were 
following the clinical guidelines of that trust, as well as the operational model of that 
trust, in relation to deployment models, use of senior clinicians etc. As was noted in 
earlier chapters, the increase in ROSC over the three phases of the study may have 
been influenced by the changes in operational model of the Trust. So too, different 
response models in other ambulance services may impact on the generalisability of 
these findings. Also, it was noted in chapter 2 that the incidence of VF arrests may 
be declining with time. If this trend continues, the number of patients eligible for pre-
hospital TOR using the CDR may increase over time. Nevertheless, this estimate of 
cost savings suggests that the implementation any of the CDRs will have financial 
benefits when compared to current practice. Furthermore, the TOR CDR was shown 
to have greater financial benefits, when compared to either the BLS or ALS CDRs. 
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9. Chapter nine – Conclusion 
The focus of this thesis was the pre-hospital termination of adult OHCA of presumed 
cardiac origin, and posed the question as to whether it is possible to predict when a 
patient suffering such an event would not benefit from transport to hospital, and the 
attempt terminated safely whilst minimising the possibility of stopping a potentially 
survivable resuscitation attempt.  
It was established that CDRs have been validated that successfully identify patients 
suffering OHCA for whom transport to hospital would be futile. However, the 
numbers of patients transported to hospital using these CDRs are relatively high, 
and they are therefore potentially recommending transport for resuscitation attempts 
that are objectively futile. It was also noted that these rules were created for 
ambulance systems that at the time the CDRs were derived were not able to 
terminate asystolic OHCAs. This meant they were intended for a larger subset of 
patients than those currently transported by the Trust in question.  
A new TOR CDR was therefore derived by performing a retrospective cohort study 
using pre-existing data gathered from a single, large UK ambulance Trust over a 26 
month period. The study evaluated 4870 individual OHCAs. Binominal logistic 
regression was performed to determine the variables associated with outcome, 
defined as either death or survival to hospital discharge. This TOR CDR predicted 
that patients without an initial VF/pVT rhythm or ROSC on scene were unlikely to 
result in survival. Applying this TOR CDR to the patients in the original dataset 
resulted in a transport rate of 52.4% and 5 (0.2%) unexpected survivors. (specificity 
= 99.0%; 95% CI: 97.7% to 99.7%, positive predictive value = 99.8%; 95% CI: 99.5% 
to 99.9%, sensitivity = 53.1%, 95% CI: 51.6% to 54.6%, and negative predictive 
20.3%, 95% CI: 19.8% to 20.9%). These results compared favourably to both the 
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BLS and ALS CDRs, which had transport rates of 63.1% and 90.2% respectively, 
although application of both of these CDRs resulted in fewer unexpected survivors 
(n=3 and n=2 respectively).  
A subsequent retrospective cohort study of 2139 adult patients who had an OHCA of 
presumed cardiac aetiology resulted in a transport rate of 60.7%, with 3 (0.4%) 
unexpected survivors (specificity = 99.1%; 95% CI:  97.4% to 99.8%, positive 
predictive value = 99.6%; 95%CI; 99.0% to 99.9%,  sensitivity = 46.5%; 95% CI: 
44.1% to 48.8%, and negative predictive value = 25.6%; 95%CI; 23.2% to 28.1%. 
Again the BLS and ALS CDRs were applied to the same data. Although neither 
resulted in any unexpected survivors in this group of patients, the transport rates 
increased to 72.8% and 95.2% respectively.  
A prospective validation of 656 patients showed resulted in 162 patients being 
recommended for TOR.  None of these survived to hospital discharge. All of the 104 
survivors in this phase of the study were recommended for transport by the CDR. 
(specificity = 100%; 95% CI:  95.6% to 100%; positive predictive value = 100%; 
95%CI; 97.1% to 100%, sensitivity = 29.3%; 95% CI: 25.6% to 33.4%; negative 
predictive value = 21.1%; 95%CI; 17.6% to 25.0%). The transportation rate was 
75.3% of those currently transported. Retrospective application of both the BLS and 
ALS CDRs to the same population showed that whilst both also identified 100% of 
survivors for transport, they did this with increased transport rates (87% and 98.2% 
respectively). 
An estimate of the cost savings of introducing the TOR CDR into practice showed 
that all three CDRs would result in cost savings, as each resulted in fewer patients 
being transported to hospital. When extrapolated, the estimated cost savings per 
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1,000 patients currently transported to hospital were £33,739 for the TOR CDR, as 
opposed to £15,933 for the BLS CDR and £1,054 for the ALS CDR. It was also 
noted that there are other effects that cannot easily be quantified. These include the 
added benefit of releasing ambulance clinicians more quickly to attend the next 
emergency, or allowing hospital clinicians to attend other patients, rather than 
dealing with time-intensive, yet ultimately futile resuscitation attempts. 
In completing these stages of the thesis, the following objectives were achieved: to 
evaluate critically the exiting validations of clinical decision rules (CDRs) relating to 
termination of resuscitation; to derive a TOR CDR for adult OHCA of cardiac 
aetiology that is appropriate for use by pre-hospital clinicians, and which reduces the 
number of futile resuscitation attempts transported to hospital; to validate 
retrospectively the CDR against an independent data-set of out-of-hospital cardiac 
arrests; to validate prospectively the CDR, to ensure that ambulance clinicians are 
able to apply the TOR CDR and identify those patients for who transport to hospital 
is futile; to estimate the cost savings of introducing the TOR CDR. 
Some of the strengths and limitations of this thesis have been discussed in previous 
chapters. The strength of the thesis is that it derived the elements of a CDR through 
the use of logistic regression, and clinical application of the results, and then proved 
the application of the CDR by both retrospective and prospective validation. 
However, as previously discussed, McGinn et al  require that in order to achieve a 
level 1 in the hierarchy of CDRs, a guideline must have undergone at least one 
prospective validation in a different population to the derivation, and one impact 
analysis, as well as having demonstrated a change in clinician behaviour and 
beneficial consequences141. This study has not achieved this standard. In particular, 
because senior clinicians assisted with the collection of missing data in phase 3, it 
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cannot be said with certainty how much of the data was provided by front-line 
clinicians. Moreover, it cannot be said that the CDR demonstrated a change in 
clinical behaviour. Therefore, this study can be said to have reached the standard of 
a level 3 validation, which is one that has utilised only one narrow, prospective 
sample. Nevertheless, McGinn et al argue that level 3 validations can result in a 
decision rule being implemented 141. Therefore, whilst this thesis has provided the 
evidence to introduce the CDR into the practice of the Trust, it cannot be generalised 
to other locations, or EMS systems. In order to strengthen the validity of the tool, it 
should be assessed prospectively in either one large prospective study or several 
smaller studies, but within different settings. Ideally, to prevent bias, such a 
validation would be performed by a different research group 145. 
It is recommended that further research should also look in more detail into the 
potential cost savings and other benefits of introducing this CDR. By necessity, the 
cost savings illustrated in this thesis were broad and generalised, aiming to provide 
an indication of the minimum savings associated with the introduction of the CDR. 
More detailed research into the costs of futile transportation, including the effects on 
availability of resources both in terms of ambulances and hospital clinicians is 
required.  
Despite the limitations discussed throughout this thesis, it has nevertheless achieved 
the aims it has set out to achieve. It has shown that it is possible to reduce safely the 
number of futile, adult OHCA patients who are currently transported to hospital. The 
tool with which this can be done has been derived and validated both retrospectively 
and prospectively. It compares favourably with two existing decision rules, by 
identifying more futile transportations than either the BLS or ALS CDRs.  The CDR is 
applicable to adult patients who have suffered an OHCA of presumed cardiac 
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aetiology and who would presently be transported to hospital. The rule states that if 
the patient did not present in a VF/pVT rhythm and did not achieve ROSC on scene, 
then it is futile to transport them to hospital for further resuscitation attempts, and the 
attempt can safely be terminated on scene. For these purposes, futility is defined as 
a probability of survival of less than one percent. 
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APPENDIX 1 – Search terms 
Search completed January 2013: 
Initial Search 
1. TOPIC: (resuscitation) AND TOPIC: ("out of hospital") AND TOPIC: (predict*) AND 
TOPIC: (survival); 476 results 
 
Web of Science Search 
# 16 77 #9 AND #6 
Refined by: [excluding] WEB OF SCIENCE CATEGORIES: AND DOCUMENT TYPES: ( 
ARTICLE ) AND ( PEDIATRICS ) AND [excluding] DOCUMENT TYPES: ( PROCEEDINGS 
PAPER ) 
# 15 119 #9 AND #6 
Refined by: [excluding] WEB OF SCIENCE CATEGORIES: ( PEDIATRICS ) 
# 14 11 #14 AND #6 
# 13 42 #13 AND #9 
 
# 12 280,942 TOPIC: (validation) 
 
# 11 124 #9 AND #6 
 
# 10 44 #9 AND #4 
 
# 9 3,044 #3 AND #2 
 
# 8 46 #7 AND #4 
 
# 7 427 #6 AND #2 
 
# 6 36,825 #5 OR #1 
 
# 5 36,825 TOPIC: ((resuscitation)) 
 
# 4 5,093 TOPIC: ((futil*)) 
 
# 3 611,541 TOPIC: ((rule* OR guideline*)) 
 
# 2 132,325 TOPIC: ((terminat*)) 
 
# 1 13,609 TOPIC: (((cardiopulmonary resuscitation))) 
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MEDLINE Search 
# 8 24 (((cardiopulmonary resuscitation OR resuscitation) AND (rule OR 
guideline)) AND terminat*).ti,ab  
# 7 334 ((cardiopulmonary resuscitation OR resuscitation) AND 
terminat*).ti,ab  
# 6 28,204 (cardiopulmonary resuscitation OR resuscitation).ti,ab 
 
# 5 28,204 (resuscitation).ti,ab 
# 4 3,726 (futil*).ti,ab  
# 3 261,106 (rule* OR guideline*).ti,ab  
# 2 66,119 (terminat*).ti,ab  
# 1 8,253 (cardiopulmonary resuscitation).ti,ab  
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Appendix 2 - Results of literature search 
Ser First Author Year Title 
Excluded 
by Title 
Excluded 
by 
Abstract 
Review 
1 Ågård 2012 
Guidance for ambulance personnel on decisions 
and situations related to out-of-hospital CPR. 
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2 Berdowski 2010 
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3 Birkholz 2009 
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the basis of a clinical guideline 
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6 Botran 2011 
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8 Caralis 1992 
Attitudes of medical-students, house staff, and 
faculty physicians toward euthanasia and 
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9 Cave 2009 
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10 Chan 2013 
Comparison of clinical prediction rules for 
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11 Charapov 2012 
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12 Considine 2009 
Termination of resuscitation: Potential benefits of 
clinical prediction rules 
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13 Cooper 2007 
Reliability testing and update of the Resuscitation 
Predictor Scoring (RPS) Scale 
   
14 Darragh 2012 
A low tilt waveform in the transthoracic 
defibrillation of ventricular arrhythmias during 
cardiac arrest 
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15 de Vos 1998 Decisions to terminate resuscitation    
16 Deakin 2008 
Changes in transthoracic impedance during 
sequential biphasic defibrillation    
17 Diepenseifen 2011 
Cardiopulmonary Resuscitation Ongoing CPR 
During Transport - When Does it Make Sense? 
   
18 Elo 2005 
Ethical considerations behind the limitation of 
cardiopulmonary resuscitation in Hungary - the    
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role of education and training 
19 Goldberger 2012 
Duration of resuscitation efforts and survival 
after in-hospital cardiac arrest: an observational 
study 
   
20 
Gonzalez-
Mesa 
2013 
Unfavorable course in pregnancy-associated 
thrombotic thrombocytopenic purpura 
necessitating a perimortem Cesarean section: a 
case report. 
   
21 Goto 2013 
Termination-of-resuscitation rule for emergency 
department physicians treating out-of-hospital 
cardiac arrest patients: an observational cohort 
study 
   
22 Govindarajan 2012 
Practice variability among the EMS systems 
participating in Cardiac Arrest Registry to 
Enhance Survival (CARES). 
   
23 Hassan 1996 
Prehospital cardiac arrest in Leicestershire: 
Targeting areas for improvement 
   
24 Inomata 2011 [Usage of a defibrillator].    
25 Jamerson 2008 
Benazepril plus amlodipine or 
hydrochlorothiazide for hypertension in high-risk 
patients. 
   
26 Kajino 2013 
Current termination of resuscitation (TOR) 
guidelines predict neurologically favorable 
outcome in Japan. 
   
27 Kellermann 1993 
Predicting the outcome of unsuccessful 
prehospital advanced cardiac life-support 
   
28 Kingsnorth 2010 
Family presence during trauma activations and 
medical resuscitations in a pediatric emergency 
department: an evidence-based practice project 
   
29 Klein 2007 
Another case of apparent death - A discussion of 
guidelines for emergency medical personnel in 
the pronouncement of death 
   
30 Kolar 2008 
Partial pressure of end-tidal carbon dioxide 
successful predicts cardiopulmonary 
 resuscitation in the field: a prospective 
observational study 
   
31 Koster 2008 
Recurrent ventricular fibrillation during advanced 
life support care of patients with prehospital 
cardiac arrest 
   
32 Lewis 2001 
Monitoring a clinical trial conducted under the 
food and drug administration regulations 
allowing a waiver of prospective informed 
consent: The diaspirin cross-linked hemoglobin 
traumatic hemorrhagic shock efficacy trial 
   
33 Lockey 2002 
Recognition of death and termination of cardiac 
resuscitation attempts by UK ambulance 
personnel 
 
   
34 Lockey 2001 
Decision making by emergency physicians when 
assessing cardiac arrest patients on arrival at 
   
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hospital 
35 Maertens 2013 
Patients with cardiac arrest are ventilated two 
times faster than guidelines recommend: An 
observational prehospital study using tracheal 
pressure measurement 
   
36 
Martinez-
Rubio 
2003 
Advances for treating in-hospital cardiac arrest: 
Safety and effectiveness of a new automatic 
external cardioverter-defibrillator 
   
37 Memtsoudis 2006 
The usefulness of transesophageal 
echocardiography during intraoperative cardiac 
arrest in noncardiac surgery 
   
38 Millin 2013 
Withholding and termination of resuscitation of 
adult cardiopulmonary arrest secondary to 
trauma: Resource document to the joint 
NAEMSP-ACSCOT position statements 
   
39 Millin 2011 
Termination of resuscitation of non-traumatic 
cardiopulmonary arrest: resource document for 
the National Association of EMS physicians 
position statement 
   
40 Mohr 2003 
To resuscitate or not? The emergency physician's 
decision in the prehospital setting 
   
41 Morrison 2007 
Inter-rater reliability and comfort in the 
application of a basic life 
support termination of resuscitation clinical 
prediction rule for out of hospital cardiac arrest 
   
42 Morrison 2009 
Validation of a universal prehospital termination 
of resuscitation clinical prediction rule for 
advanced and basic life support providers. 
   
43 Morrison 2007 
Derivation and evaluation of a termination of 
resuscitation clinical prediction rule for advanced 
life support providers. 
   
44 Morrison 2006 
Validation of a rule for termination of 
resuscitation in out-of-hospital cardiac arrest. 
   
45 Morrison 2008 
Termination of resuscitation: a guide to 
interpreting the literature.    
46 Morrison 2006 
Summary of the methodology for the validation 
study for a termination of resuscitation clinical 
prediction rule. 
   
47 NAEMSP 2003 
Guidelines for withholding 
or termination of resuscitation in prehospital 
traumatic cardiopulmonary arrest 
   
48 Niemann 2007 
Is all ventricular fibrillation the same? A 
comparison of ischemically induced with 
electrically induced ventricular fibrillation in a 
porcine cardiac arrest and resuscitation model 
   
49 Nurmi 2005 
Layperson positioning of defibrillation electrodes 
guided by pictorial instructions    
50 Omarcaigh 1993 
Cessation of unsuccessful pediatric resuscitation - 
how long is too long    
51 Ong 2007 
Comparison of termination-of-
resuscitation guidelines for out-of-hospital 
   
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cardiac arrest in Singapore EMS 
52 Ong 2006 
Comparison of termination-of-resuscitation 
guidelines for basic life support: defibrillator 
providers in out-of-hospital cardiac arrest. 
   
53 Orlowski 1993 
Forgoing life-supporting or death-prolonging 
therapy - a policy statement 
   
54 Paal 2012 
Termination of Cardiopulmonary Resuscitation in 
Mountain Rescue 
   
55 Paulsen 2012 
Empirical Hospital and Professional Charges for 
Patient Care Associated with Out of Hospital 
Cardiac Arrest Before and After Implementation 
of Therapeutic Hypothermia for Comatose 
Survivors 
   
56 Pierce 1992 
Metabolic demands and perceived exertion 
during cardiopulmonary-resuscitation    
57 Reinhardt 2010 The Gottingen AED model    
58 Richman 2008 
Independent evaluation of an out-of-hospital 
termination of resuscitation (TOR) clinical 
decision rule. 
   
59 Ristagno 2012 
Comparison of defibrillation efficacy between 
two pads placements in a pediatric porcine model 
of cardiac arrest 
   
60 Roberts 2000 
Adult and pediatric CPR: Attitudes and 
expectations of health professionals and 
laypersons 
   
61 
Rodriguez-
Nunez 
2006 
Pediatric defibrillation after cardiac arrest: initial 
response and outcome    
62 Roessler 2008 
Guidelines for resuscitation 2005 - What is their 
effect, what is new?    
63 Ruygrok 2009 
Validation of 
3 Termination of Resuscitation Criteria for Good 
Neurologic Survival After Out-of-Hospital Cardiac 
Arrest 
   
64 Sanders 2001 
Searching for a predictive rule for terminating 
cardiopulmonary resuscitation. 
   
65 Sasson 2009 
A Qualitative Study to Identify Barriers to Local 
Implementation of Prehospital Termination of 
Resuscitation Protocols 
   
66 Sasson 2008 
Prehospital termination of resuscitation in cases 
of refractory out-of-hospital cardiac arrest. 
   
67 Schmidt 1995 Family response to out-of-hospital death    
68 Schoenenberger 1994 
Survival after failed out-of-hospital resuscitation - 
are further therapeutic efforts in the emergency 
department futile 
   
69 Schultz 1996 
Predicting in-hospital mortality during  
cardiopulmonary resuscitation 
   
70 Sherbino 2010 
Clinical decision rules for termination of 
resuscitation in out-of-hospital cardiac arrest. 
  
Review 
of 
studies 
71 Skrifvars 2010 
Comparison of Helsinki and European 
Resuscitation Council "do not attempt to 
   
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resuscitate" guidelines, and a termination of 
resuscitation clinical prediction rule for out-of-
hospital cardiac arrest patients found in asystole 
or pulseless electrical activity. 
72 Stockinger 2004 
Additional evidence in support of withholding or 
terminating cardiopulmonary resuscitation for 
trauma patients in the field 
   
73 Stratton 2008 
Out-of-hospital unwitnessed cardiopulmonary 
 collapse and no-bystander CPR: A practical 
addition to resuscitation termination guidelines 
   
74 Strote 2008 
Transfer of care is associated with longer 
unsuccessful resuscitations. 
   
75 Taghavi 2012 
Paramedics experiences and expectations 
concerning advance directives: A prospective, 
questionnaire-based, bi-centre study 
   
76 Turner 2009 
Timing of defibrillation shocks for resuscitation of 
rapid ventricular tachycardia: Does it make a 
difference? 
   
77 Vaagenes 2003 
Rapid rewarming after mild hypothermia 
accentuates the inflammatory response after 
acute volume controlled haemorrhage in 
spontaneously breathing rats 
   
78 Valenti 1996 
Impact of the implantable cardioverter-
defibrillator on rehospitalizations    
79 Verbeek 2002 
Derivation of a termination-of-resuscitation 
guideline for emergency medical technicians 
using automated external defibrillators. 
   
80 Wampler 2012 
Cardiac arrest survival is rare without prehospital 
return of spontaneous circulation 
   
81 Wang 2013 
Biphasic versus monophasic defibrillation in out-
of-hospital cardiac arrest: a systematic review 
and meta-analysis 
   
82 Wieneke 2009 
Automatic External Defibrillator - Mode of 
Operation and Clinical Use    
83 Willis 2006 
Cardiopulmonary resuscitation after traumatic 
cardiac arrest is not always futile    
84 Wirth 2009 
Computed tomography during cardiopulmonary 
resuscitation using automated chest compression 
devices-an initial study 
   
85 Wong 2007 
The laryngeal mask airway prevents supraglottic 
leak during ventilation through an uncuffed 
cricothyroidotomy 
   
86 Zive 2011 
Variation in out-of-hospital cardiac 
arrest resuscitation and transport practices in 
the Resuscitation Outcomes Consortium: ROC 
Epistry-Cardiac Arrest 
   
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Result of ‘Snowballing’ 
 
Articles identified post-initial search 
Ser First Author Year Title 
Excluded 
by Title 
Excluded 
by 
Abstract 
Review 
92 Chiang 2015 
Predictive performance of universal termination of 
resuscitation rules in an Asian community: are they 
accurate enough? 
  
 
89 Hauck 2015 
Cardiac arrest with initial arrest rhythm of pulseless 
electrical activity: do rhythm characteristics 
correlate with outcome? 
   
91 Iqbal 2015 
Predictors of Survival and Favorable Functional 
Outcomes After an Out-of-Hospital Cardiac Arrest in 
Patients Systematically Brought to a Dedicated 
Heart Attack Center (from the Harefield Cardiac 
Arrest Study) 
   
93 Cheong 2016 
Termination of resuscitation rules to predict 
neurological outcomes in out-of-hospital cardiac 
arrest for an intermediate life support prehospital 
system 
  
 
94 Verhaerta 2016 
Termination of resuscitation in the prehospital 
setting: A comparison of decisions in clinical 
practice vs. recommendations of a termination rule 
  
 
 
 
 
 
 
 
 
 
 
Ser First Author Year Title 
Excluded 
by Title 
Excluded 
by 
Abstract 
Review 
87 Bailey 2000 
Termination of resuscitation in the prehospital 
setting for adult patients suffering nontraumatic 
cardiac arrest. 
   
88 Goto 2013 
Neurological outcomes in patients transported to 
hospital without a prehospital return of spontaneous 
circulation after cardiac arrest 
   
90 Haukoos 2004 
Prediction rules for estimating neurologic outcome 
following out-of-hospital cardiac arrest. 
   
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Appendix 3 - Summary of studies identified in literature review 
Cheong, Li, Nausheen et al, (2016). Termination of Resuscitation Rules to 
Predict Neurological Outcomes in Out-of-Hospital Cardiac Arrest for an 
Intermediate Life Support Prehospital System 154 
Rule. Two rules were validated: 
1. A BLS-TOR rule, Termination where there is no ROSC, no defibrillation, and the 
arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered.  
EMS System.  A single-tier system run by the Singapore Civil Defense Force 
(SCDF), which operates at an intermediate life support (ILS) service, including AED, 
laryngeal mask airways (LMAs), administration of IV adrenaline and a limited range 
of other medications. Diagnosis of death at scene is only applicable for patients who 
are obviously dead (i.e., signs of rigor mortis, lividity, decapitation). 
Population. The study used data from Singapore, which is a city-state with an area 
of 715 km2 and a population of 5.31 million in 2012. Data included all OHCA patients 
over 18 years old and transported to 7 participating hospitals from April 2010 to May 
2012. The mean age was 65.6. 68.7% were male 
Study design. This was a retrospective cohort study based on data from a large, 
pre-existing database.  
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Primary outcome(s). The primary outcome measure was survival with good 
neurological outcome. The secondary outcome was survival to hospital discharge, or 
survival to 30 days of admission. 
Exclusion criteria. Patients were excluded if: they were below the age of 18; were 
brought into the ED by means other than the EMS sevice; the OHCA was due to 
non-cardiac cause, as determined at scene (e.g., trauma, drowning, drug overdose, 
etc.); and patients who were obviously dead (e.g., rigor mortis, lividity, decapitation) 
or had DNACPR orders. 
Main results. 2,193 eligible OHCA cases were reviewed. The BLS TOR guideline 
would have recommended TOR in 1,411 (64.3%) of all cases. Of these, none 
survived with good neurologic outcomes. For good neurologic outcome the 
specificity of BLS TOR rule was 100% (95% CI: 91.9% to 100%), and the PPV was 
100% (95% CI: 99.7% to 100%). However, 5 (0.4%) survived to discharge (or 30 day 
in hospital survival). For survival the specificity of BLS TOR rule was 93.4% (95% CI: 
85.3% to 97.8%), and the PPV was 99.7% (95% CI: 99.2% to 99.9%). 
The ALS TOR rule would have recommended TOR in 587 (27.3%) cases. Of these 
none survived to hospital discharge with good neurologic outcome. The specificity of 
ALS TOR rule for predicting good neurologic outcome was 100% (95% CI: 91.9% to 
100%), and the PPV was 100% (95% CI: 99.4% to 100%) for predicting survival with 
good neurologic outcome. One patient (0.2%) did survive, despite being 
recommended for TOR. The specificity of ALS TOR rule for predicting survival was 
98.7% (95% CI: 92.9% to 99.8%), and the PPV was 99.8% (95% CI: 99.1% to 
100%). 
Transport rate. For the BLS rule – 35.6%. For ALS rule – 73.2%. 
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With this study both the ALS-TOR rule and the BLS-TOR rule meet Level 4 criteria 
for the hierarchy of evidence for CDRs. 
 
Chiang, Ko, Chang et al, (2015). Predictive performance of universal 
termination of resuscitation rules in an Asian community: are they accurate 
enough? 155. 
Rule. Two rules were validated: 
1. A BLS-TOR rule, Termination where there is no ROSC, no defibrillation, and the 
arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered.  
The two rules were each assessed against three groups of EMS provider; BLS, ALS 
and mixed responders. 
EMS System. This was a fire department-based BLS system with early defibrillation 
capability. From 2008 to 2010, a prehospital ALS service covered 3 of 12 
administrative districts in Taipei, comprising a staff of 65 EMT paramedics. Although 
this system did not allow EMTs to pronounce death of OHCA patients in the field, the 
authors report anecdotal evidence that families may have chosen not to allow 
transport of the patient if they were very old or had been bedridden. Where patients 
had not been transported to the hospital, they were not included in the analyses. 
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Population. A metropolitan area of 272 km2 with a registered population of 2.65 
million and up to 3.0 million when daytime workers are also included. The majority of 
the population are Taiwanese and Chinese. Registered data of patients over 18 
years suffering an OHCA from 1 January 2008 through 31 December 2009 were 
included. The mean age was 73.0. 62.7% were male. 
Study design. This was a retrospective cohort study based on data from a large, 
pre-existing database.  
Primary outcome(s). The primary outcome measure survival to hospital discharge. 
Exclusion criteria. Patients were excluded if they had traumatic injuries or where 
resuscitation was not attempted due to obvious death or an existing DNACPR order. 
Main results. 3489 eligible OHCA cases were reviewed. 1727 of these patients 
received only BLS care, 240 received ALS care and 1522 received mixed care.    
The BLS TOR guideline would have recommended TOR in 2,156 (61.8%) of all 
cases. Of these, 51 (2.4%) survived to hospital discharge. The specificity of BLS 
TOR rule was 74.1% (95% CI: 67.3% to 80.0%), and the PPV was 97.6% (95% CI: 
96.9% to 98.29%). 240 eligible patients received ALS care. The ALS TOR rule would 
have recommended TOR in 82 (34.2%) cases. Of these 4 (4.9%) survived to hospital 
discharge. The specificity of ALS TOR rule was 81.8% (95% CI: 59.0% to 94.0%), 
and the PPV was 95.1 (95% CI: 87.3% to 98.4%) for predicting lack of survival. For 
all enrolled OHCA the ALS TOR guideline would have recommended 1,944 (55.7%) 
terminations. Of these, 48 (2.5%) survived. The specificity of ALS TOR guideline for 
all OHCA was 75.6% (95% CI: 68.9% to 81.3%), and the PPV was 97.5 (95% CI: 
96.7% to 98.2%) for predicting lack of survival. 
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Transport rate. For the BLS rule against BLS response – 37.5%. For BLS against 
all OHCA – 61.7%. For the ALS rule against ALS response - 65.8%. For ALS against 
all OHCA – 44.2%. 
With this study both the ALS-TOR rule and the BLS-TOR rule meet Level 4 criteria 
for the hierarchy of evidence for CDRs. 
 Goto, Goto and Maeda (2013)Termination-of-resuscitation rule for emergency 
department physicians treating out-of-hospital cardiac arrest patients: an 
observational cohort 158 
Rule: no prehospital ROSC, unshockable initial rhythm, and unwitnessed by 
bystanders.  
EMS System. This was a fire department model with 804 fire departments, covering 
the whole of Japan, which has an area of approximately 378,000 km2 and a 
population of approximately 127 million. Each ambulance has a crew of three 
emergency providers, which includes at least one emergency lifesaving technician. 
ALS measures in Japan are limited to advanced airway management and 
epinephrine. In this system all patients on whom resuscitation is attempted are 
transported to hospital. 
Population. 105,030 adult OHCA victims who received EMS in Japan between 
January 2005 and 31 December 2009.  Age was 76 (64 to 84), and 58.7% were 
male. 
Study design. This was a retrospective cohort study based on data from a large, 
pre-existing database.  
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Primary outcome(s). The primary outcome measure was overall rates of one-month 
survival and CPC categories 1 and 2. 
Exclusion criteria. Patients were excluded if they were under 18 years; if there was 
missing 1-month CPC data; where a physician-manned ambulance attended; where 
call-to-response time unknown; where AED use unknown; or where the data was 
improper 
Main results. TOR rule showed a specificity of 0.903 (95% CI, 0.894 to 0.911), 
sensitivity of 0.595 (95% CI, 0.592 to 0.598) PPV of 0.993 (95% CI, 0.992 to 0.993) 
and NPV of 0.078 (95% CI, 0.077 to 0.079). 
Transport rate. The transport rate was 42.7% 
With this study the rule meet Level 4 criteria for the hierarchy of evidence for CDRs. 
 
Kajino, Kitamura, Iwami et al, (2013). Current termination of resuscitation 
(TOR) guidelines predict neurologically favourable outcome in Japan 153. 
Rule. Two rules were validated: 
1 A BLS-TOR rule, Termination where there is no ROSC, no defibrillation, and the 
arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered.  
EMS System. This was a fire department model with 804 fire departments, covering 
the whole of Japan, which has an area of approximately 378,000 km2 and a 
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population of approximately 127 million. Each ambulance has a crew of three 
emergency providers, which includes at least one emergency lifesaving technician. 
ALS measures in Japan are limited to advanced airway management and 
epinephrine. In this system all patients on whom resuscitation is attempted are 
transported to hospital. 
Population. Patients aged ≥ 18 years who had an OHCA of presumed cardiac 
origin, treated by EMS, and were transported to hospital from January 1, 2005 to 
December 31, 2009.  Patients were classified according to the level of EMS care 
they received. Those who received only BLS were classified into the BLS group. 
Those who received BLS plus ALS were classified into the ALS group. Out of Out of 
530,084 patients with resuscitation attempts, 294,193 were enrolled. The mean age 
was 75.5 years, 56.8% were male. 
Study design. This was a retrospective cohort study based on data from a large, 
pre-existing database.  
Primary outcome(s). The primary outcome measure was neurologically favourable 
one-month survival. 
Exclusion criteria. Patients were excluded if they were deemed to have obvious 
signs of death, such as decapitation, incineration, decomposition, rigor mortis, or 
dependent lividity. 
Main results. 151,152 eligible patients received only BLS care.  The BLS TOR 
guideline would have recommended TOR in 113,140 (74.9%) cases. of these, 193 
(0.2%) had one-month survival with neurologically favourable outcome. The 
specificity of BLS TOR rule was 96.8% (95% CI: 96.3% to 97.2%), and the PPV was 
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99.8% (95% CI: 99.8% to 99.9%) for predicting no neurologically favourable one-
month survival. For one-month survival, the specificity of BLS TOR rule was 87.8% 
(95% CI: 87.2% to 88.4%), and the PPV was 99.0% (95% CI: 98.9% to 99.0%). 
137,986 eligible patients received ALS care. The ALS TOR rule would have 
recommended TOR in 41,030 (27.1%) cases. Of these 37 (0.1%) survived to 
hospital discharge with neurologically favourable outcomes. The specificity of ALS 
TOR rule was 98.1% (95% CI: 97.3% to 98.6%), and the PPV was 99.9 (95% CI: 
99.8% to 99.9%) for predicting lack of one-month survival with neurologically 
favourable outcome. The specificity of ALS TOR rule, for one-month survival was 
92.3% (95% CI: 91.6% to 93.0%), and the PPV was 99.0% (95% CI: 98.9% to 
99.1%). 
Transport rate. For the BLS rule – 45.6%. For the ALS rule - 69.0%. 
With this study both the ALS-TOR rule and the BLS-TOR rule meet Level 4 criteria 
for the hierarchy of evidence for CDRs. 
 
Morrison, Kiss, Verbeek et al (2006) Validation of a rule for termination of 
resuscitation in out-of-hospital cardiac arrest. New England Journal of 
Medicine 147. 
Rule. Termination where there is no ROSC, no defibrillation, and the arrest is not 
witnessed by EMS personnel. 
EMS System. 12 participating sites in one of 24 EMS systems in Ontario, Canada  
(communities with populations of 40,000 to 2.5 million persons). This system 
included only Emergency Medical Technicians (EMTs) trained in the use of an 
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automated external defibrillator (AED), who were not previously using any other TOR 
CDRs, but were transporting all patients to hospital.  
Study Population. Consecutively enrolled adult patients who were treated for 
OHCA of presumed cardiac aetiology between January 1, 2002, and January 30, 
2004. Of 1620 OHCA, 1240 patients were enrolled. The mean age was 69.2 years, 
69.0% were male. 
Study design. This was a prospective, observational validation study. After a patient 
was transferred to the receiving hospital, the EMTs completed a data-collection form. 
This included relevant clinical characteristics of the cardiac arrest and all elements of 
the prediction rule. Patients were categorised for termination or transport according 
to the recommendations of the prediction rule.  
Primary outcome(s). The outcomes were analysed as either “died” or “survived”. A 
secondary outcome(s) of cerebral performance, either at discharge from the hospital 
or at six months for those in the hospital at that point was also analysed. 
Exclusion criteria. Patients were excluded if they received ALS interventions (e.g., 
intubation or the administration of intravenous fluids and medication); those who had 
a written or oral do-not-resuscitate order; those who had an arrest attributable to an 
obvious non-cardiac aetiology (e.g., trauma or asphyxia); and those under 16 years 
of age. 
Main results. Of the 776 patients for whom the prediction rule recommended the 
termination of basic life support resuscitation efforts, 4 survived (0.5 %; 95 % CI: 
0.1% to 0.9 %). Of these, 3 were considered to have good cerebral performance. 
The CDR had a positive predictive value for death of 99.5% (95 % CI:  98.9 to 99.8 
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%), a specificity of 90.2% (95 % CI: 88.4% to 91.8%), and sensitivity of 64.4% (95% 
CI: 61.6% to 67.0%) 
Transport rate. 35.6% 
With this study the BLS-TOR rule meets the Level 2 criteria for the hierarchy of 
evidence for CDRs 
 
Morrison, Verbeek, Vermeulen et al, (2007). Derivation and evaluation of a 
termination of resuscitation clinical prediction rule for advanced life support 
providers 112. 
Rule. Two rules were validated: 
1. A BLS-TOR rule which recommends TOR where there is no ROSC, no 
defibrillation, and the arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered.  
EMS System. Paramedic EMS crews located in 21 urban and rural communities. It 
is unclear whether a TOR CDR was available to the providers during the study 
period, but all patients undergoing resuscitation attempts were included for the 
purposes of this validation. 
Population. Of 5274 cardiac arrest patients attended to by paramedics, 4673 were 
included in the study.  The mean age was 66 years. 374 (62%) were male. 
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Study design. This was a retrospective cohort study based on data from a large, 
pre-existing database.  
Primary outcome(s). The primary outcome was defined as survival to hospital 
discharge. 
Exclusion criteria. Patients were excluded from the study if the arrest was of a non-
cardiac aetiology, including trauma; the patient was obviously dead (rigor mortis, 
lividity, decomposition or decapitation); the patient was under 16 years old; ALS was 
available at the scene before the arrival of EMS; a DNACPR order was present; or 
the event was determined not to be OHCA after review by the steering committee. 
Main results. The BLS TOR guideline would have recommended TOR in 2263 
patients (48%). Of these, none (0%) survived to hospital discharge. The PPV for 
death was 99.8% (95% CI: 99.6% to 99.9%). Sensitivity (the ability to identify 
survivors) was 100% (95% CI: 99.9% to 100%), specificity (the ability to identify 
patients who died) was 50% (95% CI: 49% to 52%) and the negative predictive value 
(probability that a patient who fulfilled the TOR rule would not survive), was 100% 
(95% CI: 99.9% to 100%). 
The ALS TOR guideline would have recommended TOR in 1425 cases (30%). Of 
these none survived to hospital discharge. The sensitivity was 100% (95% CI: 99.9% 
to 100%). The specificity was 32% (95% CI: 30% to 33%). The negative predictive 
value was 100% (95% CI: 99.9% to 100%). 
Transport rate. For the BLS rule – 51.6%. For the ALS rule – 69.9%. 
With this study both the ALS-TOR rule and the BLS-TOR rule meet Level 4 criteria 
for the hierarchy of evidence for CDRs. 
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Morrison, Verbeek, Zhan et al, (2009). Validation of a universal prehospital 
termination of resuscitation clinical prediction rule for advanced and basic life 
support providers 151. 
Rule. Two rules were validated: 
1. A BLS-TOR rule, Termination where there is no ROSC, no defibrillation, and the 
arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered.  
EMS System.  This system used a tiered response involving Police, Fire, 
defibrillation-only EMTs, and Paramedic crews from EMS Systems in the city of 
Toronto and 5 adjacent municipalities (Peel, Durham, Hamilton, Muskoka and 
Simcoe), plus a province-wide air ambulance service. The EMS systems served a 
population of 6.7 million by land and 11 million by air. There is evidence that 
Paramedic crews within this study were using existing TOR CDRs, as it is reported 
that 1069 patients (44.3%) died on scene. It is unclear what tool was used to 
terminate these attempts, but appear to be based on decisions made by physicians 
providing medical control to ambulance staff. 
Population. The registry included 4854 cases of OHCA between from 1 April 2006 
to 1 April 2007.  Of 4854 patients, 2415 patients were enrolled. The mean age was 
69.4 years, 63% were male 
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Study design.  This was a retrospective cohort study of data prospectively collected 
from 1 April 2006 to 1 April 2007 by one site. 
Primary outcome(s). The primary outcome measure was to determine if any patient 
survived to hospital discharge having met either the BLS or ALS TOR criteria. 
Exclusion criteria. Patients were excluded from the study if the OHCA was of non-
cardiac aetiology, including trauma; were obviously dead as defined by local 
legislation; were under the age of 18; had a valid ‘Do Not Resuscitate’ order.  
Main results. The BLS TOR guideline would have recommended TOR in 1302 
patients (54.3%). Of these, none (0%) survived to hospital discharge. The PPV for 
death was 100% (95% CI: 99.8% to 100%). The specificity was 100% (95% CI: 
99.8% to 100%). The sensitivity was 57.5% (95% CI: 57.3% to 57.7%). 
The ALS TOR guideline would have recommended TOR in 743 cases (31%). Of 
these none survived to hospital discharge. The PPV for death was 100.0% (95% CI: 
99.7% to 100.0%). The specificity was 100% (95% CI: 99.8% to 100%). The 
sensitivity was 32.8% (95% CI: 30.8% to 34.7%). 
Transport rate. For the BLS rule – 45.6%. For the ALS rule - 69.0%. 
With this study both the ALS-TOR rule and the BLS-TOR rule meet Level 4 criteria 
for the hierarchy of evidence for CDRs. 
Ong, Jaffey, Stiell et al (2006). Comparison of termination-of-resuscitation 
guidelines for basic life support: Defibrillator providers in out-of-hospital 
cardiac arrest 110. 
Rule. Three rules were validated: 
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1. (Petrie 222) TOR where the initial rhythm is asystole and response time is greater 
than 8 minutes. 
2. (Verbeek et al 111)TOR where there is no ROSC, no defibrillation, and the arrest is 
not witnessed by EMS personnel. 
3. The final rule (Marsden, Ng, Dalziel et al 223) will not be discussed. This rule 
proposes termination if there is no initial shockable rhythm; no evidence of CPR in 
the past fifteen minutes; no evidence of drowning, hypothermia, poisoning or 
overdose, and the patient is neither under eighteen years nor pregnant; there is no 
ROSC after one minute of CPR; there is asystole for ten seconds. As current UK 
guidelines allow for diagnosis of death (i.e. the decision can be made not to start a 
resuscitation attempt) when no CPR has been performed for the past fifteen minutes 
and the patient is in an asystolic rhythm, this subset of patients will not have 
resuscitation attempted by UK ambulance staff, and so do not require a TOR 
decision to be made. 
EMS System. Data collected from 21 Ontario urban or suburban communities, which 
range in population from 16,000 to 750,000 (total 2.7 million). The EMS system is 
two-tier, with AED–equipped fire fighters, followed by BLS defibrillator ambulance 
providers. No TOR CDR was available to the providers, and all patients undergoing 
resuscitation attempts were transported. 
Population.  Of 21,913 OHCA patients taken from the registry between 1988 and 
2003, 13,684 were enrolled in the study. The mean age was 69.1 years. 67.3% were 
male. 
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Study design. This was a retrospective cohort study based on data from a, pre-
existing database.  
Primary outcome(s). The primary outcome was survival to hospital discharge.  
Exclusion criteria. Patients were excluded from the study if they were younger than 
16 years, showed sign of decomposition, rigor mortis, or were clearly non–cardiac 
aetiology (eg, trauma, drowning, choking).  
Main results.  The Petrie guideline would have recommended TOR in 1,293 cases. 
Of these, 1 (0.08%) survived. The Verbeek guideline would have recommended 
TOR in 6,908 cases. Of these, 3 (0.04%) survived. The comparative sensitivity 
(ability to predict survivors) was 99.8% (95% CI: 99.5% to 100.0%) (Petrie rules), 
and 99.5% (95% CI: 99.0% to 100.0%) (Verbeek rules). Negative predictive value 
(ability of TOR guideline to predict death) was 99.9% (95% CI: 99.8% to 100.0%) 
(Petrie rules), and 100.0% (95% CI: 99.9% to 100.0%) (Verbeek rules). 
Transport rate. For the Petrie rule – 90.6%. For the Verbeek rule – 49.5%. 
With this study both the Petrie and the Verbeek rules meet Level 4 criteria for the 
hierarchy of evidence for CDRs. 
Ong, Tan, Ng et al, (2007). Comparison of termination-of-resuscitation 
guidelines for out-of-hospital cardiac arrest in Singapore EMS 149. 
Rule. Three rules were validated: 
1. (Petrie 222) TOR where the initial rhythm is asystole and response time is greater 
than 8 minutes. 
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2. (Verbeek et al 111)TOR where there is no ROSC, no defibrillation, and the arrest is 
not witnessed by EMS personnel. 
3. The final rule (Marsden, Ng, Dalziel et al 223) will not be discussed, as the patient 
group would be captured by TOR guidelines currently in place for all UK ambulance 
services. 
EMS System. Data collected from Singapore, which has a population of 4.1 million. 
The EMS system is run by the Singapore Civil Defence Force and utilises BLS 
providers with AEDs. No TOR CDR was available to the providers, and all patients 
undergoing resuscitation attempts were transported. 
Population.  Between 1 October 2001 and 14 October 2004, 2269 were enrolled in 
the study. The mean age was 61.1 years. 68.4% were male. 
Study design. This was a retrospective cohort study based on data from a, pre-
existing database.  
Primary outcome(s). The primary outcome was defined as the patient leaving the 
hospital alive or survival to 30 days post cardiac arrest. 
Exclusion criteria. Patients were excluded from the study if they were ‘obviously 
dead’ as defined by the presence of decomposition, rigor mortis or dependant lividity. 
Main results.  The Petrie guideline would have recommended TOR in 716 cases. Of 
these, 2 (0.28%) survived. The Verbeek guideline would have recommended TOR in 
1559 cases. Of these, 6 (0.38%) survived. The comparative sensitivity (ability to 
predict survivors) was 93.8% (95%CI: 79.9% to 98.3%) (Petrie) and 81.3% (95%CI:   
64.7% to 91.1%) (Verbeek). Negative predictive value (ability of TOR guideline to 
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predict death) was 99.7% (95%CI:  99.0% to 100.0%) (Petrie) and 99.6% (95%CI:   
99.2% to 99.8%) (Verbeek). 
Transport rate. For the Petrie rule – 68.4% For the Verbeek rule –31.3%. 
With this study both the Petrie and the Verbeek rules meet Level 4 criteria for CDRs . 
 
Richman, Vadeboncoeur, Chikani et al (2008). Independent evaluation of an 
out-of-hospital termination of resuscitation (TOR) clinical decision rule 148. 
Rule. Termination where there is no ROSC, no defibrillation, and the arrest is not 
witnessed by EMS personnel. 
EMS System. 30 EMS systems in Arizona (population 5,939,292). These included a 
mix of EMT-Basics, EMT-Intermediates and EMT-Paramedics. Existing rules allowed 
for crews not to initiate resuscitation if the patient was over 18 years of age and there 
were obvious sign of death, such as rigor mortis. Otherwise, all resuscitation 
attempts were transported. 
Population. Consecutively enrolled adults in non-traumatic OHCA between October 
2004 and October 2006.  Of 2,239 eligible OHCA, 2,180 patients were enrolled. The 
mean age was 64 years, 65% were male. 
Study design.  This was a retrospective cohort analysis, using data taken from 
ambulance first care reports. Patients were categorised for termination or transport 
according to the recommendations of the prediction rule.  
Primary outcome(s). The primary outcome was survival to hospital discharge.  
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Exclusion criteria. Patients were excluded if they had obvious signs of death (e.g. 
lividity, rigor, decapitation). 
Main results. It was reported that of 1,160 (53%) of patients who met all three TOR 
criteria, only one (0.09%; 95%CI: 0 to 0.5%) survived to hospital discharge. 
However, only 804 patients for whom the BLS TOR rule recommended TOR were 
transported to hospital. The potential outcomes for those not transported cannot be 
assessed, as they did not get the benefit of full hospital resuscitation. When this 
group is excluded from the calculation, survival to hospital discharge of those 
recommended for TOR increases to 0.12%. 
Transport rate. 46.8%.  
With this study the BLS-TOR rule meet Level 4 criteria for CDRs 
 
Ruygrok, Byyny, Haukoos et al, (2009). Validation of 3 Termination of 
Resuscitation Criteria for Good Neurologic Survival After Out-of-Hospital 
Cardiac Arrest 168 
Rule. Three rules were validated: 
1. A BLS-TOR rule, Termination where there is no ROSC, no defibrillation, and the 
arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR has been administered.  
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3. A neurologic TOR rule, which recommends TOR when the OHCA is not witnessed 
by a bystander or EMS personnel; patient aged 78 years or older; or asystole as the 
initial arrest rhythm. 
EMS System. This was a 2-tiered response system, with fire-based first responders 
providing BLS, including use of AEDs, and ALS paramedic responders. It is unclear 
whether there was an existing TOR CDR in place during this study. However, all 
resuscitations attempted by Paramedics were included for statistical purposes.  
Population. A secondary analysis of the Denver Cardiac Arrest Registry, which 
includes consecutive adult patients (age ≥18 years) who had non-traumatic OHCA 
from January 1, 2003 to December 31, 2004.Of the 715 patients included in this 
study, the median age was 65 years, and 69% were male. 
Study design. This was a secondary analysis study based on data from a pre-
existing database.  
Primary outcome(s). The primary outcome measure for this study was survival to 
hospital discharge with good neurologic function as defined by a Cerebral 
Performance Categories Scale score of 1 or 2. 
Exclusion criteria. Patients were excluded if they experienced trauma resulting in 
arrest or were younger than 18 years. 
Main results. 715 (36%) of recorded patients were enrolled on the study.  The BLS 
TOR guideline would have recommended TOR in 231 (32%) cases.  The ALS TOR 
rule would have recommended TOR in 162 (23%) cases. The neurologic TOR rule 
would have recommended TOR in 39 (5%) cases. The proportion of patients with 
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good neurological survival to hospital discharge correctly identified for continued 
resuscitation was 100% (95% CI: 92% to 100%) for all 3 TOR criteria.  
Transport rate. For the BLS rule – 70.2%. For the ALS rule – 77.3%. For the 
neurologic TOR 94.5%. 
With this study both the ALS-TOR rule, the BLS-TOR rule and the neurologic TOR 
rule meet Level 4 criteria for CDRs. 
Sasson, McNally, Krass et al, (2008). Prehospital termination of resuscitation in 
cases of refractory out-of-hospital cardiac arrest 150. 
Rule. Two rules were validated: 
1. A BLS-TOR rule, Termination where there is no ROSC, no defibrillation, and the 
arrest is not witnessed by EMS personnel. 
2. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered.  
EMS System. 19 EMS agencies and 111 hospitals located in 8 US cities: 
Anchorage, Alaska; metropolitan Atlanta, Georgia; Boston, Massachusetts; Raleigh, 
North Carolina; Cincinnati, Ohio; Columbus, Ohio; Austin, Texas; and Houston, 
Texas. Local TOR CDRs were in place at the time of the study. This is evidenced by 
947 (17.2%) patients being pronounced dead on scene. No details of these existing 
CDRs are reported. 
   212 
 
Population. The registry included 7235 cases of OHCA between October 2004 and 
October 2006.  Of 7235 patients, 5505 patients were enrolled. The mean age was 
64.4 years, 60% were male 
Study design. This was a retrospective cohort study based on data from a large, 
pre-existing registry.  
Primary outcome(s). The main outcome measures were the specificity and positive 
predictive value of both the BLS and ALS rules for identifying patients with OHCA 
who likely would not survive to hospital discharge. 
Exclusion criteria. Patients were excluded from the register if EMS personnel 
determined that arrest was due to a non-cardiac aetiology (e.g. trauma, 
electrocution, drowning, or respiratory); Resuscitation was not attempted based on 
local protocols (e.g. obvious signs of death such as rigor mortis, decomposition, 
lividity); or the patient was younger than 16 years. 
Main results. The BLS TOR guideline would have recommended TOR in 2592 
patients (47.1%). Of these, 5 (0.2%) survived to hospital discharge. Of these, four 
were documented as having good cerebral performance. The PPV for death was 
99.8% (95% CI: 99.6% to 99.9%). 
The ALS TOR guideline would have recommended TOR in 1192 cases (21.7%). Of 
these none survived to hospital discharge. The PPV for death was 100.0% (95% CI: 
99.7% to 100.0%). 
Transport rate. For the BLS rule – 52.9%. For the ALS rule – 78.3%. 
With this study both the ALS-TOR rule and the BLS-TOR rule meet Level 4 criteria 
for the hierarchy of evidence for CDRs. 
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Skrifvars, Vayrynen, Kuisma et al, (2010). Comparison of Helsinki and 
European Resuscitation Council “do not attempt to resuscitate” guidelines, 
and a termination of resuscitation clinical prediction rule for out-of-hospital 
cardiac arrest patients found in asystole or pulseless electrical activity 167. 
Rule. Three rules were validated: 
1. Current guidelines of the European Resuscitation Council (not reported here, as it 
is the equivalent of that currently used by the Trust, as detailed previously). 
2. Helsinki “do not attempt to resuscitate” guidelines: 
a) In asystolic arrests: Termination where there is a delay in arrival of the 
ambulance exceeding 15min, or if ROSC cannot be achieved despite 
20min of ALS. 
b) In witnessed PEA: Termination where there is a delay in arrival of the 
ambulance exceeding 15min, or if ROSC is not achieved within 20min 
of ALS. 
c) In un-witnessed PEA: Termination where ROSC is not achieved within 
10min of ALS.  
3. An ALS-TOR rule, which recommends TOR when there is no ROSC, no 
defibrillation, the arrest is not witnessed by either bystanders or EMS personnel, and 
no bystander CPR is administered, but which was applied here only to patients 
presenting in a non-shockable rhythm.  
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EMS System. Nurses or paramedics and Emergency Medical Technicians 
throughout Sweden. In this system, resuscitation attempts can be terminated in 
cases of ongoing asystole despite 30min of CPR. 
Population.  Of 44121 OHCA patients on the Swedish Cardiac Arrest registry taken 
from 1990 to December 2007, 12107 with asystole or PEA as the initial rhythm were 
enrolled in the study. Patients with an arrest of non-cardiac cause were also included 
(excluding patients with drowning or trauma). The mean age was 71 years. 66% 
were male. 
Study design. This was a retrospective cohort study based on data from a large, 
pre-existing database.  
Primary outcome(s). The primary outcome was defined as survival at one month 
from the arrest. 
Exclusion criteria. Patients were excluded from the study if it was an EMS-
witnessed arrest; patients with a shockable initial rhythm; patients in whom the initial 
rhythm was not specified as either asystole or PEA; patients with drowning or trauma 
as the cause of the arrest. 
Main results. The Helsinki guidelines guideline would have recommended TOR in 
11315 patients (54.6%). Of these, 57 (0.5%) survived to hospital discharge: 
sensitivity: 53.3% (95% CI: 52.4% to 54.2%), specificity: 81.9% (95% CI: 73.7% to 
88.4%), PPV: 99.7% (95% CI: 99.5% to 99.8%), NPV: 1.7% (95% CI: 1.4% to 2.0%). 
The ALS rule would have recommended TOR in 5466 patients (26.4%). Of these, 2 
(0.04%) survived. sensitivity: 23.4% (95% CI: 23.1% to 24.6%), specificity: 99.2% 
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(95% CI: 95.3% to 99.9%), PPV: 99.9% (95% CI: 99.8% to 100.0%), NPV: 1.2% 
(95% CI: 1.0% to 1.5%) 
Transport rate. For the Helsinki rule – 45.3%. For the ALS rule – 73.6%. 
With this study both the Helsinki and the ALS-TOR rules meet Level 4 criteria for the 
hierarchy of evidence for CDRs. 
 
Verhaerta, Bonnesa, Nas et al (2016) Termination of resuscitation in the 
prehospital setting: A comparison of decisions in clinical practice vs. 
recommendations of a termination rule 157.  
Rule This study compared the ALS-TOR rule, which recommends TOR when there 
is no ROSC; no defibrillation; the arrest is not witnessed by either bystanders or 
EMS personnel; and no bystander CPR is administered, with current termination 
results. The study did not provide details of the reasons for current terminations, so 
these will not be discussed further. 
EMS System.  An ALS Paramedic response of two vehicles is sent to each 
suspected cardiac arrest, with additional police and fire service BLS-AED personnel 
if required. 
Population. The study used data from Gelderland-Zuid in Holland, which has a 
population of 530,000 and covers 1040 km2, including urban, suburban and rural 
areas. Data included all OHCA patients over 18 years old from April 2008 to January 
2011. The mean age was 66 years and 69% was male.  
Study design. This was a retrospective cohort study.  
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Primary outcome(s). The primary outcome measure was in-field termination of 
resuscitation 
Exclusion criteria. Patients were excluded if: they were below the age of 18; 
traumatic arrests (including hanging and drowning); and patients with DNACPR 
orders  
Main results. A total of 598 patients were studied. 17% survived to hospital 
discharge. The ALS guideline would have recommended termination for 35 (6%) 
patients. None of these survived to discharge. The sensitivity of the rule was 7% 
(35/477) and specificity 100% (89/89). The NPV and PPV of the ALS-TOR rule were: 
17% (89/531) and 100% (35/35), respectively. 
Transport rate. For ALS rule – 94%. 
With this study the ALS-TOR rule meets Level 4 criteria for the hierarchy of evidence 
for CDRs. 
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APPENDIX 5 - Participant information 
 
 
   
 
Pre-Hospital Termination of Resuscitation Study 
Information Sheet 
 
These forms are part of a study that is looking at the patients we attempt to 
resuscitate and their outcomes. We are trying to establish whether there are any 
factors, over and above present Termination of Resuscitation (ToR) Guidelines, 
which can be used to determine that resuscitation efforts will not be successful.  
The forms will not be used to audit how you have performed the resuscitation; rather, 
the information from these forms will be compared against the actual survival 
outcomes of the patients. 
Please complete one of these forms after ALL cardiac arrests where resuscitation is 
attempted or continued by NWAS crews. Please complete the forms as fully as you 
can, so that we can capture all the relevant information. 
 
These forms MUST NOT be used to determine whether or not to transport a patient 
to hospital following a cardiac arrest.  
 
At all times, follow NWAS ToR Guidelines or the advice of an Advanced 
Paramedic in determining whether to transport your patient.  
 
Once completed, the forms should be left on station, in the designated area, from 
where they will be collected and sent via internal mail to Matt House at Salkeld Hall, 
Cumbria, for analysis. 
 
Please note that by completing these forms, you consent to the information on them 
being used for the purposes of this study. 
 
 
We thank you for your time in completing this documentation 
For further information, please contact Matt House: 
Email matthew.house@nwas.nhs.uk 
Tel: 07812 305548 
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APPENDIX 6 - TOR Form 
 
Termination of Resuscitation Study 
 
Complete this form after ALL cardiac arrests where resuscitation is attempted or continued by NWAS 
crews and the patient is transported to hospitlal. 
 
This should NOT be used to determine whether or not to transport a patient to 
hospital following a cardiac arrest. 
 
At all times, follow NWAS ToR Guidelines or the advice of the Clinical Support Hub or an Advanced 
Paramedic in determining whether to transport.  
 
 
INCIDENT NUMBER _______________ DATE__________________ 
 
 
 
 
  
 
 
 
 
 If NO – Stop here 
If YES – Complete Table C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          If ALL answers in Table C were NO, tick here                        Terminate
   
  
  If ANY answers in Table C were YES, tick here                      Transport 
 
 
 
 
 
 
 
 
 
 
ONCE COMPLETE, LEAVE THIS FORM IN THE DESIGNATED AREA ON STATION 
TABLE B YES NO 
Presumed cardiac cause   
TABLE C YES NO 
Patient is thought to be pregnant 
 
  
Patient is under eighteen years old 
 
  
Was the presenting (first)  rhythm shockable (VF/VT) 
 
  
Was ROSC achieved before transport? 
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APPENDIX 7 - email relating to cost of ambulance provision 
 
